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ABSTRACT 
BINDING OF MYCOBACTERIUM TUBERCULOSIS TO COMPLEMENT 
RECEPTOR TYPE 3 EXPRESSED IN MAMMALIAN CELLS: 
DEPENDENCE ON SERUM OPSONINS 
Colette Cywes 
11 
Departments of Medicine and Medical Biochemistry, University of Cape Town, South 
Africa 
February 1996 
Nonopsonic invasion of mononuclear phagocytes by Mycobacterium tuberculosis (M 
tb.) is likely important in the establishment of a primary infection in the lung. M tb. 
binds to a variety of phagocyte receptors, of which the mannose receptor and the 
complement receptor type 3 (CR3) may support nonopsonic binding. CR3, a ~2 
integrin, is a target for diverse intracellular pathogens, but its role in nonopsonic 
binding remains uncertain. We have examined the binding of M tb. to human CR3 
heterologously expressed in Chinese hamster ovary (CHO) cells, thereby 
circumventing the problems of competing receptors and endogenously synthesised 
complement, which are inherent in studies with mononuclear phagocytes. The surface 
expression and functional activity of CR3 were confirmed by rosetting with beads 
coupled to anti-CR3 monoclonal antibodies (MAbs) and with C3bi-coated 
microspheres, respectively. We found thatM tb. binds 4-7-fold more avidly to CR3-
expressing CHO cells than to wild-type cells, and importantly, that this binding is very 
similar in the presence of fresh or heat-inactivated human or bovine sera, or no serum. 
The binding of M tb. to the transfected CHO cells is CR3-specific, as it is inhibited by 
ill 
anti-CDllb and anti-CD18 MAbs; interestingly, binding is not inhibited by a MAb 
(2LPM19c) specific for the C3bi-binding site on CDI lb. Electron micrographs of 
infected CR3-expressing CHO cells reveal the presence of intracellular bacteria 
enclosed in well-defined, membrane-bound vacuoles. We conclude that the binding of 
M tb. to CR3 is nonopsonic and that the organism likely expresses a ligand that 
directly binds to CR3. 
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Tuberculosis (TB) has claimed millions of lives in past centuries throughout the world, 
with no real sign of abating in the near future, making the causative agent, 
Mycobacterium tuberculosis, one of the most successful human pathogens known to 
man. Presently one third of the world's population is infected with Mycobacterium 
tuberculosis, and of these more than 50 million people harbour drug-resistant strains. 
It is predicted that thirty million people will die from TB in this decade alone (WHO 
1995). Twenty-six percent of all adult deaths in the developing world are due to TB, 
and every year almost 300 000 children die of the disease. Moreover, in AIDS TB is 
one of the leading causes of death. 
These astounding statistics seem incredible, but they are a testament to the organism's 
remarkable infectiousness: every year a single untreated person infects 10 to 15 people, 
in each case often via a single cough carrying 1-3 bacilli. 
1.1 History of Tuberculosis: 
For many generations the origins of TB and its effects on various populations and 
cultures have been the topic of widespread research and discussion. How and why the 
now- curable disease continues to maintain such a high profile in many countries is not 
well understood, but the fact that these epidemics are accompanied by poverty, 
overpopulation and poor socio-economic standards is widely accepted. When 
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reviewing the literature on the history of TB, it is evident that the complete story may 
never really be known, as available evidence suggests that TB predates written 
documentation. Useful records that may have been produced by earlier communities 
are largely lost or destroyed and are therefore sparse. Such early documentation may 
have described not only the origin of the disease, but also the subsequent effects on 
community growth and development. 
Early indications of TB-like disease occurring during the Neolithic period have given 
rise to the debate whether M tb. originated from M bovis or vice versa; the Neolithic 
was the period in which man began to domesticate animals, such as cattle in the 
Mediterranean (5000-7000 BC) and the Middle East (4000-5000 BC) and elephants in 
India (before 2000 BC). It was from one of the early domesticated Indian elephants 
that the first account of animal-related TB was documented (Manchester, 1984). 
As far as can now be determined, the history of human TB is thought to have 
originated in Egypt between 3700-1000 BC, with suggestive skeletal discoveries, but 
care must be taken not to assume that all skeletal deformities were the result of M tb., 
as M bovis and non-tuberculosis spondolytis may also have been responsible. A 
Neolithic skeleton discovered in Heidelberg, Germany dating ± 5000 BC, has been 
thought to show tuberculosis lesions, but this is still hotly debated (Metcalf, 1991). 
Definitive evidence for ancient TB was first obtained from an Egyptian mummy of a 5-
year-old child from the Dynastic period ± 3400 BC, from which acid-fast bacilli 
(AFBs) were obtained from the lungs and spine. A young male mummy from the 
Bronze Age in Jordan (3150-2200 BC) revealed similar bacilli-filled abscesses and 
organs, suggesting that TB initially originated in the near East (Salo etal, 1994) . 
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In comparison with these findings, northern Europe and the United Kingdom have 
been infected only recently with M tb., as the earliest findings of skeletal TB occurred 
in Denmark with a skeleton dated 2500-1500 BC. Britain's first evidence of TB dates 
to 3-5 AD, with the Americas thought to follow when explorer Columbus landed in 
America in 1492 (Snider, 1994). A later theory that the Vikings may also have 
contributed to the establishment of TB in America is becoming more popular, as is the 
possibility that TB spread from South America to North America, as suggested by the 
recent discovery of a Nazca culture mummy child (700 AD), discovered in Southern 
Peru (Metcalf, 1991). 
As art was often used as a historical record in earlier civilisations, it may be deduced 
from the many hunchbacked figures adorning tombs and pyramid walls in Ancient 
Egypt during the Dynastic period before 3400 BC that TB affected Egyptian 
civilisation. Similar artistic interpretations of the humpbacked Kokopelli rain-priest 
from Central and Southern America, in the Pueblo and Inca cultures, are suggestive of 
TB in these communities as well, which predate the recent discovery of the Nazca 
mummy (Wellmann et al. , 1970; Morse, 1967). 
Written documentation tends to follow the same distribution as that described above, 
with the first documented evidence originating from an Egyptian medical papyrus, in 
which TB and its symptoms are described. The first Asian documentation of 
pulmonary TB described it as 'tung fever" and 'tung cough" in the early Chinese 
writings of± 2700 BC and later in the Rega-Vedas hymns of the Hindu Indo-Ayran 
civilisation in 1500 BC (Morse, 1967; Metcalf, 1991 ; Snider, 1994). 
· The earliest Greek literature describing consumption were from the early works by 
Homer in 800 BC, followed by a detailed description of 'phthisis" by Hippocrates in de 
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Morbis (500 BC). Aristotle was the first to suggest the contagiousness of 'phthisis" 
(384-322 BC), with later reports by Galen in 131-200 AD substantiating Aristotle' s 
belief . Plautus, 184 BC, was the earliest Roman to document TB, followed by many 
accounts of TB-like infections during the Byzantine era (Metcalf, 1991; Snider, 1994). 
This evidence suggests that TB has been widespread for many millennia, with its origin 
possibly in the near East, which supports the theory that the domestication of animals 
and social civilisation led to the development of TB. 
More recent studies of TB began in the Renaissance, when Girolamo Fracastora 
(1483-1553) re-documented the contagiousness of TB, and Franciscus Sylvius (1614-
1672) described the characteristic tissue nodules as 'tubercules". This was followed 
by the historic experiments of Pasteur in 1862, which suggested the airborne nature of 
the bacilli; but it was Robert Koch's physical evidence, with his isolation of the M th. 
bacillus in 1882, which convinced the medical profession that TB was the result of a 
bacterial infection and therefore clearly transmissible (Morse, 1967; Snider, 1994). 
Subsequent documentation of the spread and incidence of TB was as infrequent and 
inaccurate as in earlier centuries. Over- and under-reporting of TB, due to the many 
other wasting diseases of those eras, and the stigma associated with TB, hindered the 
collection of accurate epidemiological data. It was only in the late 19th century, when 
compulsory notification of the disease was initiated in New York in 1897, followed in 
the 1900s by Norway, Cape and Natal colonies of South Africa, Denmark, England 
and Scotland, that more realistic statistics were obtained (Metcalf, 1991). 
The epidemic proportions that alarmed communities around the world were thought to 
have originated in Western Europe and Northern America during the rapid 
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industrialisation in the 19th century, after which the disease spread to Eastern Europe 
(Snider, 1994). Sub-Saharan Africa seems to have been spared the past epidemics, 
probably due to its relative isolation, but this has resulted in the current epidemic 
sweeping the continent, as discussed later in this chapter. 
1.2 Conditions Influencing the Occurrence of Tuberculosis: 
Increases in population, urbanisation and later industrialisation were maJor 
determinants in the progression of the disease. Industrialisation brought joblessness 
and poor health conditions, including poor diet and lack of sun exposure, due to the 
long work-days indoors. This together with the overcrowding in the cities led to 
widespread disease and increased mortality rates. Migration to cities to find work and 
then back into the country or to other cities, associated with the lack of work, helped 
to spread the disease from one geographical point to another and probably served to 
infect otherwise unexposed individuals. During this period, documentation of the 
environmental modifying effects on disease progression by Dr Ernest Livingstone 
Trudeau, led to the development of the first sanatoria for the treatment of tuberculosis, 
with exposure to high altitudes, dry air and sunshine, thereby serving to spread the 
disease as far afield as the Swiss Alps, Rocky mountains in America, Australia and 
South Africa. Colonisation of the New and Old World by European invaders served as 
a catalyst for the initiation and spread of TB amongst indigenous populations. The 
exploitation of their land and natural lifestyle led to impoverishment of the local 
populations and produced overcrowding and severe shortages of food in the 
settlements, orchestrating the ideal niche for the TB bacillus to thrive and make full use 
of the absence of innate immunity. The controversial suggestion that racially 
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determined genetic differences account for a higher susceptibility to TB amongst 
Blacks has long been debated. Genetic variation, as opposed to increases in disease 
due to changes in social standards and environment, has been the subject of many 
studies, but this proposition has not been established beyond reasonable doubt, and 
therefore remains speculative (Metcalf, 1991; Snider, 1994). 
The frequent occurrence of war in the W estem world has done little to stem the 
disease or the spread thereof. The common theme of overcrowding and decline in 
living conditions and nutrient intake, which associates with the spread of TB 
epidemics, is surely one of the most destructive and longest enduring features of any 
war, as highlighted by the TB mortality figures in England during the .First and Second 
World Wars (Figure 1.1) (Metcalf, 1991 ). 
1.3 Past Treatments of TB: 
Prior to the development of chemotherapy in 1910, a few early abortive attempts to 
develop a protective agent for the eradication of the infection were initiated by Koch. 
The pre-chemotherapeutic treatments of tuberculosis, although not as powerful as 
drugs, have provided the medical profession with insight into the disease and its 
progression, making it the cornerstone of current therapy. 
Initial documentation and treatment of "phthisis" by Hippocrates, the father of modem 
medicine, revolved around his humeral theory, which entailed resection, emetics and 
purgation, as well as the use of leeches, to correct the altered state of the four humours 
(body fluids, namely blood, phlegm, yellow and black bile) thought to be instrumental 
in the disease process. Similarly, Thomas Sydenham treated London consumptives in 
Figure 1.1: Effects of World Wars I and 11 on the tuberculosis mortality rate 
among the English and Welsh during 1905-1955 
(Source: Coovadia, H.M. and S.R. Benatar. A Century of Tuberculosis: South 
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Comparing the mortality factor for respiratory tuberculosis, using the incidence of 
tuberculosis during 1938 as the standard (=I). This figure depicts the increases in 
deaths due to tuberculosis during the World Wars I and II as compared to the pre- amd 
post-war periods. 
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the 1600s with pectorals and sugar liquorice tablets, to try and remove the 'hot and 
acrid blood" caused by the sulphur and fumes breathed in by the factory workers. 
Francois Broussais ( 1772-183 8) enforced starvation, purgation, venesection and 
leeches on his patients, with the thought that the disease originated in the gut via the 
ingestion of toxins which in turn irritated the organs. G-L Bayle (1774-1816) and later 
R.T. Laennec (1781-1826) were the first to move away from the humeral theory and 
depicted the disease as an organ-specific disease, as deduced from their multiple 
autopsies, probably established without prior inflammation. 
Hermann Brehmer (1826-1889) pioneered the first Sanatoria in the German mountains, 
to enforce the current theories of his colleagues, which entailed high altitudes and 
exercise to strengthen the heart, rest in fresh air and later hyperalimentation. The well 
documented Davos in the Swiss Alps started the sanatoria movement in the rest of 
Europe, as described in Thomas Mann's famous Magic Mountain. In the late 19th 
century, Dr E. Livingstone Trudeau's documentation of the environment's modifying 
effect on the development of the disease led to the start of the sanatorium era in the 
USA. His involvement in research into the immune function of these individuals 
earned him world-wide respect and acknowledgement. 
The close patient-doctor interactions developed in these sanatoria allowed the first 
specific treatments for tuberculosis to be instituted. This invasive procedure known as 
artificial pneumothorax was developed by Carlo Fornalini in 1894, based on 
experimental data describing the elasticity of animal lungs produced by James Carson 
(1772-1843) of the UK. This was the first procedure to show specific clinical 
improvement for tuberculosis patients. An extension of this procedure developed by 
John B. Murphy in 1899, known as 'Murphy' s button", relied on anastomosing the 
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hollow abdominal viscera, forcing the lung to rest with co-cicatrization of the tubercle 
foci . These direct interventions served to reduce the high mortality rate of TB and 
were widely used for many years. 
In South Africa, a variation of Sauerbach and Schepelman' s paralysis and raising of 
one diaphragm was developed, in which not only one but both diaphragms were raised, 
thereby reducing the risk of air embolism experienced with conventional acute 
pneumothorax. Permanent collapse of the lung (thoracoplasty) in which the 5-7th ribs 
were removed and the lung resected from the lung apex, to allow concentric collapse, 
was shown to reduce sputum positivity dramatically, and therefore frequently used in 
South Africa among the White population, but not for Black TB patients as it reduced 
their capacity for physical labour. 
It was only with the development of Streptomycin in 1943 by Albert Schatz and 
Selman Waksmann, from the soil actinomycete Streptomyces griseus, followed by the 
discovery of para-amino salicylic acid (PAS), by Jorgen Lehmann in 1944 and later the 
development of Isoniazid in 1952, that heralded the start of effective treatment of the 
disease in the New World. Although these drugs initially served to stem the disease, it 
also spurred the development of mutations within the bacilli, resulting in the recent 
identification of multi- drug resistant (MDR) strains of TB, which are selected for by 
the inappropriate administration of chemotherapeutic agents (Dubovsky, 1991). 
1.4 The Global EfTect of Tuberculosis: 
Inaccurate, or complete lack of, documentation of TB and TB-related cases has made 
the determination of the incidence of TB problematic, but as stated previously, it is 
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estimated that annually 8 million new cases, of which 95% occur in the Developing 
World. The highest incidence of death affects the most productive age group of the 
population, namely individuals between the ages of 15 and 59 years of age, serving to 
economically cripple developing nations (Snider, 1994; WHO 1995). As seen during 
the decades of disease in the New World, TB is closely linked to the demographic, 
historical, financial, political and environmental changes in the world, making 
industrialisation, wars, mass urbanisation and over-population key determinants of the 
disease process and progress; all factors that are affecting the Sub-Saharan countries 
at present. 
Recent upsurges of TB in the Western world have brought home the realisation that 
TB will not be eradicated by 2010, as was predicted during the planning of the USA 
health strategies in 1989. Unemployment, immigration of people from high incidence 
countries to the Western world and the world-wide explosion of HIV and drug abuse 
have helped to undermine the effectiveness of TB control programs. These factors 
together with the inability to treat MDR TB have once again served to make TB a 
major threat to public health in both developed and developing countries. 
1.5 The South African Experience: . 
TB in South Africa (SA) is an excellent example of the effects that socio-economic 
conditions, politics and demographics have on the incidence and spread of TB. Little if 
any information is available regarding the existence of TB in pre-colonial SA, other 
than the reports made by missionaries and travellers to remote parts of Africa before 
the colonisation of the Cape by the 1652 Dutch settlers, who used the Cape of Good 
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Hope as a trading station for the ships travelling to the East. Thus until the 1711.t 
century, few episodes of TB were thought to exist south of the equator. Once 
European colonisation started, and native people were exposed to the bacillus, the 
disease spread quickly, with the first documented case of TB identified in late 1811.t 
century, signifying the spread of TB to the locals. Dr John Polsen recorded that no TB 
was seen in the Bantu tribes in the late 1911.t century, but that in contrast the ethnically 
distinct Khoikhoi (Hottentots) and San (Bushmen) had suffered severely; it is 
significant that the latter two populations had the earliest and most extensive contact 
with the European sailors. Controversy still exists whether TB had existed on a low 
level in Blacks prior to colonisation, and Dr Peter Allan, who has researched the topic 
extensively, suggested that there was evidence of endemic TB in the Ciskei and 
Transkei, as well among the Zulu's of Natal, before colonisation, but certainly not of 
the epidemic proportions encountered after colonisation. It was only after the turn of 
the century with the introduction of health statistics and death registration that the 
extent of the racial and geographic distribution of TB was realised. 
As with the industrialisation of the Western world, the development of the mining 
industry in South Africa in the late 1800s is closely associated with the extensive 
migration of thousands of Blacks as cheap labour from within South Africa' s borders 
and from neighbouring African states, which initiated epidemic proportions of 
pulmonary TB amongst this population. Similar to the industrialised countries, the 
miners spent long hours underground, in poorly ventilated, confined spaces with 
hundreds of others, and were accommodated in close, overcrowded living conditions, 
with poor socio-economic standards and nutrition. This helped to lower their immune 
status and enhance the incidence and spread of TB amongst this community. The 
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repatriation of sick workers back to their rural homes served as the perfect vehicle for 
the dissemination of the disease to the indigenous rural populations not yet in contact 
with the colonials. In 1912, the incidence of TB in rural communities could be traced 
directly to the number of migrant workers in the community. 
A further influence on the spread of TB in SA was the extensive advertising campaign 
for SA as a health resort for 'ailing consumptives" from Europe in the late 1800s. 
Most of these resorts were in the Northern Cape, but all the passengers disembarked in 
Cape Town en route, helping to introduce and spread the disease further. The 
development of urban centres, with greater job opportunities, attracted large numbers 
of rural Blacks to towns and cities, thereby exposing them to TB, which was 
compounded by the overcrowded, poor socio-economic housing conditions similar to 
those on the mines, making TB three times more prevalent in urban than rural areas. 
These housing areas were fast classified as slums and the introduction of the Slums 
Clearance Act of 1934 served to force large populations of Black and Coloured people 
to the outskirts of cities, thereby providing false statistics of the subsequent decrease of 
TB in these areas. The racially based political constraints introduced after the 
declaration of SA as a Republic in 1963 served to keep Blacks in confined areas, both 
in the work place and at home, that were of a poor economic standard and aided the 
spread and virulence of the disease. Subsequently, with the abolition of the 
immigration (pass) laws in the 1970s, large numbers of Blacks sought work in the 
cities, emigrating from areas of high TB prevalence. This rapid urbanisation by Blacks 
in Cape Town and the Western Cape region coincides with a remarkable increase in the 
incidence of TB among the Coloured population, who are the traditional residents of 


























Figure 1.2: Age-, gender- and ethnic-group incidence rate of tuberculosis in 
South Africa in 1993 
(Source: Epidemiological Comments. 1993 . Department of Health, Republic of South 
Africa) 
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Figure 1.3: Historical perspectives of the tuberculosis incidence rate in South 
Africa between 1921 and 1993 
(Source: Coovadia H.M. and S.R. Benatar. A Century of Tuberculosis: South African 
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Tuberculosis increased steadily in South Afiica from 1921 to peak during the mid-
1960s, with a sharp decline after the introduction of chemotherapeutic agents in the late 
1960s. 
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incidence rates in home communities in the W estem Cape exceeding 1000 per 100 000 
(Metcalf, 1991; Packard, 1991; Strebel and Seager, 1991). 
1.5.1 South African Statistics: 
It is estimated that 6-10 million South Africans are infected with M tb., with 
approximately 60 000 new cases notified and 6 000 registered deaths per annum. It 
must be realised that, as in the past, the notification and registration of infections and 
disease are often far below real values, due to the lack of education and primary health 
care in the rural areas of South Africa. Adding to this problem are the continual 
influxes of refugees and people from North Africa, often infected with TB, which adds 
to the inaccuracy of both the population statistics and the infection incidences for our 
country. Migration between provinces within SA also cause confusion and lack of 
accurately documented data (Packard, 1991; Strebel and Seager, 1991). 
Although most South African children are inoculated at birth with BCG to protect 
them from the high incidence of TB meningitis, figures for childhood tuberculosis are 
still high, 0.3/100 000 in children below 5 years (Strebel and Seager, 1991). 
Interestingly, there seems to be no difference in the incidence of TB between boys and 
girls below the age of 10 (Figure 1.2), but a 9% increase is recorded in young males 
between the ages of 12 and 19 years, suggesting an increased susceptibility during 
puberty, probably related to the growth spurt accompanying this period. As indicated 
in Table 1.1, the highest incidence of TB seems to occur between the ages of 1 and 4 
years, with an incidence of 240.8/100 000, in 1994, as compared to 164.95/100 000 in 
1992, with a similar incidence occurring again in adulthood, 215.18/100 000, with 
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pulmonary TB featuring predominantly in all age groups. Figure 1.2 indicates clearly 
the age-, gender- and group-specific distribution of tuberculosis in SA for 1993, 
highlighting two peaks of TB, during puberty and then again in adulthood for males. 
As expected, TB is most prominent within all race groups in old-age, as the older 
individual's immune-system is not able to deal with the bacterial load, making old-age 
homes and frail-care hospitals a prime target for TB epidemics (Epidemiological 
Comments, 1993). 
Judging by the trends indicated in Figure 1.3, the TB epidemic seems to have peaked in 
SA in the 1960s, with approximately 350 cases reported per 100 000, predominantly in 
the Black population. In 1994, it is interesting to note the increase in the TB rate was 
2-fold greater in Indians, 11-fold greater in Blacks, and a stunning 43-fold greater in 
the Coloured population, as compared to the incidence in Whites for the same period 
in 1993 (Table 1.2). Although this increase in the incidence of TB has continued over 
the last decade, the incidence of TB in the Coloured population has sky-rocketed from 
633/100 000 in 1987, to a current incidence of 705 .86/100 000 for 1994, suggesting a 
shift in the affected population group rather than an eradication of the disease (Table 
1.3) (Epidemiological Comments, 1995). 
The apparent shift in TB from the Black to the Coloured populations is reinforced by 
the data in table 1.4 highlighting the geographical distribution of TB through the 
country, as the greatest percentage of the Coloured population resides in the Western 
Cape, where the incidence of TB is the greatest, at 711.3/100 000. 
The TB mortality rate in South Africa is one of the highest in the world, with 2408 
individuals dying during 1994, and 80 609 new cases reported for the same period 
(Epidemiological Comments, 1995). 
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Table 1.2: Ethinic Distribution of the Incidence of TB in 1993 and 

















Table 1.3: Ethnic Distribution of TB in South Africa for the Period 
January to December 1994 
ETHNIC POPULATION PTB TOTAL INCIDENCE 
.......... GROUPS ..................... {Xl 0002.. ............................................................. PTB ............................ <Per .. 1 oo .. oOOL. 
Asian 1037 381 399 38.47 
Black 30902 48393 53586 173.4 
Coloured 3446 19854 24324 705 .86 
White 5177 665 844 16.30 
Table 1.4: Geographical Distribution of TB in South Africa in 1994 
PROVINCE POPULATION TOTAL INCIDENCE 
.................................................................... (XlOOO) ........................................ TB ............................. (per .. 100. 000) ................... . 
Western Cape 3589 25530 711.2 
Eastern Cape 6517 14961 229.5 
Northern Cape 762 3257 427.4 
Free State 2813 13567 482.3 
KwaZulu/Natal 8597 6510 75 .72 
Eastern Transvaal 2918 2251 77.14 
Northern Transvaal 5115 1686 32.96 
Gauteng 6886 9703 140.9 
North-West 3369 3004 89.16 
RS.A. Total 40562 80469 198.4 
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1.6 Pathogenesis of Tuberculosis: 
Tuberculosis represents a continual struggle between bacilli with a remarkable capacity 
for long-term persistence, and the host immune system which attempts tosuppress or 
even eradicate their growth. The outcome of this struggle depends not only upon the 
dose and strain of the invading bacteria, but also on the ability of the host to respond 
quickly and efficiently to the invasion. There are a number of well documented 
outcomes of a primary M tuberculosis infection. First, many individuals are exposed, 
but successfully eliminate the pathogen, so that only a delayed hypersensitivity 
response remains upon skin testing. Second, the infected individual develops a 
calcified lesion, visible on radiological examination, but suffers no symptoms of the 
disease, suggesting an efficient cell-mediated response (CMI) and containment of the 
bacilli. This explains why 1/3 of the world's population is infected with TB but only 
3 0 million have active tuberculosis, or why only 5-10% of infected individuals develop 
fulminant TB during their lifetime, suggesting the development of protective immunity 
(Ehlers, 1995). Third, the infected individual requires a longer time to respond to the 
invasion and can only limit disease spread once the bacilli are shed into the 
bloodstream and lymph, where they are eradicated by a local immune response, after 
which the infection is stabilised. Fourth, the individual is unable to arrest bacillary 
growth, with liquefaction of the granulomatous lung lesions and dissemination of the 
disease throughout the body, establishing systemic tuberculous disease (Dannenberg 
and Rook, 1994). 
One of the most accepted theories of the pathogenesis of TB is that it represents a 
balance between the bacilli' s ability to multiply and the host's ability to respond 
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appropriately. There are two ways in which the host can respond and staunch the 
bacterial growth: first, by damaging the cells in which the bacilli initially find 
themselves, i.e. the unactivated alveolar macrophage, and thereby exposing the bacilli 
to an unfavourable extracellular environment; and second, by evoking a CMI that 
recruits activated monocyte/macrophages, which will phagocytose the extracellular 
bacilli and contain and attempt to kill the bacilli intracellularly. The balance of these 
two responses will dictate the nature of the disease and the extent of the tissue 
damage, as they are both accompanied by varying levels of inflammatory events 
involving clotting factors, enzymes, cytokines, nitric oxides and oxygen radicals. 
Much of our understanding of the pathogenesis of TB has originated from the Bowden 
and Lurie studies in inbred, and therefore susceptible, rabbits, which seem to develop 
TB in much the same way as humans. In this model, resistant rabbits depict adult 
humans, whereas immune-compromised individuals and infants correspond to the 
susceptible, inbred rabbits. On studying the disease process in this model, Dannenberg 
has identified four stages, which are widely accepted as representative of the human 
disease, namely stage I, the stage of no bacillary growth; stage 2, the symbiotic stage; 
stage 3, the cell-mediated and delayed-type hyersensitivity immune response; and stage 
4, the liquefaction of the caseous center (Dannenberg, 1991). 
The infection is initiated by the inhalation of M tb. bacilli, usually as a clump of 
between I and 3 bacilli (I unit), probably in the form of a droplet of 5µM in diameter, 
which is able to pass unhindered through the bronchial passages into the mid-lower 
zone of the subpleura, where there is a high oxygen tension, and where the bacilli are 
rapidly phagocytosed by resident alveolar macrophages. The alveolar macrophage is a 
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resident macrophage of the lung, which is continually stimulated by small particles of 
dust, carbon and other organisms that are inhaled, contributing to the fast removal of 
particles from the alveolar environment. These cells are part of the first line of defence 
in the lung and must contain many potential infections, which thereby remain 
subclinical; however, their ability to kill invading pathogens is variable. Lucas (1994) 
suggests that upon initial infection (primary infection) with M tb. , the alveolar 
macrophages carry the bacilli to the nearby lymph nodes, thereby establishing a second 
focus, distinct from the local lesion, which may explain the lymphadenopathy 
accompanying early TB; moreover, all patients undergo a bacteremia at this stage, in 
which bacilli are potentially culturable from the blood and urine. 
Once the initial infection is established, the bacilli multiply within immature host 
macrophages, which have been recruited from the bloodstream and bone marrow by 
the cytokine response, lyse the cell, and are again phagocytosed by newly recruited 
monocyte-macrophages. These newly recruited macrophages are unable to contain 
and kill the bacilli, but allow the formation of granulomas, with bacilli surrounded by 
recruited macrophages. No tissue destruction occurs at this stage, as the host has not 
yet become hypersensitive to the tuberculin toxin secreted by the invading pathogen. 
Cytokines are continually being secreted by both the damaged cells and the recruited 
cells, eventually leading to the recruitment of the T-lymphocytes, which will serve to 
activate the incoming macrophages and allow intracellular killing to occur. At this 
stage a major cell mediated immune response is established in the immune-competent 
host. 
At this point, two to three weeks post-infection, the bacilli are in log phase and the 
host has become tuberculin-positive. Due to hypersensitivity to the tuberculin toxin 
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from the bacilli, necrosis of the granulomatous lesion may now take place, suggesting a 
toxic reaction between host and bacilli, leading to destruction of local tissue. This 
destruction of the tissue enables the host to inhibit bacillary replication, because of the 
unfavourable conditions created by the high fatty acid content, low pH, and anoxia 
accompanying caseous necrosis. The success of containment of the bacilli at this stage 
depends upon the multiplication rate of the bacilli - an expression of bacterial virulence 
- and the efficiency of the host to limit bacterial growth. The cytokine-activated 
macrophages surrounding the granuloma are able to phagocytose and inhibit growth of 
the bacilli, and may be able to kill them. 
Cytokine activation of macrophages ts a component of T -cell mediated 
hypersensitivity, which develops as the I-lymphocytes are exposed to mycobacterial 
antigens presented to them by the infected macrophages and possibly other antigen-
presenting cells. To enable an effective immune response, bacterial proteins are 
presented to the host immune system in the context of either major histocompatibility 
complex class I (MHC I) or MHC class II (MHC II) proteins. Classically, the 
p[resentation of MHC I-associated antigens has been thought to initiate cytolytic 
activity mediated by CDS T cells, as in the case of viral infections. In contrast, the 
MHC II response comprises of CD4 T cell enhancement, which usually accompanies 
protozoan and bacterial infections (Kaufinann, 1995; Marrack and Kappler, 1994). In 
some bacterial infections, such as TB, the microbial localisation may dictate the antigen 
processing pathway or the entire peptide may be required and not only the epitopes, 
for T cell recognition, suggesting that more than just one T cell population may be 
involved in the immune response (Kaufinann, 1995). 
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Responder T helper cells react by secreting cytokines to activate local macrophages to 
ingest M tb. as well as to recruit activated macrophages from the bloodstream, which 
may enable the macrophage to contain or even kill the bacilli. However, the lack of in 
vitro evidence that human macrophages can actually kill M tb. has caused much 
controversy, leading to a modification of our concept of protective immunity. The 
cellular immunity is dependent upon the secretion of inteferon-gamma (IFN-gamma) 
and the recruitment of both CD4 and CD8 T cells to effectively contain and eliminate 
the infection. The subpopulations of T cells involved in the protective immunity during 
tuberculosis has long been debated, and current theory suggests that a subpopulation 
ofCD44+ and CD45Rff CD4 T (Thl) cells develop in response toM tb. (Griffin et al. , 
1994), which are responsible for the secretion of IFN-gamma, IL-2, and TNF-a in 
response to M tb. antigens, Ag85B and low molecular weight peptides, ESAT-6 and 
ST-CFP (Marrack and Kappler, 1994; Boesen et al., 1995; Porcelli et al., 1992). 
A second subset of T cells recently recognised as co4·cns· ap T (Th2) cells respond 
to mycolic acids and lipoarabinomannan commonly found in M tb . and M leprae, 
respectively, that enable the host to induce T cell proliferation, via induction of IL-10 
and IL-4 secretion, and lysis of infected cells via the CD lb receptor ( Kaufinann, 1995; 
Cooper and Flynn, 1995), as well as the stimulation ofB cells to produce antibodies to 
the bacterial antigens presented (Marrack and Kappler, 1995). These cells are thought 
to develop as part of the early innate response to infection ( Beckman et al. , 1994). 
A third T cell population consists of yo T cells, whose role in M tb . infection is 
thought not to be crucial in the initial containment of the bacilli, ( although they are able 
to respond to non-proteinacious phosphate-containing M tb. antigens), but rather to 
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respond to the increase in IL-2 and IFN-gamma preceeding the Thl CD4 response 
(Cooper and Flynn, 1995). 
A Th2 CD4 T cell response has shown not to be enhanced systemically or at the site of 
pathology in humans, unlike in M leprae; the Thl response together with the CD8 T 
cell proliferation are more apt to contain and eliminate a primary infection. The direct 
role of CDS T cells, although still controversial, has been recognised to transfer 
immunity and cytotoxic specificity toM tb. infected macrophages (Lin et al. , 1996). It 
is now proposed that cytotoxic T-lymphocytes (CTL), as well as helper T-lymphocytes 
and macrophages, are recruited to the site of infection, but it is the CTLs that 
recognise and lyse the incapacitated, infected macrophage, thereby releasing the bacilli 
to: ( 1) expose the bacilli to toxic radicals secreted during the lysis of the macrophage; 
(2) expel the bacilli into the unfavourable necrotic environment of the granuloma focus; 
or (3) expose the bacilli to fresh, highly activated MDMs that are better able to contain 
ingested Mtb (Kaufmann, 1995). 
At three weeks post infection, if the lesion is not calcified and contained, the 
susceptible host will allow the bacilli to escape the necrotic focus and continue growth 
in the surrounding macrophages. This together with increased tissue destruction and 
an inability to contain bacillary growth will lead to an increase in the size of the lesion 
and possible erosion through the tracheobronchial walls into surrounding lymph nodes 
and blood vessels, by which the bacilli will be efficiently disseminated throughout the 
body, eventually resulting in death. In the resistant host, a strong CMI develops, 
which will aid in locally activating macrophages, which will in tum contain the spread 
and replication of the bacilli. The increased cytokine production, and T-cell activation 
enhances the recruitment and activation of macrophages. A dense macrophage layer is 
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therefore formed around the caesous centre, walling off the lesion and arresting the 
disease process. If bacilli should escape the mantle of protection, the CMI response 
· will be evoked efficiently and the bacilli inhibited wherever they appear. 
The debate whether post-primary TB is actually a re-infection or reactivation of an old 
lesion is a source of much controversy. Lucas (1994) estimates that 5-10% of all TB 
diagnosed in childhood will reactivate at some later stage in the infected individual's 
life, often aided by the onset of old age, diabetes, or alcohol or drug abuse. Studies by 
pathologists during 1927, found that one quarter to one half of patients with 
radiologically normal lungs revealed at autopsy, old calcified tuberculoid lesions in the 
lung, suggesting that an effective protective immunity - consisting of a complex 
interplay between infected and bystander macrophages, as well as the interactions of T-
lymphocytes, both helper and cytotoxic - is responsible for the low incidence of disease 
progression. 
One of the most characteristic differences between re-infection and reactivation is the 
position of the infective focus in the lung. As discussed earlier, a primary TB infection 
usually initiates in the mid-lower zone of the lung, as the bacilli are breathed in from 
the outside, whereas reactivation disease is frequently in the upper zone of the lungs, 
suggesting dissemination of the original infection. These lesions are also necrotic in 
nature, suggesting a prior sensitisation to the tuberculin toxin, and subsequently on 
reactivation a hypersensitivity to the tuberculin protein, resulting in extensive necrosis. 
Due to the varied disease patterns, it has been suggested by Lucas (1994) that in the 
immune-competent individual, a classical tuberculoid granuloma is evident, with 
epithelia cells and giant cells in the granuloma, but little or no accompanying necrosis 
or caseation, and subsequently few culturable AFB. In the immunocompromised host, 
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a different granulomatous reaction is described, classified as the non-reactive immune 
response, characterised by granuloma necrosis with extracellular AFB in large 
numbers, with few giant and epitheloid cells. A range of varying granulomas are seen 
amongst different individuals and with various strains of bacilli. Interestingly, this non-
reactive granuloma is not seen in M avium, M leprae or M intracellulare infections, 
as these bacilli do not seem to have an adverse effect on the macrophages, apparently 
allowing symbiotic growth within the macrophage. In contrast, M th. infection 
appears to have a toxic effect on macrophages, resulting in cell lysis with large 
numbers of extracellular bacteria. In HIV, the immunocompromised host has a 10% 
annual risk of developing TB, as compared to the 10% lifetime risk of the 
immunocompetent individual. This together with the high level of mortality, often 
90% of cases within 4-16 weeks, and the high incidence of :MDR TB contracted by 
HIV sufferers, has significantly contributed to the resurgence of TB in the Western 
world. The rapid initiation and progression of the disease in these individuals is 
thought to result from the inability to orchestrate delayed-type hypersensitivity 
required to activate macrophages and start the CMI. The inability to evoke this 
response is directly related to the destruction of the T-helper lymphocytes by the HIV 
virus, explaining why the progression of TB in HIV is so rapid. 
It remains perplexing that, apart from immunocompromised individuals, only 5-10% of 
healthy people experience a breakdown in their protective immunity, allowing 
establishment of clinical disease. The reasons for this are still widely researched and 
may be related to the genetic makeup of an individual or the bacilli, as discussed 
further in Chapters 3 and 4. 
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1. 7 In Conclusion: 
· The history of tuberculosis is ancient, and yet the disease remains one of the greatest 
scourges of the developing world. As new and more lethal diseases emerge, 
tuberculosis can only continue to increase, as it is one of the most opportunistic and 
virulent facultative intracellular pathogens known to man. The fact that the bacteria 
can apparently survive within the host for decades, only to emerge when the individual 
is immuno-compromised, suggests that the pathogen cannot easily be eradicated at a 
cellular level. Unfortunately, M th., although known for over one century, is poorly 
understood, and much of the bacteria's ability to invade and colonise the host is still 
under intensive investigation. The molecular details of the interaction between the 
inhaled bacilli and the host phagocyte, the macrophage, remain mysterious. It is well 
documented that M tb. enters host macrophages and seems to be able to orchestrate 
the entry to its advantage, but the mechanisms are debatable. In approaching this 
problem, it is instructive to consider the strategies used by pathogens. On this basis, 
one of the most likely portals of entry to be exploited by M tb. is the cell-surface 
complement receptor type 3, (CR3), also known as Mac-1, Mo-1, or CD11b/CD18. 
As described in ensuing chapters, CR3 is required for many cell-cell and cell-matrix 
interactions and is a key receptor in the migratory abilities of the immune cells. To 
target this receptor and to exploit it to the bacteria's advantage would require either a 
bacterial surface moiety that can provide a CR3 ligand or the ability to bind opsonins 
(mainly complement components) that are known to interact with CR3 . To explore 
this, we have designed a research strategy to aid in demonstrating the requirement for 
CR3 and the conditions needed for the bacteria to interact with this receptor. 
28 
CHAPTER TWO 
STATEMENT OF HYPOTHESIS, AIMS, AND STUDY 
SIGNIFICANCE 
2.1 HYPOTHESIS: 
Mycobacterium tuberculosis is a well known facultative intracellular pathogen that 
multiplies both intracellularly and extracellularly in its host, the human. The ability of 
the pathogen to invade and survive within its host cell, the mononuclear phagocyte, is 
a critical component of its virulence modus operandi, in that it provides it with a 
distinct advantage over host defences. We hypothesize that the bacterium evades 
normal host defence mechanisms by binding directly (ie, nonopsonically) to 
complement receptor type 3 (CRJ), by means of a specific, CRJ-binding cell 
surf ace ligand. CRJ is a key macrophage receptor and adhesion protein, and is a 
frequent target of intracellular pathogens because CRJ-mediated phagocytosis is 
not accompanied by a respiratory burst. Nonopsonic binding to CRJ may be 
critical in the complement-poor alveolar space, and, we speculate, may further 
enhance intracellular survival by unknown mechanisms. 
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2.2 AIMS: 
The central aim of this thesis is to study the interaction between CR3 and M tb., with 
particular reference to the role of serum opsonins. 
This will be accomplished by: 
1. Examining the capacity of human peripheral blood monocyte-derived 
macrophages to phagocytose M tb. in the absence of complement. 
2. Heterologously expressing human CR3 in a non-phagocytic cell line to 
investigate the direct interaction between M tb. and CR3 without the 
involvement of other macrophage surface receptors. 
3. Determining the extent to which serum opsonins are required for the 
interaction betweenM tb. and CR3-expressing cells. 
4. Establishing whether the C3bi-binding site of CR3 is involved in the interaction 
with M tb. in the absence of complement. 
2.3 STUDY SIGNIFICANCE: 
The ability to invade, survive and establish longterm persistence in host mononuclear 
phagocytes is the single most pathogenic feature of M tb. For reasons to be explored 
in detail in this thesis, complement receptor type 3 (CR3) is hypothesised to be the 
preferred receptor for M tb. Moreover effective use of this receptor by M tb. in the 
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establishment of the initial infection in the complement-poor, quiescent lung likely 
depends on direct, nonopsonic binding by the bacilli. It is the aim of this study to 
rigorously establish whether direct, nonopsonic binding of M th. to CR3 can occur. If 
so, it is strong evidence for the existence of a specific, CR3-binding ligand on the 
surface of the pathogen. The isolation and identification of such a ligand will be the 
subject of later work, and it offers the prospect of designing novel preventive and 




MYCOBACTERIUM TUBERCULOSIS CULTURES 
3.1 INTRODUCTION: 
Mycobacteria are a large group of Gram-positive bacteria that cause a wide range of 
diseases in humans and animals, which may be localised or disseminated in nature. 
Most Mycobacterial species are saprophytes that inhabit water or soil and it is likely 
that modern pathogens evolved from saprophytic ancestors, adapting to infect their 
current hosts. Tuberculosis-like infections contracted by humans in earlier millennia 
were thought to be of M bovis origin, which probably evolved to establish the highly 
infectious human pathogen, M tb. (Bloom, 1994) (see also Chapter 1). 
Mycobacteria are classified into four broad categories, according to their natural 
habitat, degree of pathogenicity, and hosts. These categories are a) obligate 
pathogens, exclusively found in humans; b) facultative pathogens, primarily found in 
animals or the environment, but can cause human infections; c) opportunistic, 
environmental pathogens, that can take advantage of the immune compromised human; 
d) saprophytic bacteria, mainly environmental, with no pathogenicity in humans. Table 
3 .1 displays the vast number of mycobacteria identified and which are classified 
according to the above criteria (Berlin, 1990). 
Mycobacterium tuberculosis (M tb) is a facultatively intracellular, obligate pathogen, 






















































































































































































































































































































































































































































































































































It is a slow-growing mycobacterium that is spread from one host to another by means 
of small aerosols of 1-Sµm in diameter, expectorated from the lungs of an individual 
with active pulmonary disease. These droplets are able to pass unnoticed through the 
bronchial passages into the alveoli of the lung, where the bacilli adhere to and invade 
the alveolar macrophages. As described in Chapter One, a wide range of pathological 
scenarios may ensue from the initial infection, all dependent on the host ' s ability to 
evoke an immune response and the bacilli ' s ability to withstand the attack. As the 
disease progresses, the bacilli may be forced to revert to their earlier saprophytic 
nature and feed off the necrotic matter encasing them in the centre of necrotic lesions 
(Lucas, 1988; Lucas, 1989). 
Mycobacterium bovis is a slow-growing pathogen which was originally a soil 
bacterium. Its natural host is cattle but it may cause disease in humans through oral 
ingestion of contaminated milk. The disease is usually limited to the gastrointestinal 
tract and lymph nodes, but has a similar pathogenesis as Mtb. The incidence of M 
bovis infections in humans has declined since the introduction of pasteurisation 
procedures, with destruction of the bacilli in dairy products, but may still occur in rural 
or developing communities. 
Bacille Calmette-Guerin (BCG) is a laboratory strain of mycobacteria not found in the 
wild, and the origin of which is somewhat disputed, but which is thought to be a 
unique strain of M bovis. It has been used extensively as a vaccine to protect infants 
against Mtb. BCG disease in humans is rare and usually due to inability to cope with 
the subcutaneous load used in inoculations (Lucas, 1989). 
Mycobacterium leprae is an extremely slow growing, obligate intracellular pathogen 
whose only natural host is humans, and which can not be cultured in vitro. In many 
35 
respects, it is an extreme representation of the pathogenic mycobacteria, highlighting 
the many problems encountered with mycobacteria in vitro. M leprae infection is 
fascinating, as it passes through three stages in the host and only at the last stage is the 
host able to recognise and combat the infection. The initial stage occurs in the skin of 
the host, where the bacteria replicate undisturbed, until they disseminate to peripheral 
neive endings and establish the second stage of infection. Once the final tuberculoid, 
granulomatous stage is reached, the host attempts to mount a cell-mediated immune 
(CMI) response to eradicate the infection, which by now is often rampant (Berlin, 
1990; Bloom, 1994). One of the most striking differences between M tb. and M 
leprae infection is the absence of necrotic matter in leprosy, due to its silent 
intracellular growth, whereas M tb. is a much more toxic intracellular pathogen. 
The rate of infection and the severity of the disease, as well as the ability of the host to 
respond, depend on the virulence of the bacterial strain and species, which are not fully 
understood. It was thought that the slower growing pathogens, such as M tb, 
M leprae and M avium, are more virulent than the fast growers, such as M smegmatis 
and M fortuitum, but this is not entirely true, as the laboratory strain H37Rv, a 
virulent strain of M tb, is faster growing in the guinea pig, due to its virulence, than the 
less infectious, avirulent strain, H37Ra, which is also a slow grower in vitro, 
suggesting that the growth rate in vitro has little significance to the virulence of the 
pathogen in vivo. The search for virulence determinants and factors is underway in 
laboratories throughout the world. 
The natural characteristics of these bacteria make them difficult to culture in vitro, if at 
all, and pose a number of basic fundamental obstacles that will be discussed under 
Materials and Methods in this chapter. Understanding the complexity of the bacterial 
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cell wall and the growth characteristics of the bacteria may provide insight into a 
possible ligand on the cell wall that could interact with host cell receptors such as CR3 . 
Similarly, understanding different growth stages, some of which may be more invasive 
to host cells, would also aid in the infection assays. 
3.1.1 Cell Wall Structure: 
The characteristic cell wall, which has earned the Mycobacterium species its identifying 
hallmark, namely the ability to retain dye in its cell wall after acid washing, commonly 
referred to as acid fastness, is often said to be responsible for the bacteria' s 
pathogenicity and resistance against eradication. However the cell wall, although 
previously thought to be unique, maintains close similarities with that of other Gram-
positive bacteria, such as Nocardia, Corynebacterium; and Rhodococcus. 
Remarkably, the cell wall consists of greater than 60% lipid. The cell wall core 
comprises of a complex, covalently linked, tripartite polymer, consisting of a 
peptidoglycan backbone, an arabinogalactan layer, and an outerlayer of waxy mycolic 
acids. Each of these are covalently linked to each other to provide a semi-rigid 
supramolecular structure. The peptidoglycan skeleton is similar to those seen in Gram-
positive bacteria, made up of polysaccharide chains of glucosamines and muramic acids 
that are cross-linked to tetrapeptide side chains. The arabinogalactan layer is 
covalently linked to the peptidoglycan muramic acids, by means of galactose 
homopolysaccharides, similar to those identified in Corynebacterium and Nocardia. 
The mycolic acids are esters that terminate in arabinose residues, with high molecular 
weight 13-hydroxy fatty acids and long a side chains. These structures are similar to 
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waxes in nature, as identified in the above mentioned species. A number of other 
glycolipids, glycopeptidolipids, and proteins are non-covalently associated with these 
structures, and perform different functions for the bacteria. Of these an important 
polysaccharide, lipoarabinomannan, LAM, with arabinose and mannose subunits 
covalently linked to a phosphatidylinositol tail, provides immunological activities 
similar to lipopolysaccharide, LPS, well described in Gram negative bacteria. 
Trehalose-based glycolipids provide the characteristic 'tord factor' ' that is often said 
to be indicative of bacterial virulence, including sulphated acyl trehaloses that form the 
basis of the surface sulfatides found on mycobacteria. Finally, there are a host of 
phenolic glycolipids, peptidoglycolipids, and ceramides (true waxes) that interdigitate 
with the mycolic acids and contribute to the well-described lipophilicity and waxiness 
of the outer envelope (Ehlers, 1994; Douglas and Duncan, 1995). 
3.1.2 Metabolism and Nutrient Requirements: 
Mycobacteria have a range of growth rates that seem to broadly, but not entirely, 
indicate the pathogenicity of the bacterial strain, with the slower growers being the 
most pathogenic and the faster growers the least pathogenic. The slow growers are 
greatly retarded when compared to the replication rate of20 minutes of E. coli, as they 
take on average 12-20 hours to divide, whereas the faster growers divide 
approximately every 1-2 hours; in all cases, division is by means of binary fission . A 
possible reason for the slow growth may be the rigidity of the cell wall and the 
interesting paucity of rRNA genes (1 copy versus 7 in E. coli) . The lack of a 
requirement for essential nutrients and the ability to exist in relatively oxygen-depleted 
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environments enable these bacteria to exist m harsh conditions and compete m 
nutrient-poor environments for basic salts and carbon sources. 
These bacteria have adapted remarkably to the famine-or-feast cycle characteristic of 
natural environments, including the immunocompetent host, and seem to have won the 
survival race against the human. Unfortunately, simulating in vivo conditions during in 
vitro culture is extremely difficult, and much has still to be optimised and understood 
before we can rid ourselves of the animal model ( Davis et al., 1967; Wayne, 1994b) . 
3.1.3 Growth Characteristics of Mycobacterium tuberculosis: 
The type of culture media and the conditions of growth are fundamental in dictating 
the physiology, pathogenicity, and antigenicity of the organism, and should be adapted 
to suit the eventual aim of the experiment. 
For a number of years the bacteria were thought to survive only in rich media 
containing complex nitrogen, lipid, and carbohydrate components, but subsequently 
this has been found to be relevant only in the subculture of clinical isolates, where 
accompanying tissue destruction probably inhibits the growth of the bacteria and 
therefore the coaxing of bacterial growth is required. For experimental purposes, a 
simple salt solution with the addition of a nitrogen and carbon source are the only 
nutrients essential for growth. The oxygen provision will affect the growth rate and 
virulence state of the bacteria. A number of articles have been published to validate 
the requirement of, for example, glycerol or a detergent to enable effective in vitro 
culture of the bacteria, but this complicates the growth pattern of the bacteria, as the 
ultrastructural alterations and accompanying effects are not physiological. It is of great 
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importance to remember that no in vitro culture will be homogeneous, but rather a 
heterogeneous mixture of bacilli at different growth stages and ages, and with different 
virulence characteristics (Wayne, 1994b). 
The temperatures at which the bacteria are reported to grow range quite broadly, from 
between 29°C to 39°C, with the optimum being around 37°C, and this affects the 
growth rate of the bacteria significantly. Similarly, the controversy of stationary versus 
shaking cultures depends on the type of bacterial culture required. Stationary bacteria 
will grow as a pellicle that thickens with age and may contain large amounts of cord 
factor, whereas shaking bacteria, depending on the type of shaking, will grow in small 
clumps of suspended bacteria. The dispersion of these clumps and the number of 
bacilli per clump affects the inoculum given to animals in vivo and to cells in vitro, as 
the particulate size may dictate the fate of the bacilli and the response of the cells or 
tissues (Wayne, 1994a). 
Reported growing techniques suggest a requirement for additional quantities of either 
glycerol or Tween 80, a detergent, as aids in providing a relatively single-cell 
suspension. These factors were considered, but decided against in our culture 
protocols, as their effects, when in large volumes, on the bacteria were potentially too 
non-physiological for the type of experiments planned. High percentages of glycerol 
not only may alter the normal metabolism of the bacteria, but may also result in 
excessive production of lipids and polysaccharides. Similarly Tween 80 may be toxic 
to the bacteria, due to its high oleic acid content. The oleic acid can be mopped up by 
the presence of albumin, but this again may alter the extrinsic surfaces of the bacteria 
and mask secreted antigens, thereby detracting or adding to the pathogenicity of the 
bacteria. It was therefore at the risk of not being able to generate single-cell 
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suspens10ns, that the bacteria were cultured in the most physiological conditions 
possible, to minimise the introduction of culture artefacts (Berlin, 1990; Wayne, 
1994b). 
Due to the nature of mycobacterial growth, it is difficult to obtain a single culture in 
which all the bacteria are synchronised, with respect to their growth stage. This has 
been said to be due to the characteristic clumping or pellicle growth observed during 
culturing. The bacteria are thus in differing degrees of contact with nutrients and 
oxygen, and therefore tend to be at various stages of the growth curve. Recently it has 
been suggested that if a bacterial culture is allowed to reach stationary phase and 
maintained there for some time, all the bacteria will shut down DNA synthesis and 
become 'tlormant", but not dead. Such bacteria, when inoculated into fresh media and 
exposed to more oxygen, will then all be synchronised to start RNA synthesis and 
divide within 8 hours, whereafter they will begin to synthesise DNA, suggesting that 
these cultures will be synchronised for 24 hours after re-inoculation (Wayne, 1994a). 
3.2 MATERIALS AND METHODS: 
3.2.1 Culture Media: 
Bacteria were cultured initially on Loewenstein Jensen (L-J) agar slopes (Addendum 
A.2) to establish an identifiable culture as indicated in Figure 3 .1. The bacteria were 
then grown in liquid Kirchner's medium (Addendum A.2), which consists of a low 
quantity of a simple carbon source, of 2% glycerol, and Asparagine as the nitrogen 
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source, together with a mixture of essential minerals and salts. The pH of the medium 
was maintained at 7.2. The medium is bulk autoclaved at 15 lb./sq. inch for 20 
minutes. No detergents were added to the culture. 
3.2.2 Bacterial Stocks: 
Stocks of M th. , strain H37Rv 27294, were obtained from the ATCC as lyophilised 
cultures and reconstituted on L-J slopes at 37°C for 2-3 weeks, before being cultured 
for experimental use. 
3.2.3 Culture techniques of M th.: 
The original ATCC stock grown on L-J slopes was washed in 3 ml Kirchner' s medium 
and gently dislodged with a sterile cotton bud. The dislodged bacterial suspension was 
aspirated and transferred into a sterile tube. The suspension was then forced through 
the tip of a 1-ml Gilson pipette, to break up the largest clumps. Once an 
approximately homogeneous suspension was achieved, a further 5 ml Kirchner' s was 
added to the suspension and mixed well. The suspension was left at room temperature 
for 10 minutes to precipitate out the largest clumps and the top 5 ml of generally 
single-cell bacteria was carefully removed and added to 100 ml of fresh Kirchner' s 
medium in a 500-ml glass bottle. The liquid culture was then incubated, shaking at 200 
rpm, at 3 7°C for two weeks, before inoculating the final bacterial stock culture. (The 
100 ml culture was grown first to provide a higher density inoculum for the final stock 
culture). Fifty millilitres of the two-week-old culture were inoculated into 200 ml of 
fresh Kirchner' s medium in a I-litre glass bottle and incubated under the same 
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Figure 3.1: Loewenstein-Jensen slope of Mycobacterium tuberculosis (H37Rv) 
Both clinical and laboratory samples of M tb. are streaked onto LJ slopes to aid 
selection from co-contaminants. 
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conditions for 7 to 10 days. At this stage the bacteria comprised an opaque culture 
with a few uniform clumps in suspension. The culture was aliquoted into O. 5 ml 
aliquots, and frozen at -20°C for subsequent use in experiments. Quantitation and 
screening for contamination were done at each step as described below. 
To ensure that the mycobacterial stock cultures were not contaminated with 
adventitious micro-organisms, regular Ziehl-Neelsen (ZN) staining of aliquots of the 
cultures was performed (Addendum A.1.15). The ZN smears gave an indication of the 
state of the bacteria and revealed any cross contamination that may have occurred. All 
contaminated cultures were discarded after autoclaving. 
3.2.4 Quantitation of Bacterial Stocks: 
Although this is not accurate, bacterial cultures were quantitated by visual turbidity, by 
comparison to McFarland' s standards (Addendum A.2) that are used for quantitating 
E. coli, and also by means of optical density at 550 nm. To validate these readings, an 
aliquot of the suspension was plated for colony forming units (CFU) on Kirchner' s 
agar and incubated for three weeks at 37°C with 5% CO2. 
Before quantitation, all bacterial aliquots were first syringed through various gauges of 
needles culminating in an insulin syringe ( Addendum A.1 .16). This aided in providing 
a relatively single-cell suspension, as viewed by light microscopy. As indicated in 
Addendum A.1.17, most bacterial cultures were grown to approximately McFarland' s 
standard 3 or 4, with an optical density of 0.408 at OD 550. The CFU were not that 
accurate in determining the number of bacteria present, as the culture method 
produced small clumps of bacteria even after sequential syringing to disrupt the 
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Figure 3.2: Ziehl-Neelsen stain of Mycobacterium tuberculosis (H37Rv) 
To ensure no co-contamination of the H37Rv culture has occurred, bacteria are heat-
fixed onto glass slides and stained with carbolfushcin, followed by acid washing to 
differentiate between acid-fast bacilli and contaminating Gram positive bacteria. 
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clumps, and this results in an underestimate of the true number of bacteria where this is 
based on CFU s. 
Viability of all cultures was established qualitatively at each experiment, by culturing 
an aliquot on both L-J slopes and in Kirchner's medium. 
3.3 RESULTS OF BACTERIAL CULTURES: 
H3 7R v was grown and stored as described above. The bacteria were examined 
microscopically after ZN staining and displayed features of characteristic M tb., as 
shown in Figure 3 .2. The rod-like bacilli were either in small clumps of 3-5 bacteria or 
as single pink rods across the slide. No blue Gram-negative contaminants were 
present. 
The bacterial culture that was used for most of the experimental assays was checked 
for viability by reculturing on L-J slopes, which indicated growth after 2 weeks at 
37°C. 
The bacterial stock culture was quantitated by comparison to McFarland's standard 3 
or 4 and resulted in an approximate value of 12 x 108 organisms per ml of culture 
medium. Similarly, an aliquot of the culture diluted 1 :2 in Kirchner's media gave a 
reading of 0.408 at OD 550, which is equivalent to 6 x 108 organisms per ml (Smibert 
and Kreig, 1994). 
All the bacterial aliquots were stored at -20°C in the culture supernatant until required, 
and no culture was defrosted and then refrozen. 
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3.4 CONCLUSION AND DISCUSSION: 
During the course of this study, additional literature became available about the effects 
of various culture methods and storage techniques on M th., and gave rise to a number 
of interesting questions regarding our method of culture. First, shaking the bacteria 
might be the most '\mphysiological" method of bacterial culture, whereas a slow-pulse 
shake may provide the necessary agitation to prevent cord formation, but not result in 
the solid small clumps encountered with continuos shaking, and therefore mimic 
growth in the alveoli more closely. What effects our culture method has on the 
bacterial physiology is unknown, but it is certainly worth investigating further. 
Second, attempts at synchronising the bacteria are also important in the infection 
assays, as it would be of interest to identify at which stage the bacteria express the 
relevant cell wall moiety that interacts with the complement receptor type 3 (CR3) or 
other host cell receptors. 
Culture techniques similar to ours were used by both Schlesinger et al. (1990b) and 
Stokes et al. (1993) for the preparation of their bacterial inoculum. Schlesinger 
cultured his bacteria on Midddlebrook' s 7Hl 1 agar for 9 days at 3 7°C with 5% CO2, 
after which he scraped off the bacteria and resuspended them in RPMI with 20 mM 
HEPES and 3 glass beads and vortexed the suspension to disrupt the clumps. The 
suspension was left for 30 minutes at room temperature, before aspirating the top half 
of the suspension, which contained single-cell bacteria and these were used in his 
infection studies. Similarly, Stokes grew his Erdman to late log phase in Proskauer 
and Beck medium with 0.05% Tween 80, which he then aliquoted and froze at -70°C 
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until required. Before inoculation, the bacteria were resuspended by syringing through 
a 25-gauge needle, to break up clumps. 
In an attempt to standardise the growth stages of our cultures, a comparison was made 
to a bacterium similar in nature and growth characteristics to mycobacteria, namely 
Nocardia. These organisms, although dividing at a faster rate than M tb., establish a 
similar infection and mode of host entry, and have been reported to cause confusion in 
the diagnosis of tuberculosis in areas of cross-contamination. Although my growth 
stages were based on Nocardia growth curves, the true growth rates for M tb. are still 
unknown. Once these are identified and the bacteria can be cultured in a synchronised 
fashion, the importance of true log-phase or stationary-phase cultures on infectivity can 
be assessed. M tb. has approximately a 3.33-fold longer division cycle than Nocardia, 
making the log phase anywhere from 3 to 10 days after initial inoculation. Usually at 
this stage the bacteria are too sparse in number to provide an efficient inoculum, and it 
was therefore decided to prime the final culture with a two-week growth that contains, 
it was hoped, bacteria at or near early stationary phase; the final culture was then 
grown for 7 to 10 days. 
A third question concerning the method of culture was the rate and level of 
oxygenation that is required for both optimal and '\)hysiological" growth. This is 
relevant to the in vivo setting in which the bacteria apparently survive in 
microaerophilic or even anaerobic conditions in the necrotic lung. Such conditions 
may alter the virulence and pathogenicity of the bacteria, in particular in regard to our 
interest of invasion of host cells. 
Despite the validity of these questions we have generated bacteria under defined 
conditions, similar to others, and have consistently used these stocks in our infection 
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experiments. Further comprehensive analyses of bacterial variations in growth stages 
and environmentally determined expression of virulence factors will be required to gain 
a fuller understanding oftheM tb.-host cell interaction. However, for the purposes of 
this study, the defined bacterial stocks generated have been adequate in performing the 
experiments described in the ensuing chapters. 
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CHAPTER FOUR 
MACROPHAGE - MYCOBACTERIAL INTERACTIONS 
4.1 INTRODUCTION: 
4.1.1 The origin and kinetics of macrophages: 
Macrophages are the most primitive but versatile immune cells of the body. Not only 
do they aid in normal maintenance and repair functions, but they are also the main 
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defence cells encountered by invading pathogens. Macrophages are the major 
differentiated cells of the mononuclear phagocyte system and are distributed widely 
throughout the body. Their structural and functional heterogeneity allows them to 
participate in a variety of physiological and pathological processes, although they all 
originate from the colony forming unit, granulocyte-macrophage, (CFU-GM), in the 
bone marrow. Interestingly, the same progenitor gives rise to the neutrophil (Auger 
and Ross, 1992; Stewart et al. , 1994). 
Macrophage precursors - monoblasts, promonocytes and monocytes - differentiate 
within the bone marrow before migrating into the blood stream as monocytes. These 
precursors of the macrophage differ in morphology and ultrastructure from the 
macrophage as described in Figures 4.1 and 4.2, depicting the characteristics of each 
cell stage. 
The kinetics of these cell stages differ from species to species. In the mouse, the 
monocyte remains in the bone marrow for less than 24 hours before emigrating into the 
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Figure 4.1: The development of macrophages and their precursors 
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Figure 4.2: Characteristics of developing macrophages 
(Source: Lewis C.E., and J.O 'D. McGee. The Macrophage. 1992. IRL Press) 
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blood stream where it will circulate for 25 hours before leaving the blood stream for its 
final destination in the tissues. In contrast, in man the monocyte remains 70 hours in 
the circulation before egress into the tissues. The process of tissue selection appears to 
be a random event, unless there is an inflammatory response to which the cells will 
migrate en masse (Auger and Ross, 1992; Stewart et al. , 1994). 
Most macrophages found in organs have migrated there from the blood stream as 
monocytes and will finally differentiate into macrophages upon entering the organ. At 
this stage, the macrophage does not recirculate into the blood stream, but remains in 
the tissues for several months before either dying there or migrating to lymph nodes to 
senesce. Recently it has been found that 5% of macrophages found in the tissues are 
the result of the division of mononuclear phagocytes arriving directly from the bone 
marrow as promonocytes and then completing their division in situ. A small fraction 
of bone marrow-derived monocytes will alter morphologically, in response to a 
particular anatomical position and accompanying environmental stimuli, derived from 
the extracellular matrices and local cell signalling, to represent a group of highly 
specialised macrophages classified · as resident macrophages. These cells are found in 
specific sites in the normal tissue and may participate in infl4mmation, but generally 
perform specialised functions in the organ in which they reside, such as the specialised 
scavenging functions of Kupffer cells in the liver and macrophages in the spleen 
(Crocker and Milon, 1992; Auger and Ross, 1992; Stewart et al. , 1994). 
4.1.2 The morphology and distribution of the macrophage: 
The monocyte differs from the macrophage in both size and ultrastructure. The 
monocyte is a small rounded cell, approximately 12-18 µm in diameter, with a large 
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irregular nucleus, whereas the macrophage is much larger, 25-50 µmin diameter, and 
varying in size and shape, with a ruffled surface and many large intracellular structures. 
Macrophages adapt to the organ or tissues in which they mature, often leading to 
heterogeneity amongst resident macrophages. They may function with antibacterial 
activity in the mucosa} wall of the gut or as a filter in the lymph. Alveolar 
macrophages are thought to reside in the lung for approximately three months before 
migrating to lymph nodes to die. During their residence in the lung they are the first 
line of defence against invading pathogens or foreign particles, and only after being 
overwhelmed will they recruit circulating monocytes and neutrophils. Alveolar 
macrophages adapt to deal with these events by altering their ultrastructure to contain 
large membrane-bound vesicles containing proteolytic enzymes. They also play 
important roles in the formation of granulomas and walling off of persistent pathogens 
(Auger and Ross, 1992; Adams and Hamilton, 1992). 
Other protective sites in which macrophages find themselves are the liver, spleen, 
intestine and artery walls. Giant cells are thought to be the terminal stages of the 
macrophage, as they comprise a multinucleated cell with large intracellular vacuoles 
containing a variety of particulate matter. These cells, although they have lost the 
ability to phagocytose as effectively as macrophages, contain large stores of lysosomal 
and respiratory enzymes, suggesting a functional role in the inhibition of intracellular 
pathogens. Therefore, not unexpected, they are a major cell type found in granulomas 
(Adams and Hamilton, 1992; Stewart et al. , 1994). 
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4.1.3 Macrophage cell-surface receptors: 
To provide effective communication between itself and the environment, the 
macrophage displays a vast number of cell surface receptors that not only keep it 
informed of the external milieu, but also enable it to differentiate, migrate, and respond 
to extracellular stimuli. Many of these receptors have been found as a result of 
interactions with ligands or after the generation of panels of cell surface-specific 
MAbs, and many more are still to be explored. Often these receptors will not work in 
isolation, but rather as a stimulus to initiate a cascade of intra- and inter-cellular events 
(Celada and Nathan, 1994; Mosser, 1994; Crocker and Milon, 1992). 
The receptors of greatest interest to us are those that induce the macrophage to 
phagocytose foreign particles. Of these, the Fe receptor and complement receptors are 
the most frequently discussed. The Fe receptor binds to the Fe region of the lg 
molecules, which in tum stimulates intracellular signalling events that initiate 
cytoskeletal rearrangements and promote phagocytosis of the lg-coated particle. 
Similarly, the complement receptors CRl , CR3 and CR4 interact with the C3b and 
C3bi fragments of the complement cascade to promote phagocytosis of complement-
coated, opsonised particles (Mosser, 1994; Speert, 1992). 
The receptor -ligand interaction is often dependent on the nature of the bacterial 
surface, but once the bacteria has been opsonised by complement components, IgG 
and fibronectin, the bacteria interact with these specified receptors, such as the 
complement receptors, FcR, and fibronectin receptors, which in tum promote their 
phagocytosis (Silverstein et al. , 1989; Horwitz, 1982). Depending on the phenotype of 
the macrophage, its receptor expression will also be limited as demonstrated by the 
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lack of CR3 on Kupffer cells as opposed to the high expression levels seen in 
circulating monocytes (Gordon et al. , 1988). Similarly Fcx.R differs depending on the 
tissue distribution of the cells, as shown by high levels of Fcx.RIII in neutrophils and 
macrophages, as compared to circulating monocytes (Unkeless, 1989). It is therefore 
not suprising that the melieu in which the macrophage resides may often dictate its 
receptor expression, as seen in macrophages stimulated by IFN-gamma during an 
immune response, where the levels of surface F cx.R are enhanced to interact with any 
opsonised particles (Wright et al. , 1986). Similarly, macrophages that are resident in 
tissues that are more frequently in contact with foreign particles, will display a vast 
number of surface receptors that aid phagocytosis, but this increase in receptor 
expression is not all that is required for effective phagocytosis as the activation state of 
the cells is crucial to the fate of the particle. A number of experiments performed 
using C3bi-coated erythrocytes clearly indicated this requirement, by showing that 
these coated cells were able to bind effectively but not induce phagocytosis, which 
suggests that a more active communication is required, as indicated by the process of 
'zippering" phagocytosis discussed in a later chapter (Griffin et al. , 1975; Wright and 
Silverstein, 1982). 
For bacteria that appear to be non-opsonised the macrophage has receptors or receptor 
epitopes that are able to bind to moieties either directly on the bacterial cell wall, or by 
utilising serum opsonin such as mannose binding protein to interact between the 
mannose containing bacterial cell wall and the mannose receptor on the macrophage 
(Mokoena and Gordon, 1985; Ezekowitz and Stahl, 1988). These receptors then 
allow phagocytosis either by interacting directly with the cytoskeleton or by co-
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stimulation of another surface receptor that 1s able to interact directly with the 
cytoskeleton. 
Receptors for cytokines, lipoproteins, advanced glycosylation endproducts and various 
glycoproteins all initiate interactions between the macrophage and the receptors ligand 
to induce internalisation, either to store the particle or to induce a variety of functional 
responses in the macrophage, including the secretion of cytokines or inhibition factors, 
and functional changes, such as activation. In this way the macrophage not only aids 
to 'tlean up" the extracellular milieu, but also activates and signals bystanding cells. 
An aspect of these activities is antigen presentation, and it is not surprising that 
macrophages are excellent antigen-presenting cells, processing various foreign antigens 
for display by MHC class I and II molecules to appropriate T-cell populations (Adams 
and Hamilton, 1992; Safley and Ziegler, 1994). 
The integrin adhesion receptors are used essentially to aid migration of the cells from 
the blood stream, through the wall of the blood vessel to the site of inflammation. This 
will be discussed in more detail in a later chapter. Without these adhesion receptors 
the cells are powerless to act as defenders at the site of pathology. The various 
receptors discussed are linked by an intricate network of inter- and intra-cellular 
communications that are initiated by cells of the immune system, culminating in the 
activation of the macrophage. Tables 4.1 and 4.2 indicate the complex interactions 
between the surface receptors, ligands, and the effects of cytokines on macrophage 
function (Adams and Hamilton, 1992; Crocker and Milon, 1992). 
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Table 4.1: Macrophage Surface Receptors and their Ligands 
(Adapted from Auger and Ross, 1992) 
RECEPTORS 
Anticoagulant and coagulant receptors 
Complement receptors 
Cytokine receptors 












coagulation factor VII; 
fibrinogen-fibrin; 
heparin 
C3; C3b; C3bi; C5a; 
Clq 
MIF; MAF; LIF; CF; 
MFF; IL-1; IL-2; 
IL-3; IL-4; IFN-a; 
IFN-~; IFN-gamma; 
GM-CSF; M-CSF 









apolipoproteins B and 
E· 
) 










endorphins; H1; H2; 
5HT; N-formylated 
peptides; substance P; 
1,25 Vitamin D3 
transferrin 
ABBREVIATIONS: C., complement; CSF, colony-stimulating factor; GM, 
granulocyte macrophage; H, histamine; lg, immunoglobulin; IL, interleukin; LIF, 
leukocyte migration inhibition factot; LT, leucotriene; MAF, macrophage activating 
factor; MFF, macrophage fusion factor; MIF, macrophage inhibitory factor; PG, 
prostaglandinn; 5HT, 5-hydroxytryptamine. 
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Table 4.2: Cytokine Effects on Macrophages 












EFFECT ON MACROPHAGE 
stimulate IL-1 ; TNF; CSF 
growth and differentiation of macrophages 
antigen presentation; fusion; MHC II expression; 
F cR induction 
activation; growth and differentiation 
activation; antiviral activity 
activation; antiviral activity 
MHC II expression; respiratory burst; MFR 
suppression; antiviral activity 
growth and differentiation 
IL-1 ; P AF and PGE2 release; chemotaxis 
deactivation; chemotaxis; growth factor release 
ABBREVIATIONS: GM-CSF, granulocyte-macrophage colony stimulating factor; 
IL, interleukin; M-CSF, macrophage colony stimulating factor; MFR, mannose-
fucose receptor; PAF, platlet activating factor; TGF, transforming growth factor; 
TNF, tumor necrosis factor. 
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4.1.4 Macrophage functions: 
The functions of macrophages are varied and related to the role of the organ in which 
they reside. In most cases, their main function is to act as the first line of defence, 
phagocytosing and eliminating any foreign invading organisms. Macrophages are 
attracted to areas of pathology by chemotactic gradients generated by cytokines 
secreted by damaged and participating cells. These recruited macrophages are 
activated and have altered cell surface receptor expression, as well as enhanced ability 
to secrete toxic compounds. Locally activated macrophages will also alter their 
receptor expression, but tend to be less effective at killing invading pathogens than 
recruited, monocyte-derived macrophages (Adams and Hamilton, 1992). 
Initial interactions are either by direct binding of macrophage surface receptors and 
pathogen cell envelope adhesins, or following deposition of opsonising agents, such as 
IgG, C3, or C3bi. The deposition of C3/C3bi on the pathogen surface may be either 
by the presence of serum, or the active production of complement components by the 
macrophage. Intracellular pathogens that specifically target macrophages may 
facilitate opsonisation in order to enhance internalisation. The active induction of 
complement deposition by pathogens may result from initiation of the classical or 
alternate complement cascades, depending on the nature of the pathogen surface. 
Alternatively, some organisms have evolved to express surface receptors that bind 
directly to macrophage receptors, thereby circumventing the need for prior 
opsonisation (Mosser, 1994; Speert, 1992). The advantages to pathogens of 
nonopsonic binding and internalisation are not clearly understood, but speculatively 
these could include: greater speed of entry; efficient binding even in opsonin-poor 
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environments; and binding host receptors or receptor epitopes different from those 
bound by opsonins and which result in a mode of internalisation that favours 
subsequent survival. These mechanisms of non-opsonic entry are thought to take place 
mostly in areas with low concentrations of lg and complement, such as the human 
bronchoalveolar region, even though alveolar macrophages express FcR and 
complement receptors. Interestingly, the alveolar macrophage is unique in that it 
requires specific oxygen tensions to enable effective phagocytosis, which may affect its 
activity in the granuloma (Reynolds et al., 1973). 
4.1.4.1 Genetics of macrophage-dependent host resistance: 
The genetic basis of host susceptibility has long been a controversial subject, and 
studies attempting to distinguish between racial or ethnic factors on the one hand and 
socio-economic conditions on the other hand failed to establish clearly a pattern of 
genetic inheritance in humans. Nevertheless, the phagocytic and bactericidal capacity 
of the human macrophage has been studied in detail, with a view to shedding light on 
possible genetically determined differences in disease incidence. Animal studies 
indicate specific relationships between genetic variations and the host immune response 
when confronted with M tb. In the mouse this is a two phased procedure, with an 
initial innate immunity that determines the extent to which an infection is established, 
followed by protective immunity that controls, and may eliminate, the initial infection, 
and which prevents progression to disease. The innate immunity possessed by some 
mice to M bovis BCG has been traced to a single autosomal dominant gene, the Beg 
gene, which has been found to be identical to the well characterised Ity and Lsh genes 
that provide animals with resistance to Salmonella typhimurium and Leishmania 
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donovani. Extensive studies have shown that this gene is expressed in the macrophage 
and the Beg (resistant) phenotype is characterised by an enhanced capacity of 
macrophages to effectively phagocytose and inhibit the intracellular growth of 
pathogens. A protein known as the natural resistance-associated macrophage protein 
(NRAMP) is the product of the Nramp gene identified as a candidate for the Beg locus 
(Vidal et al. , 1993). It is exclusively expressed in macrophages, and it has been 
speculated that NRA.MP allows nitric oxide to be retained and concentrated in bacilli-
containing phagolysosomes of the macrophage, achieving high nitric oxide 
concentrations that are toxic and lethal to the bacilli (Vidal et al. , 1993; Blackwell et 
al. , 1995). Research on human NRA.MP is intense, but although a human homologue 
of the mouse Nramp gene has been found, its effect on innate immunity in the human 
host still has to be proven (Ehlers, 1995; Gros et al. , 1981 ; Buschman et al. , 1989; 
Sadick, 1992; Vidal et al. , 1993; Blackwell et al. , 1995). With the help of studies such 
as these the dispute surrounding epidemiological data on populations in old age homes 
and prisons, which suggest a genetic basis for an increased susceptibility of Black 
individuals to TB rather than a purely socio-economic basis, may be resolved (Stead et 
al. , 1990; Crowle et al. , 1990). 
4.1.4.2 Macrophage microbicidal defences: 
Once an organism has been internalised, the macrophage has a number of microbicidal 
mechanisms, both oxidative and non-oxidative, to destroy the particle. The activation 
of these intracellular defence mechanisms is related, in part, to the pathway of entry. If 
bacteria enter the macrophage via the Fe receptor, they initiate the release of large 
amounts of oxygen radicals and arachidonic acids, commonly referred to as the 
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phagocytic respiratory burst. This enables the macrophage to attack the phagosomal 
contents and thereby destroy the organism. On the other hand, organisms that enter 
via the C3-complement receptor interaction are able to evade the respiratory burst and 
may manipulate the intracellular environment for their own benefit (Speert, 1992). 
Some organisms may disarm the macrophage' s second line of defence, by inhibiting, 
inter alia, lysosome-phagosome fusion, thereby avoiding contact with lysosomal 
contents, which consists of a number of microbicidal and fungicidal hydrolases and 
peroxidases. Other pathogens do not attempt to halt phagosome-lysosome fusion, 
preferring instead to survive in this compartment, and may even utilise the low pH to 
promote growth and differentiation. The non-oxidative, lysosomal mechanism of 
intracellular bactericidal activity is constitutively present in the macrophage and does 
not require activation, but not all resident macrophages contain the full complement of 
enzymes required for effective bactericidal activity, as, for instance, the alveolar 
macrophage (Stokes et al. , 1993; Sadick, 1992). 
4.1.4.3 Macrophage-derived cytokines and inflammation: 
Macrophages, in order to react effectively to noxious stimuli and invasive pathogens, 
must be able to respond rapidly to chemotactic signals, such as tuberculin or pertussis 
toxin. In addition to migration, quiescent macrophages must be activated to enhance 
their microbicidal and antigen-presenting capacities. Activation is achieved by various 
cytokines, of which interferon-gamma (IFN-gamma) is the most important. The 
cytokines initiate a cascade of intracellular events that allow the macrophage to 
migrate and interact with the organism. This interplay between signals and responses 
is carefully regulated so as to control the effects and terminate the responses. The 
64 
most carefully studied area of cellular regulation is the protein kinase C pathway, 
which regulates both intra- and inter-cellular responses. Macrophages not only receive 
and respond to cellular signals, but also directly interact with and stimulate other cells, 
by secreting a panel of macrophage-derived cytokines ( often referred to as 
inflammatory cytokines), including IL-1 , IL-6 and TNF-a. Table 4.3 describes a 
number of macrophage secreted components and their functions (Celada and Nathan, 
1994; Reiner, 1994). 
Similarly, the ability of a lymphocyte to respond to a chemotactic signal will often 
depend upon the presentation of a foreign antigen on the macrophage cell surface. 
Antigen processing and presentation is a major function of the macrophage. This may 
either take the form of Class I-restricted antigen presentation, where the antigen is 
derived from the cell cytoplasm, transported into the endoplasmic reticulum (ER), and 
then transferred to the surface, or as Class II-restricted antigen presentation, in which 
exogenous antigens are presented after endocytosis and/or phagocytosis (Safley and 
Ziegler, 1994). 
Apart from the protective role that macrophages play in the body, they are intimately 
involved in the acute phase response to disturbances in the homeostasis of the body. 
Hepatic monocyte-macrophage products are central to the effective interaction 
between cells during the acute phase response and lead to the common symptoms 
associated with acute and chronic disease, such as fever and enhanced protein 
catabolism, often resulting in cachexia. Macrophages also aid in tissue damage repair 
and the disposal of degraded material, both self and non-self, by recognising and 
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Table 4.3: Products Secreted by Macrophages 

























proteases,lipases, phosphatases, sulphatases 
collagenases, elastases, angiotensin convertases, 
cytolytic proteinases 
lipoprotein lipase, phospholipase A2 
a.i-macroglobulin, plasminogen activator inhibitor, 
collagenase inhibitor 
Cl,C4,C2,C3,C5 
factors B and D 
C3a,C3b,C5a,Bb 
C3b inactivator 
superoxides, hydrogen peroxide, hydroxyl radical 
II, VII, IX, X, XIII 
IL-1, IL-6, IL-8, TNF-a., IFN-a., IFN-f3, fibroblast and 
platelet-derived growth factors, GM-CSF, M-CSF, 
erythropioetin, angiogenesis factor 
thrombospondin, fibronectin, liprofectin, transferrin, 




phagocytosing old or damaged cells (Polloc
k and Etzioni, 1992). 
Despite their dominant and vital protective
 role in the body, macrophages may also 
become defective and thereby play an in
tegral part in a number of autoimmune 
diseases, an example of which is sarcoidosi
s, an inflammatory disease of the lungs of
 
unknown aetiology, which results in th
e formation of granulomas similar to 
tuberculous granulomas. It is thought th
at this irregular response is due to the 
inappropriate activation of the immune s
ystem by macrophage-secreted cytokines,
 
resulting in the formation of "protective" gr
anulomas. These irregularities are few in 
comparison to the effective "housekeeping"
 functions that the macrophages perform 
and their crucial role in first-line host defenc
e, without which the body certainly would 
not function effectively and coordinatedly 
in the maintenance of homeostasis and in 
protection against pathogen invasion (Polloc
k and Etzioni, 1992). 
4.2 MATERIALS AND METHODS: 
4.2.1 Isolation and Culture of Monocyte-d
erived Macrophages (MD Ms): 
Forty millilitres of peripheral blood were dr
awn directly into 4 heparinised 10ml glass 
tubes, from a Mantoux negative individual. 
An additional 20 ml of blood was drawn, 
in a glass clotting tube, to provide autolog
us serum. Blood was processed within 2 
hours. The heparinised blood was diluted 
1 :2 with room temperature PBS, in 12ml 







Fresh heparinised blood, diluted with PBS and layered onto a Ficoll density gradient 
results in the separation of the blood cells, as indicated. 
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plastic tubes. Seven millilitres of the diluted blood were then carefully layered onto 3 
ml of Ficoll Histopaque (Sigma) in 10ml plastic tubes. The tubes were centrifuged at 
1800 rpm for 20 minutes to generate a sedimentation gradient, as indicated in Figure 
4.3. The peripheral blood mononuclear cells (PBMCs) are at the interface, just above 
the Ficoll layer, and were aspirated with a sterile Pasteur pipette and transferred into a 
clean 10ml tube. The PBMCs were washed three times in PBS, with pelleting of the 
cells at 1600 rpm for 10 minutes between washes. The PBMCs were counted on a 
Haemocytometer and resuspended in 20% autologus fresh serum and RPMI-1640 to 
obtain approximately 5 x 106 cells/ml. Two millilitres of the suspension were seeded 
per well in a 6-well plate and incubated at 37°C with 5% CO2 for 11h hours, to allow 
adherence of the monocytes to the plastic. The non-adherent PBMCs were washed off 
with RPMI-1640 and the cells were reincubated as before for a further 3 days. On day 
3 the culture supernatant was aspirated and saved, the cells washed once with RPMI-
1640 and refed with 10% autologus serum in RPMI-1640, supplemented with 25% 
culture supernatant. This culture supernatant was, centrifuged to remove all the non-
adherent cells, and referred to as conditioned medium as it contains cytokines and 
components secreted by the PBMCs during maturation that aid the monocytes in 
maturing further. Only after day 6 were the monocytes classified as :MDMs and used 
in experiments as macrophages, for reasons described in Figures 4.1 and 4.2. 
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4.2.2 Seeding of MD Ms: 
MDMs were lifted from the plastic tissue culture dish by adding 1 ml of cold 5mM 
EDTA/HBSS solution per well and incubating the cells at 37°C with 5% CO2 for 5 
minutes. The cells were then washed off the plastic with a Gilson P 1000 pipette and 
resuspended in 10 ml of PBS. The cells were centrifuged at 1600 rpm for 10 minutes 
to remove the EDTA and the pellet resuspended in 1 ml of medium. The cell 
suspension was quantitated by diluting the cells in Trypan blue and counting on a 
Haemocytometer, after which they were seeded onto 12mm glass coverslips at a ratio 
of 1 x 1 o5 cells per coverslip in a 24-well tissue culture plate. The cells were 
incubated in 10% autologus, fresh serum in RPMI-1640, at 37°C with 5% CO2 for 4 
hours, before being used in an assay. Cells were seeded in duplicate or triplicate per 
experiment. 
The plated cells were then washed and incubated in the desired medium appropriate for 
the assay conditions. These were either with or without 10% fresh, autologus serum in 
RPMI-1640. No antibiotics were present in these media. 
4.2.3 Infection Ratios of MD Ms: 
Mycobacterium tuberculosis (H37Rv), cultured as described in Chapter 3, and diluted 
to McFarland's standard 0.5 (1.5 x 108 organisms/ml), was added in 50µ1 aliquots to 
the various wells, to obtain an infection ratio of approximately 50: 1 bacteria to cell. 
The tissue culture plates were swirled gently to distribute the bacteria, and incubated at 
3 7°C, 5% CO2 for 20 minutes to 2 hours, after which the non-adherent bacteria were 
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removed by gentle washing with PBS, and the cells reincubated in the appropriate 
media for up to 24 hours. 
4.2.4 Fixing and Staining of Infected Cells: 
After the required incubation period the cells were washed at least three times with 
PBS to remove any non-adherent bacteria, and then either fixed in 2.5% 
glutaraldehyde (GA) and kept at 4°C, or air dried and heat fixed. The GA-fixed 
coverslips were washed again with PBS to remove any residual GA and flooded with a 
1.4 mg/10 ml solution of acridine orange for 1 minute at room temperature, before 
being washed with PBS. The extracellular fluorescence was then quenched with a 5 
mg/10 ml crystal violet solution for 30 seconds at room temperature. Cells were 
washed again and fixed onto a glass microscope slide for examination by fluorescence 
microscopy at an excitation wavelength of 350 nm, as indicated in Figure 4.4. 
The air-dried/heat-fixed slides were stained with Ziehl Neelsen stain as described in 
Addendum A.1 .15., and viewed with light microscopy as indicated in Figure 4.5. 
4.3 RESULTS: 
4.3.1 Growth and Recovery Rates ofMDM: 
All MDMs were culturable for a period of 2-3 weeks, before they were no longer able 
to phagocytose and adhere. Most cells were used in assays before 2 weeks, during 
which time the media were changed every three days. 
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Figure 4.4: Acridine orange staining of M. th. associated with MDMs 
M tb infected MD Ms were fixed with glutaraldehyde, stained with acridine orange and 
quenched with crystal violet, to allow easy enumeration of infected cells with 
fluorescent microscopy. 
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Figure 4.5: Ziehl-Neelsen staining of phagocytosed M. tb. 
A different method of staining M tb. infected MDMs, that aid identification of any co-
contaminating pathogens. 
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The number of cells recovered from each batch of fresh blood varied from batch to 
batch, but on average 5% of the total white blood cell (WBC) count represented 
culturable monocytes. 
4.3.2 Association of M.tb with MDMs: 
The MD Ms were infected with H37Rv as described above, and the number of bacteria 
associated with the cells enumerated by both ZN staining and fluorescent microscopy 
after acridine orange staining. The number of bacteria associated with each cell was 
expressed as a percentage of the total number of cells counted per coverslip, with no 
attempt being made to distinguish between extracellular and intracellular bacteria. The 
infections were performed in the presence and absence of fresh serum, for 3 and 24 
hours. 
The cells were infected at a ratio of 500: 1 and at 50: 1, bacteria per cell. The cells were 
incubated in appropriate media for the experiment. Cells infected at greater than 100: 1 
bacteria to cell ratios, rapidly phagocytosed the bacilli, with resultant lysis of the 
overfilled macrophages. These experiments revealed only cellular debris and numerous 
extracellular bacteria. 
Macrophages infected at a 50: 1 ratio showed good phagocytic ability, with on an 
average 5 5 ± 8% ( 4. 5 bacteria / cell) of the cells associated with bacteria after 3 hours 
and 80 ± 3% (6.2 bacteria/ cell) after 24 hours incubation in medium containing 10% 
fresh autologus serum. In contrast, MDMs infected at a 50: 1 ratio in the absence of 
serum indicated an association of 23 ± 9% (3 . 9 bacteria / cell) after 3 hours and 5 7 ± 
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7% ( 5. 7 bacteria / cell) after 24 hours. Results are from counting of 100 MD Ms on 
between 2 and 5 separate coverslips. The addition of 10% fresh FCS in the assays 
gave results similar to those with autologus serum. 
Heat inactivation of the autologus serum, at 56°C for 30 minutes, resulted in a modest 
reduction in bacterial association, when compared to the results obtained with fresh 
serum. Thus, of MDMs infected at a 50:1 ratio, 37 ± 4% (3 .6 bacteria/ cell) were 
associated with bacteria after 3 hours (33% reduction), and 64 ± 6% (5 .2 bacteria / 
cell) cells were associated with bacteria after 24 hours (20% reduction) . 
4.4 DISCUSSION: 
The functions of the macrophage CR3, together with other surface receptors, as an 
integral component of macrophage defence mechanisms are well established. 
However, exactly how CR3 interacts with pathogens, notably M tb., in a complement-
deficient environment has still to be elucidated. It has been suggested that bacteria that 
enter via this pathway are able to avoid the respiratory burst and this constitutes a 
specific survival strategy. 
To investigate the role of serum opsonins in M tb. infections, MDMs were infected at 
various bacterial to cell ratios and serum conditions. The results we have obtained are 
comparable with those reported in the literature (Stokes et al. , 1993; Hirsch et al. , 
1994; Simms et al., 1989) and provide us with a reproducible, standard infection assay. 
MDMs infected at ratios greater than 100: 1 bacteria to cell do not provide useful data, 
as the vast majority of the cells loaded with bacteria lyse within 24 hours. We found 
that the association of MDMs with bacilli was similar in the presence of media 
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supplemented with fresh, autologous serum or media supplemented with fresh FCS, 
suggesting that fresh FCS constitutes a source of opsonins that is adequate for 
interaction with human MDM receptors, including CR3 . 
Based on these results, we have relied mainly on fresh FCS in later assays usmg 
transfected CHO cells (Chapter 6). The results obtained in the absence of serum 
similarly agree with published reports and provide in vitro evidence for the phagocytic 
ability of macrophages in complement-deficient environments (Stokes et al. , 1993). 
Although only 23% of the cells were associated with bacteria after a 3-hour incubation, 
most of these cells bound large numbers of bacteria, which was enhanced further after 
incubation for 24 hours. The number of bacteria per cell in assays devoid of serum 
were less than in the presence of serum, whereas assays performed with heat-
inactivated serum gave intermediate values. Most MDMs had an average of 3-10 
bacteria per cell in the presence of serum, with similar results of 1-10 bacteria per cell 
obtained with heat-inactivated serum, as compared to 1-5 bacteria per cell in the 
absence of serum. All assays had enhanced association after 24 hours. 
Interestingly differences arose from the mode of preparation of MDMs for the 
infection assays. When MDMs were seeded, cultured and infected on the same glass 
coverslip, they showed a lower association with bacteria (36 ± 4% in the presence of 
serum and 15 ± 2% in the absence of serum, after a 3-hour incubation) than when they 
were seeded and cultured in plastic culture dishes first, before detachment and seeding 
onto glass coverslips prior to infection (55 ± 8% in the presence of serum and 23 ± 9% 
in the absence of serum, after a 3-hour incubation); these differences were noted both 
in the presence and absence of serum. These data suggest that detachment and 
reattachment may in some way activate MDM receptors, thereby enhancing the 
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interaction with the M tb. cell wall, including in the absence of complement. These 
results corroborate recent data by Stokes et al. , 1993, which document the importance 
of the phenotype and activation state of murine macrophages with regard to 
complement-independent phagocytic ability. 
There are a number of factors that influence the number of cells isolated, the adherence 
capacity, and the viability of the cells, many of which are difficult to control. These 
include the immune status of the individual at the time of venesection as well as the 
lipaemic state of the serum. Care must be taken to obtain age- and sex-matched 
donors for this purpose. 
The use of MDMs in vitro as representative of in vivo resident macrophages has 
advantages and disadvantages, such as the procurement of macrophages representative 
of the in vivo conditions, for example alveolar macrophages, the culture conditions 
required for these cells in vitro and the lifespan of the harvested cells in culture. 
Whatever their final merits, they do provide a useful reference or baseline for M tb. -
host cell interactions. Our main aim in using the macrophage system was to set up a 
reproducible, standard infection assay as a reference to evaluate subsequent studies 
involving the infection of CR3-expressing CHO cells withM tb. 
There are many unanswered questions regarding the role of CR3 in binding M tb. and 
its dependence on complement, as well as the ability of the human macrophage to kill 
M tb. Some of these questions are difficult to answer with studies based on in vitro 
infections of macrophages, including MD Ms, because of complications arising from the 
large number of cell surface receptors and functions of the macrophage. It was for this 
reason that we decided to construct a non-phagocytic cell line that expressed the 
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receptor of interest, CRJ . In this way we are able to study this receptor, in isolation 
from the other macrophage receptors and functions. 
CHAPTER FIVE 
CONSTRUCTION AND FUNCTION OF CR3-EXPRESSING 
CELLS 
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As explained in detail in Chapter 4 , Mth . binds to a number of different cell-surface 
receptors on mononuclear phagocytes. We have hypothesised that the binding to CRJ , 
in particular, confers specific advantages and facilitates the survival and growth of 
M th after invasion of mononuclear phagocytes. To enhance our understanding of the 
interaction between M th. and CR3, we decided to clone the receptor into a non-
phagocytic cell, thereby avoiding, inter alia, the possible interference of other 
macrophage receptors and the endogenous synthesis of complement components. The 
interaction with and manipulation of CR3 by pathogens, to exploit host cells, is not 
novel, suggesting that M th. may make use of a similar mode of entry. The following 
chapter provides a broad overview of the functions and structure of integrins and 
describes the subcloning and transfection procedure for human CR3 . 
5.1 INTEGRJNS: STRUCTURE AND FUNCTIONS 
5.1.1 Introduction: 
During invasion by pathogens, professional phagocytes, including macrophages and 
neutrophils, are activated to defend the host against invasion, progression of an 
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infection to disease, and dissemination. For this reason macrophages, the first line of 
defence in tissues, have evolved to display a number of cell surface receptors that will 
aid them to recognise and react to foreign bodies, usually leading to the engulfment 
and destruction of the pathogen in the immuno-competent host. But it is exactly these 
cell surface receptors that the facultative, intracellular pathogens utilise to manipulate 
the host cells to benefit their own ends. The most commonly manipulated cell surface 
receptors are the complement receptors CRl , CR3, and CR4, which interact with 
opsonised particles. Of these, the CR3 and CR4 belong to the highly conserved family 
of heterodimeric, glycoprotein cell adhesion molecules, otherwise known as Integrins, 
which are responsible for a number of cell-cell and cell-matrix interactions that 
determine the fate of most cells. The receptors were named integrins to describe their 
function of integrating the intracellular cytoskeleton with the extracellular matrix (Haas 
et al. , 1994). CRl , on the other hand, is also closely involved with opsonised 
phagocytosis, but is characteristically a single subunit glycoprotein with four allotypes 
that are known to interact mainly with complement component C3b, but also with C4b 
and C3bi, and induces phagocytosis in this manner in activated macrophages (Ross and 
Medof, 1985). 
5.1.2 Cellular Distribution of Integrins: 
Integrins are universally distributed throughout host tissues, with individual cells 
expressing a range of integrins in varying numbers and proportions. Most tissues 
express the Bl family of collagen adhesion receptor, namely a U3 l , a3 Bl and a6B 1, as 
well as the fibronection binding receptor, a5Bl , which is less well expressed. 
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Leukocytes of the immune system are, so far, the sole expressors of the B2 integrin 
family, aLB2, aMB2 and aXB2. These cells also express collagen receptor alBl and 
a2Bl , and the fibronectin receptor a5Bl , to aid in cell-matrix interactions. Most of the 
integrins do not function independently, but rather synergistically with other adhesion 
molecules, to achieve a complex integration of adhesion events (Albelda et al., 1992; 
Arnaout, 1990) (Table 5.1). 
5.1.3 Biosynthesis and Structure of Integrins: 
The a and f3 integrin subunits have separate precursors, which are independently 
synthesised and released from the Golgi, after which they associate in a non-covalent 
manner before reaching the cell surface; stable expression of each subunit depends on 
assembly into a heterodimer. The associated heterodimer now has an increased 
molecular mass and takes about 50-80 minutes to reach the cell surface. The a subunit 
usually dictates the glycosylation pattern of the f3 subunit, but this may be altered 
according to the cell type or ligand specificity required, thereby making integrins 
adaptable for a variety of adhesive interactions (Arnaout, 1990). 
Complete heterodimers are stored in their inactive forms in secondary and tertiary 
granules in granulocytes, and in intracellular vesicles and peroxidase-negative granules 
in monocytes. Once the cells are activated in response to a stimulus, defined 
intracellular events take place and integrin surface expression is upregulated within 
minutes by means of translocation of the intracellular granules and resultant fusion with 
the plasma membrane. This occurs in most cells except resident tissue macrophages, 
which contain no intracellular pools (Arnaout, 1990; Hynes, 1987; Hynes, 1992). 
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Table 5.1: The Integrin Receptor Family 
SUBUNITS ALTERNATE CELLULAR I DOMAIN 
NAMES DISTRIBUTION 





activated T & B 
cells 
a2~1 CD49b/CD29; Platelets; Yes 
VLA-2; gplaIIA; fibroblasts; 
ECMRII connective tissue; 
endothelial, 
epithelial, LAK and 
activated T cells 
a3~1 CD-/CD29; VLA- Epithelial and LAK No 
3; ECMRI cells; fibroblasts; 
connective tissue; 
monocytes 
a4~1 CD49d/CD29; Neural crest, B & T No 




a5~1 CD-/CD29; VLA- Fibroblasts; No 







and T cells 





aVPl CD51/CD29 Neural crest; No 
fibroblasts; 
connective tissue 
aLp2 CD1 la/CD18; B & T cells; Yes 
LFA-1 monocytes; 
granulocytes 
aMP2 CD1 lb/CD18; Monocytes; Yes 
MAC-1 ; CR3 granulocytes 
aXP2 CD1 lc/CD18; Monocytes; Yes 
plS0,95 granulocytes 
aIIbP3 CD41/CD61 ; Platelets; No 
gpllbffia endothelium 
aVP3 CD51/CD61 ; VNR Endothelium; No 
monocytes; 
activated B cells 
aRP3 PMN; monocytes No 
a6P4 CD49f/CD-; aEP4 Epithelial cells No 





ABBREVIATIONS: CD, cluster denomination; VLA, very late antigen; ECM, 
extracellular matrix; LAK, lymphokine-activated killer; FNR, fibronectin receptor; 
LF A, leukocyte functional antigen; VNR, vitronectin receptor; PMN, 
polymorphonuclear leukocyte. 
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Integrin a8 heterodimers consist oflarge globular N-terminal extracellular domains, 
which function as the ligand-binding domain; a short highly conserved transmembrane 
region; and a short cytoplasmic domain, which interacts with the cytoskeleton and 
intracellular signalling pathways (Corbi et al., 1988) (Figure 5. la). 
Each 8 subunit contains 56 cysteine residues distributed between 4 cysteine repeats in 
the extracellular stalk domain, with an internal disulphide bond that serves to efficiently 
expose the ligand-binding site contained in the 40-50 kDa N-terminus (Figure 5. la) . 
The a subunit in tum is made up of 7 homologous tandem repeats of ±60 residues, 
with repeats 5 to 7 each containing the nanopeptide providing the metal-binding region 
of the extracellular domain (Amaout, 1990). The disulphide bond in the stalk region 
of the extracellular domain provides stability and resistance to proteolytic cleavage, by 
introducing folding of the subunits. The cytoplasmic region is short and utilised for 
phosphorylation events, which link extracellular with intracellular events and vice 
versa, thereby establishing a communication system between the inside and outside of 
the cell (Figure 5. la) . 
Recent studies have indicated that the 82 subunit colocalises with talin in the 
cytoplasmic domain, suggesting either an indirect interaction, via the a -subunit and 
then the J3-subunit, or direct interaction, via the 8-subunit, with the cytoskeleton, 
enabling successful participation in phagocytosis (Amaout, 1990). 
In the 81 and 82 families of integrins an additional 200-amino acid fragment has been 
inserted between the last metal-binding region and the N-terminus of the a subunits. 
This domain is commonly known as the I or A domain, and has direct effects on the 
specificity and affinity of ligand-binding functions (Figure 5 .1 b ). Point mutations in 
this region result in an inability of the cells to adhere, diapedese and migrate in 
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Figure 5.la: Schematic structural features of integrins 
Abbreviations: S-S, disulphide bonds; Met, metal-binding region 
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Figure 5.lb: Novel and conserved domains of the f32-integrin family 
Abbreviations: TM, transmembrane domain; I, I or A domain 
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response to chemotactic factors released by pathogen-invaded cells, as demonstrated in 
the life-threatening Leukocyte Adhesion Deficiency (LAD) disease (Arnaout et al. , 
1991). 
Truncated subunits have been shown to be conformationally active in epitope-specific 
monoclonal antibody (MAb) binding studies, even without · cytoplasmic and 
transmembrane regions, implying that these regions are not required for constitutive 
activation. This may be true for certain epitopes, but does not reflect the entire 
spectrum of epitopes that could be involved in cell-ligand interactions. This would 
depend upon cell signalling events mediated via the cytoplasmic tail, to enable 
conformational changes and expose the required epitopes, as demonstrated by the 131 
and 133 subunits in association with their ligands (Hynes, 1992; Haas et al. , 1994). 
5.1.4 Functions of Integrins: 
To enable cells of various tissues to function effectively in response to stimuli, they 
need to be in constant contact with the extracellular matrix (ECM) and other cells. 
This in tum leads to activation of the cell and the upregulation of integrins to enable 
intercellular communication and ligand interactions. This function is not only 
important during embryogenesis, cellular growth and differentiation, malignant 
transformation, and hemostasis, but is also centrally involved in the host defence 
against pathogen infections and tissue destruction. During an immune response, 
integrins help by mediating chemotaxis, phagocytosis, and degranulation; the latter is 
accompanied by the release of proteolytic enzymes, superoxides and oxygen radicals, 
which disable the invading pathogen but also cause extensive tissue destruction. The 
87 
tissue destruction is limited to the area of inflammation by the immune cells adhering to 
the ECM via their integrins, thereby containing the area of destruction (O'Toole et al. , 
1994). 
Recent studies using various chimeras of integrins have indicated that the cell type in 
which a receptor is expressed has a distinct effect on the function and activation of the 
receptor, as does the cytoplasmic tail with its conserved tyrosine, threonine and serine 
residues that are phosphorylation dependent (Williams et al. , 1994; Pacifici et al. , 
1994), even though this region is 180 A away from the ligand binding site (O'Toole et 
al., 1994). 
5.1.5 Ligands of Integrins: 
Integrin ligands are protein, carbohydrate or lipid molecules that interact with defined 
epitopes on the integrin to evoke a specific response (Hynes, 1992). Individual 
integrins are capable of interacting with more than one type of ligand, but different 
integrins also interact with the same ligand by recognising separate motifs specific for 
various receptors. For example, fibronectin can be recognised by a 5131 and a 4131, 
but they interact with the RGD and ELDV motifs, respectively. The activation state 
and the type of receptor expressed, as well as the cell type in which it is expressed, will 
dictate the epitopes exposed during various forms of stimulation. In this way the cell 
can regulate the interaction between itself (via the integrin) and the ligand and alter the 
adhesive properties by selective expression. Similarly, the ligand must be in the correct 
conformation to optimise presentation of the recognition sequence (Haas et al. , 1994). 
A number of binding sites have already been identified and are steadily increasing, as 
more molecules are being explored. Known amino acid motifs of various ligands are 
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ABBREVIATIONS: Fn, fibronectin; VCAM, vascular cell adhesion molecule; 
ICAM, intercellular adhesion molecule; C3bi, preoteolytic fragment of complement 
component C3 ; Fx, factor X; LPS, lipopolysaccharide; FHA, filamentous 
haemagglutinin; ACAM, addressin cell adhesion molecule; RGD, Arg-Gly-Asp; 
KQAGDV, Lys-Gln-Ala-Gly-Asp-Val; DGEA, Asp-Gly-Glu-Ala; EILDV, Glu-Ile-
Leu-Asp-Val; GPRP, Gly-Pro-Arg-Pro. 
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well recognised and studied, as indicated in Table 5.2. These ligands tend to interact 
with related integrins, as demonstrated by the RGD-binding integrins, which are 
closely related and contain cleaved a. subunits and no I domain (Hynes, 1992). 
On further exploration of the I domain, it was noted that the ligands C3bi, fibronectin, 
ICAM-1 and factor X all bind to different epitopes of the I domain, but require the N-
terminal and the metal binding site to be in the correct conformation to bind efficiently 
(Diamond et al. , 1990). Any small deletions or substitutions in this highly conserved I-
domain region lead to the abolition of C3bi binding, making it essential for ligand 
binding. This is further complicated by the requirement for physiological levels of the 
divalent cations calcium, magnesium, and manganese, which suggests that activation of 
the epitopes is regulated by inside-out signalling from the cell, as this process is 
dependent on the influx of calcium and other divalent cations into the cell, to initiate 
intracellular signalling pathways for the stabilisation of the integrin conformation 
(Michishita et al. , 1993; Graham and Brown, 1991). 
Integrins part take in a number of other cellular functions, ranging from acting as co-
stimulatory receptors - which will activate cells to produce cytokines or initiate a 
respiratory burst, as demonstrated by neutrophils upon engagement of the I32 integrin 
(Ross et al. , 1985) - to contributing to abnormal cell differentiation and gene 
expression displayed in malignancies. The response of integrins to extracellular 
stimuli culminates in a cascade of intra- and inter-cellular communication events, 
mediated by changes in the intracellular milieu, in tum caused by the secretion of 
phospholipases, increases in intracellular calcium, and activation of protein kinase C 
(PKC). The extent to which these events affect the cellular behaviour will depend 
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upon the avidity of the initial ligand-integrin interaction and the ability of the cell to 
respond to the subsequent signals. 
The field of intra- and inter-cellular signalling via integrins is in its infancy, but already 
great headway has been made in this area. Crosslinking of integrins by ligands or 
MAbs activates protein tyrosine kinases which in tum allows clustering of the protein 
kinases in submembranous patches where they are available for activation or reaction 
with substrates. Such intracellular events are initiated, for example, by the 
extracellular binding of fibronectin to the fibronectin receptor, which initiates the 
signalling cascade and activation of the cytoplasmic tail, which in tum activates the 
receptor to enable various functions, such as the internalisation of bound particles by 
manipulation of the cytoskeleton. The reverse may also occur, where intracellular 
signalling activates the cytoplasmic tail in tum to activate the integrin, as seen with 
PMA stimulation. These two types of signalling are known as outside-in and inside-
out signalling and keep the cell in constant communication with the extracellular 
environment. 
This implies that a complex network of information is mediating through the cell at 
points of adhesion, and that the cell is constantly '~ware" of extracellular events 
(Hynes, 1992). 
5.1.6 Leukocyte Adhesion Molecules - CD11/CD18 Family: 
Among the leukocyte adhesion molecules (Leu-CAMs; CDI l/CD18 complex) the 
CDI lb and CDI le subunits are 63% identical, which is considerably higher than the 
homology between a. subunits in general (23%); this similarity between CDI lb and 
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CDllc extends to their functional homology as well. Genetically, the subunits are 
found on chromosomes 16pll-pl 1.2 and 21.q22 for the a and 13 subunits, 
respectively. This colocalisation of the a subunit with CD43 and protein kinase C on 
chromosome 16, and the 13 subunit with Down' s Syndrome on chromosome 21 , may 
explain the why there is an over-expression of the 13 subunit in Down's Syndrome 
patients and why interactions between the a subunit and PKC or CD43 are so common 
(Arnaout, 1990). 
As with other integrins, the CD11/CD18 complex seems to have originated early in 
evolution, as Candida a/bi cans has a primitive CD 18-like structure on its surface, 
which interacts with MAbs to the 13 subunit of integrins and rosettes with C3bi-coated 
red blood cells, suggesting a similar epitope structure to complement receptors (Van 
Strijp et al. , 1993; Arnaout, 1990; Hostetter, 1994). 
Ligands of the Leu-CAMs bind primarily to the I domain of the receptor and seem to 
interact in a cation-dependent fashion, which may serve to alter the integrin binding 
site conformationally, or to regulate activation of the receptor (Loftus et al. , 1994). 
C3bi, a 175k:Da, active fragment of complement component C3b, is the best-studied 
ligand and is often used as a marker for the activation state of the a Ml32 integrin. 
C3bi, although containing an RGD sequence, interacts with an epitope in the I 
domain, but is not blocked by the use of a synthetic RGD peptide, suggesting that 
there is greater involvement of the flanking regions, and that the RGD tripeptide, in 
this instance, is not of importance in this interaction (Van Strijp et al. , 1993). 
ICAM 2 and ICAM 1 (CD54), members of the IgG superfamily, and factor X and 
fibrinogen all interact with the CD 11/CD 18 complex, and their epitopes can be traced 
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to the I domain, which is thought to have originated due to exon shuffling and 
subsequent reorganisation of the integrin (Loftus et al. , 1994). The only known 
ligands to bind outside of the I domain in the CD 11/CD 18 complex are yeast, B-
glucan, and zymosan, but recent data question the validity of these findings (Ross et 
al. , 1985; Newman et al. , 1990; Szabo et al. , 1995). 
Results obtained from experiments using various ligands and cytoskeletal inhibitors 
suggest that there are two populations of CR3 on the cell membrane: one which is 
mobile and serves as a binding site only, and another that is immobile, but after 
interacting with its ligand will promote internalisation, due to its interaction with the 
cytoskeleton (Detmers et al. , 1994; Graham and Brown, 1989; Roubey et al. , 1991). 
5.1. 7 Integrin Participation During Inflammation: 
During bacterial invasion or tissue damage, cytokines are produced together with 
bacterial and cellular chemotactic factors that stimulate the expression of the adhesion 
molecules ICAM-1 , GMP140, ELAM-I , and VCAM-1 on the endothelium and a 
MJ32 on the leukocyte. In this manner the leukocyte can interact with the upregulated 
ligands on the endothelium of the blood vessel and migrate through it to the site of 
infection or tissue damage. The orchestration of all the adhesion molecules will direct 
the cellular event and contain the tissue destruction. Regulation of integrin activation 
is targeted to the cytoplasmic tail and its interactions with the signalling pathways of 
the cell. This is beautifully illustrated by the tight regulation of expression of the 132 
integrins on resting versus activated macrophages: not only are the number and activity 
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of receptors altered on the cell surface upon activation, but also the ratio between the 
various receptors, depending on the destination of the cell. 
Therefore, when a pathogen enters an irnmuno-competent host, the inflammatory 
response is usually able to contain and even eradicate the invading pathogen. Then -
how do intracellular pathogens, such as Mycobacterium tuberculosis, manage to 
establish such chronic, destructive diseases in many individuals? 
As described in detail in Chapter 4, macrophages display a host of surface receptors 
with which the invading pathogen may interact, but not all of these will be to the 
advantage of the pathogen, in general. CR3 may be the preferred receptor targeted by 
the pathogen, as unlike the FcR and CRl , CR3-induced phagocytosis does not evoke 
the toxic respiratory burst or activate the cell, allowing the pathogen a safe entry into 
an intracellular niche that is relatively free of hostile cellular defence mechanisms, 
within which to multiply and establish an infection (O'Toole et al. , 1994; Stokes, 1993; 
Isberg and van Nhieu, 1994). Our suggestion, therefore, is that CR3 may play a 
pivotal role in the fate of the M tb. during its initial entry into the host cell. For this 
reason it was decided to clone CR3 into a non-phagocytic cell line, to enable 
evaluation of the direct interaction of the CR3 with the pathogen of interest, virulent 
Mycobacterium tuberculosis, without the presence of other phagocytic receptors to 
complicate the interaction. 
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Figure 5.2a: p1tH3MCD11b and p1tH3MCD18 plasmid maps 
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p1tH3MCD1 lb and pnH3MCD18 were digested with Hind III and Xba I, and Hine II, 
Xba I and Dra I respectively and the digested DNA resolved on a 0.8% agarose gel, to 
provide digestion fragments of 4300bp and 3500bp for p1tH3M and CDllb 




5.2 CLONING AND TRANSFECTION OF INTEGRIN CR3 (CD11b/CD18; 
MAC-1; a.MJ32). 
5.2.1 Materials and Methods: 
Full-length human CDl lb and CD18 cDNAs, as well as truncated human CDl lb and 
CD 18, were obtained from Dr MA Amaout, Massachusetts General Hospital, Harvard 
Medical School, Boston (Amaout et al., 1991). These were provided as inserts 
subcloned into the Hindi/I and Dral sites of the 1tH3M vector (Little et al., 1983), 
and referred to as 1tCDllb and 1tCDl8, respectively (Figure 5.2a & b). The 7t vector 
contains (Figure 5.2a) a bacterial origin of replication, a selectable marker 5' to the 
inserted DNA fragment, and Simian Virus 40 (SV 40) splice sites and termination 
signals to enable expression in mammalian cells. Isolation of plasmid DNA is 
described in Addenda A.1 .1 and A.1 .2. 
To introduce the cDNAs into non-phagocytic CHO cells, a eukaryotic expression 
vector system was selected that would limit the number of synthesised receptors being 
expressed on the cell surface, as it was unknown at this stage if the transfected CHO 
cell could tolerate large numbers of receptors on its surface. The vector 1tH3M was 
not considered for direct transfection into CHO cells, as its transfection efficiency and 
copy number in CHO cells were unknown. 
For this reason the pJ40 vector was chosen, as it is a useful eukaryotic expression 
vector, often used in CHO cell transfections in our laboratory with good results, but 
with low to moderate expression levels. pJ40 is pBR322-based eukaryotic expression 








pBS-SKCDl lb and pBS-KSCD18 were digested with restriction enzymes Cla I and 
Xba I to release the inserted cDNAs and then resolved on a 0.8% agarose gel to 
provide a 2900bp and a 4100bp fragment for pBS-SK and CDllb respectively, and a 
2900bp and a 2700bp fragment for pBS-KS and CD18 respectively. 
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system (Figure 5.4a) containing the Moloney murine leukaemia virus promoter, a 
SV 40 splice site and termination signals, which was provided in the form of p.OACE, 
by M.R.W. Ehlers, Medical Biochemistry, UCT (Ehlers et al. , 1991). 
The restriction sites available on the multiple cloning cassette of both the cDNAs and 
the pJ4.0 were limited, making cloning complicated, and therefore to extend the 
restriction sites available, initial cloning into the high copy-number E. coli plasmid 
pBluescript II (pBS) was performed. pBS, a 2961-basepair (bp) phagemid supplied by 
Stratagene (Figure 5.3a), originating from pUC19, is provided in two forms, pBS-SK 
and pBS-KS, which refers to the orientation of the multiple cloning site in relation to 
the lacZ transcription gene. After the p.OCD 11 b and p.OCD 18 vectors had been 
constructed and CHO cells transfected, data became available from Dr T Springer' s 
laboratory in Boston, indicating the successful transfection of CHO cells with CD 11 b 
and CD 18 in a high-expression eukaryotic vector that was amplifiable, as described 
later. This dispelled our concerns that high surface expression levels may debilitate the 
cell and persuaded us to change our cloning strategy to incorporate the amplifiable 
expression vector pEE14. Although non-phagocytic CHO cells expressing CDI lb and 
CD 18 were available, we decided to continue our cloning strategy so as to provide us 
with clones expressing single subunits of either CD 11 b or CD 18, if possible, that could 
be used in later studies, for further insight into the function of CR3 . Similarly, the 
cloning of CDllb and CD18 cDNAs in which the transmembrane region had been 
excised to produce secreted CD 11 b and CD 18 was continued, in the hope that it may 
aid the isolation of the putative M tb. cell wall ligand that interacts with CR3 . 
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Figure 5.4a: Procedure for subcloning CDllb and CD18 cDNAs into pnACE 










pOCDl lb and p0CD18 were digested with restriction enzymes Cla I and Bgl II and 
resolved on a 0.8% agarose gel. Digestion fragments of 3900bp, and 2220bp, 1067bp 
and 800bp were released for pf! and CDllb respectively, and 3500bp and 2100bp for 
pO and CD18 respectively. 
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5.2.2 Cloning Strategies: 
5.2.2.1 Sub-Cloning of CDllb and CD18 cDNAs into pBluescript II: 
To isolate the full-length cDNAs of CDllb and CD18, 1tCDllb and 1tCDl8 were 
digested (experimental conditions are described in Addendum A.1.4.) with restriction 
enzymes Clal and Xbal, and HindIII and Dral, respectively (Figure 5.2b). Plasmids 
pBS-SK and pBS-KS were similarly digested with Clal and Xbal, and Hind!!! and 
Smal, respectively. Digested DNA was resolved on a 0.8% low-melting-point agarose 
(NuSieve) gel at 50 Volts and the appropriate bands excised and purified using a DNA 
extraction kit (Qiaex). Purified DNA was resuspended in 10 µl of Tris/EDTA buffer 
(TE) and an aliquot resolved on a 0.8% agarose gel to evaluate the quantity and 
quality of the retrieved DNA. 
The digested pBS-KS and pBS-SK were ligated to the respective CDllb and CD18 
cDNA inserts, at a ratio of 1:2, vector:insert (Addendum A.1.4.). The ligation 
mixtures were transformed into E. coli strain XL-1 Blue, rendered competent by the 
CaCl2 method (Addendum A.1.5 .), and plated for selection on lOOµg/rnl Ampicillin 
Luria agar (LA) plates (Addendum A.2.). Viable colonies were selected and grown up 
in liquid broth to enable small-scale isolation of plasmid DNA, which was then 
screened by restriction mapping for correct insertion of the cDNA, Figure 5.3a. 
Restriction enzymes Clal and Xbal were used to release the insert cDNA from both 
pBS-SKCDl lb and pBS-KSCD18. All bands were electrophoresed on 0.8% agarose 
to verify fragment sizes (Figure 5.3b). The identity of both constructs was confirmed 
by nucleotide sequencing with T3 and T7 primers (Addendum A.1.8.) . 
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5.2.2.2 Cloning of CDllb and CD18 into pJ4.Q: 
Using the constructs pBS-SKCDllb (with the CDllb cDNA cloned in 3' to 5' to 
provide the appropriate cloning sites), pBS-KSCD18, and pO-ACE, the cloning 
strategy outlined in Figure 5 .4a was followed. Essentially this involved releasing the 
cDNAs and cloning them into the Sall and Xhol sites of the pO-ACE vector, after 
removal of the ACE fragment, but preserving the essential features of the pJ40 
expression vector. 
To enable this, pBS-SKCDllb, pBS-KSCD18 and pO-ACE were linearized with 
restriction enzymes Xbal, Sac!, and Xhol, respectively, heated to inactivate the 
enzymes, and then blunt-ended with Kienow enzyme (Addendum A.1.5 .). After 
cleaning to remove all excess dNTPs and Kienow enzyme, the linearised plasmids were 
further digested with Sall to provide the second ligation site, releasing the CD 11 b and 
CD18 cDNAs inserts from pBS-SKCDl lb and pBS-KSCD18, respectively, and the 
ACE cDNA from pO-ACE. Samples were loaded onto 0.7% NuSieve gels and 
resolved at 50V. After gel extraction, the CDllb and CD18 cDNAs were ligated to 
pO, at a ratio of 1:4 vector:insert. XL-1 Blue competent cells were transformed as 
usual and selected on Ampicillin lOOµg/ml LA plates. Plasmid preparations of selected 
colonies grown in broth culture were digested with Clal and Bglll for both constructs, 
to release the appropriate fragments as indicated in Figure 5.4b. Plasmids representing 
the correct constructs were prepared in bulk (µg scale) by the Qiagen column 
purification method, as described in the manufacturer's protocol. 
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5.2.2.3 Transfections of CHO-Kl Cells with p0CD11b and p0CD18 Constructs: 
Large scale (µg scale) DNA pr~parations of the p.OCD 11 b and p.OCD 18 constructs, as 
well as the plasmid pSV2Neo, were obtained from 500ml broth cultures by the 
alkaline-lysis method (Addendum A.1.1), and the plasmid DNA purified by caesium 
chloride (CsCl) density centrifugation to obtain high quality DNA in good quantities 
(Addendum A.1 .3.). 
pSV2Neo was prepared for co-transfection with the relevant constructs, to allow 
selection by means of resistance to the toxic antibiotic G418 (a neomycin analogue). 
The pSV2Neo inserts randomly into the chromosome of the CHO-Kl cells, as do the 
expression vectors containing the cDNAs, thus conferring G4 l 8-resistance to the cell 
and enabling selection. This does not exclude the possibility that pSV2Neo integrates 
on its own, thereby conferring resistance to G4 l 8 without expression of the desired 
gene. 
All CsCl-prepared constructs were dialysed to remove contaminating caesium and salts 
and the quantity and quality of the DNA estimated by absorption at OD260 and 
OD280· In all cases, OD260/0D280 ratios exceeded 1.8, and DNA concentrations 
were estimated: 
SV2Neo = 5.25 µg/ml ; p.OCDl lb= 19.8 µg/ml ; and p.OCD18 = 39.8 µg/ml . 
A Chinese hamster ovary (CHO) fibroblast cell line (CHO-Kl ; ATCC CCI 61) was 
grown in complete media (Addendum A.2.) to 75% confluence in Nurre tissue culture 
flasks, after which the cells were lifted with trypsin/EDT A, washed, reseeded at 
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approximately 1 x 106 cells/lOOmm petri dish in complete media, and left overnight at 
37°C with 5% CO2. 
Three hours prior to transfection, the cells were washed and the media replaced. The 
cells were co-transfected with either pQCDllb and pSV2Neo, pQCD18 and 
pSV2Neo, or triple-transfected with pOCDllb, pQCD18 and pSV2Neo, using the 
calcium phosphate (CaP04) precipitate method, as described in detail in Addendum 
A.1.10. The precipitate was left on the cells for 4 hours at 37°C with 5% CO2, after 
which the cells were gycerol-shocked, to enhance DNA uptake, for two minutes at 
37°C with 5% CO2. The glycerol was removed by repeated washing, the cells refed 
with complete media, and grown at 3 7°C with 5% CO2 until confluent. At confluence, 
the cells were split into 48 well plates and allowed to adhere overnight in complete 
media at 37°C with 5% CO2. The following day the cells were washed and refed with 
complete media containing 0.4 mg/ml of G418 to initiate the selection of resistant 
clones. As colonies started appearing, they were lifted and seeded into small 25ml 
flasks to obtain clones. Resistant colonies were screened for expression of 
CDl lb/CD18 by Fluorescence Activated Cell Sorting (FACS). 
5.2.2.4 FACS Screening of CDllb- and CD IS-Expressing CHO Cell Clones: 
Fluorescein isothiocyanate (FITC)- or R. Phycoerythrin (PE)-conjugated MAbs to 
I 
either the CD 11 b or the CD 18 subunit were used, to determine cell surface expression 
of the respective subunits by dual-colour flow cytometry. Antibodies used were as 
follows. From Serotec were purchased mouse anti-human CD 11 b, FITC-conjugated 
MAb (clone 44), rat anti-human CD18, RPE-conjugated MAb (clone YFC118 .3), and 
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FITC-labelled mouse IgGl, as an isotypic control for the mouse anti-human CDllb; 
no isotypic control was available for the rat MAb. Second, from Dako were purchased 
mouse anti-human CDllb, RPE-conjugated MAb (clone 2LMP19c), mouse anti-
human CD18, FITC-conjugated MAb (clone MHM23), and dual-colour isotypic 
control mouse IgGl, FITC- and RPE-conjugated. Untransfected CHO-Kl cells 
(designated CHO-WT) and CHO-MAC-1 cells (see below) were used as negative and 
positive controls, respectively, in all experiments. 
Stably transfected cells and controls were grown to 75% confluence, lifted in 5mM 
EDTA/HBSS (without trypsin to preserve the receptor), and resuspended at ±2 x 106 
cells/100µ1 in 1: 100 dilution of MAb or isotypic control in PBS. Cells were incubated 
on ice for 15 minutes, after which 500 µl of lM paraformaldehyde was added to 
crosslink the receptors. Cells were kept at 4 °C for a maximum of 48 hours before 
screerung. 
Results from the first round of F ACS screening were disappointing, with very low 
levels of receptor expression; this was not improved after re-selection with G4 l 8. An 
attempt was then made to enrich for CD 11 b- and CD 18-expressing cells, by 
. . 
1mmunopanrung. 
This procedure was performed as follows. Plastic petri dishes (non-tissue culture 
treated) were coated with 50 µg/ml of Rabbit-anti mouse-lg (Dako) in PBS for 40 
minutes at room temperature, with continual swirling. CHO cells were grown in 
complete media, lifted with 5mM EDTA/HBSS, and washed to remove all traces of 
EDT A. The cells were incubated with anti-CD 11 b and anti-CD 18 MAbs, clones 
2LPM19c and MHM23, respectively (Dako), for 20 minutes at room temperature, 
shaking. During this time, the coated petri dishes were washed extensively with PBS 
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containing 1 % FCS (PBS-FCS), to block any non-specific binding. After washing the 
cells with PBS-FCS, to remove excess MAb, the cells were resuspended in 3ml of 
PBS-FCS and poured onto the coated plates and allowed to adhere for 20 minutes at 
room temperature, shaking gently. The non-adherent cells were decanted and the 
adherent cells washed five times with PBS-FCS. The adherent cells were trypsinised 
off the coated petri dish and re-plated and incubated in complete media at 37°C with 
5% CO2, to adhere (Diamond et al. , 1990). Each clone was grown to confluence in 
selective complete media and repanned to optimise selection. 
Cell surface receptor expression was re-evaluated for each clone, with F ACS, as 
discussed in the results. These results were disappointing and suggested that the 
expression of the transfected receptors, was transient. As discussed previously, the 
cloning strategy was diverted and the CDllb and CD18 cDNAs cloned into pEE14, 
for amplifiable expression. 
5.2.2.5 MAC-1 Springer Cells: 
While the construction of pO-CD 11 b and pO-CD 18 were in progress, Dr TA 
Springer, Centre for Blood Research, Harvard Medical School, Boston, reported the 
stable expression of CR3 in CHO cells, in a cell-line designated CHO-MAC-1 . 
Selection and stable expression in these cells was based on the dhfr rninigene in the 
pDCHIP plasmid, which was co-transfected with pCDM8 containing human, wild-type 
CDl lb or CD18 cDNA into CHO DG44 cells. CHO DG44 cells have the 
dihydrofolate reductase gene deleted. Transfected clones were selected in nucleoside-
and nucleotide-deficient media (Alpha-MEM with dialysed FCS), and amplified with 
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methotrexate (MTX), a dihydrofolate reductase inhibitor (Addendum A.2). CR3-
expressing cells were enriched by immunopanning and screened by F ACS (Diamond et 
al. , 1990; Current Protocols in Molecular Biology, 1991; Bebbington and Hentschel, 
1987). 
From these results it was evident that high levels of heterologous CR3 expression in 
CHO cells could be attained, which ruled out our initial concerns that led to our use of 
pJ40 as the vector of choice. While we continued with our own transfections, we 
acquired the CHO-MAC-1 cells from Dr Springer as positive controls for our 
experiments. 
5.2.2.6 Cloning of CDllb and CD18 into pEE14: 
Based on the success Springer reported with MTX-amplified expression of CR3 in 
CHO cells, we constructed additional expression plasmids for CD 11 b and CD 18, using 
the amplifiable pEE14 vector, which is based on the glutamine synthetase minigene. 
The pEE14 vector contains an hCMV-MIE promoter-enhancer, an SV40 late 
promoter, and the glutamine synthetase minigene as the selection/amplification marker 
(Bebbington and Hentschel, 1987) (Figure 5.5a). pEE14 was obtained from Celltech. 
The CDllb and CD18 cDNAs were subcloned into pEE14, to generate pEECDllb 
and pEECD18, respectively, as outlined in Figure 5.5. 
The nCD 11 b and 1tCD 18 vectors were digested with restriction enzymes Hind!!! and 
Xba!, and Xbal and Dra!, respectively; pEE14 was digested with Hind/II and Xbal, 
and Hind!!! and Smal for CDllb and CD18, respectively (Figure 5.Sa). Sspl and 
Hine!! were used as additional enzymes to cleave the 7t vector of 1tCD 18 into smaller 
llO 
Figure 5.5a: Procedure for cloning CDllb and CD18 cDNAs into pEE14 












pEECDl lb and pEECD18 were digested with Hind III and Xba I (pEECDl lb), and 
Xba I and Sal I (pEECD18) and resolved on a 0.8% agarose gel. Fragment sizes of 
9400bp and 4200bp were ressolved for pEE and CDllb respectively, and 9100bp and 
3200bp for pEE and CD18 respectively. 
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fragments, facilitating their electrophoretic separation from the CD 18 insert (Figure 
5.5b). The appropriate bands were excised and extracted from a 0.8% NuSieve gel 
and cleaned prior to ligation. The ligations were performed as described previously at 
a ratio of 1:2 vector:insert (Addendum A.1.4), and XL-1 Blue cells transformed 
( Addendum A 1. 6) and selected on Ampicillin 100 µg/ml. Colonies were screened by 
digesting small-scale plasmid preparation DNA with Hindi!! and Xbal (pEECDllb) 
and Xbal and Sall (pEECD18) to release the insert cDNAs (Figure 5.5b). 
Constructs identified as correct were grown up for large-scale preparations and 
purified by CsCl gradient centrifugation (Addendum A.1.3 .). The DNA was assessed 
by absorption at OD260 and OD280· Concentrations were found to be 1 µg/ml for 
pEECDl lb and 1.6 µg/ml for pEECD18. 
5.2.2.7 Transfection of CHO-Kl Cells with pEECDllb and pEECD18: 
Transfection conditions for pEECD 11 b and pEECD 18 were similar to those described 
for the pD. constructs. An important difference was the use of glutamine-deficient 
media (Addendum A.2.), which is required for the selection procedure. CHO cells 
were grown in the GMEM complete media to adapt the cells, before transfection with 
the pEE constructs. The cells were transfected as with the pD. constructs, but without 
the pSV2Neo vector. Following transfection and after the cells had reached 
confluence, Methionine sulphoximine (MSX) was added to the media. Selection was 
initiated at a concentration of 25 µM MSX in complete GMEM, and the surviving 
clones grown to confluence. Gene expression was amplified by increasing the MSX 
concentration to a final concentration of 300 µM MSX, in 50 µM steps. 
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5.2.2.8 Surface Expression of CDllb and CD18 in MSX-Resistant CHO Cell 
Clones: 
Cells were grown to confluence in complete GMEM media containing 100 µM MSX, 
and plated on 16mm glass coverslips at a density of 1 x 105 cells/coverslip. Surface 
expression of CD 11 b and CD 18 was then determined by one of two methods. 
Indirect immunofluorescence: This was used to assess the percentage of cells 
expressing CD11b/CD18. Cells grown on the coverslip were air dried and fixed in 
methanol for 1 minute at room temperature. The cells were blocked in 5% skim 
milk/Tris-Buffered Saline (S-TBS) for 30 minutes at room temperature, after which 
490 µl of fresh S-TBS containing 10 µl MAb, mouse anti-human CDllb or anti-CD18 
(1:50 dilution), was added and the cells incubated for 30 minutes at 4°C. The cells 
were washed and a 1 :50 dilution in S-TBS of FITC-conjugated anti-mouse lg was 
added for 30 minutes at 4°C. Cells were washed extensively in PBS to remove all 
unbound label, and the coverslips were inverted onto glass slides and fixed with nail 
polish before examination by fluorescence microscopy (Figure 5.6). 
Subsequently, we also used direct immunofluorescence. In this procedure, cells were 
grown overnight on 12mm glass coverslips as before and then washed well with PBS, 
to remove all media. The cells were incubated with 10 µl of either FITC-labelled 
mouse anti-human CD18 or RPE-labelled mouse anti-human CDllb (Dako) in 100 µl 
of 1 % BSA, for 1 hour at 4°C. The cells were then washed gently with PBS three 
times and once with 1 % BSA, and fixed with 1 % PF A. Coverslips were lifted and 
sealed as described above, before microscopy. 
Figure 5.6: lmmunofluorescent staining of pEECDllb- and pEECD18-
transfected CHO cells 
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Cells grown overnight on glass coverslips were incubated with either (A) FITC-
labelled CD18 or (B) RPE-labelled CDllb for 1 hour at 4°C, washed and fixed with 
PF A, before viewing with fluorescent microscopy. 
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Figure 5. 7: Surface expression of CD1lb/CD18 as determined by immunobead 
rosetting 
Cells grown on glass coverslips were incubated with CD 11 b/CD 18 MAb-treated beads 
for 30 minutes at room temperature, before viewing with light microscopy. (A) 
represents cells expressing both CDllb and CD18 and (B) represents the control 
CHO-WT cells which do not express CD1 lb or CD18. 
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Immunobead assay: This was used to obtain an additional semi-quantitative estimate 
of CD11b/CD18 surface expression on transfected cells. In this method, protein A-
agarose beads were coated with either mouse anti-human CDl lb or anti-human CD18 
MAb. Conjugation with protein A-agarose beads was achieved by incubation with 1 
part MAb and shaking for 1 hour at room temperature. The beads were washed with 
10 volumes of 0.2M sodium borate (Na2 B401), pH9.0, and pelleted at 3000 x g for 5 
minutes. The beads were resuspended in 10 volumes of 0.2M sodium borate , pH9.0, 
containing dimethylpimelimidate (DMPD) (Pierce) at a final concentration of 20 mM. 
After 3 0 minutes of shaking at room temperature, the reaction was stopped by washing 
the beads in 10 volumes of 0.2M glycine, pH 8.0, and incubating in the same buffer for 
2 hours at room temperature. The beads were finally washed with PBS and stored in 
10 ml PBS with 0.02% sodium azide at 4°C. Rosetting of the beads with cells 
expressing CD 11 b/CD 18 was determined after incubating cells grown on coverslips 
with the MAb-treated beads for 30 minutes at room temperature. The cells were 
scored by light microscopy, as indicated in Figure 5.7 ( Sigal et al. , 1994). 
5.2.2.9 Functional Activity of CR3 Expressed in Transf ected CHO Cells: 
One of the best characterised ligands for CR3 is complement component C3bi, which 
binds to the I domain of CD 11 b. The functional activity of the recombinant receptor 
was assessed by the binding of C3bi-coated microspheres. The latter were generated 
by first coating the microspheres with phenolic glycolipid (PGL-1) of M leprae, which 
when incubated with fresh serum activate the classical complement pathway, leading to 
the deposition of C3bi on the surface of the microspheres (Schlesinger and Horwitz, 
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1991). lµM-diameter polystyrene microspheres were washed in a 0.05M carbonate-
bicarbonate buffer, pH 9.6, (CB-buffer), and then incubated with 100 µg of PGL-1 (a 
kind gift from Patrick Brennan, Colorado State University, Fort Collins, Colorado) in 
CB-buffer for 2 hours at 37°C, shaking. Control microspheres were incubated with 
CB-buffer alone. Both sets of beads were washed with PBS and blocked by incubating 
in PBS containing 5% bovine serum albumin (BSA), for 2 hours at 37°C, shaking. 
Beads were washed again and incubated in PBS containing 0.5% BSA and reincubated 
for 30 minutes at 37°C shaking in 500 µl 2.5% fresh human serum. The microspheres 
were thoroughly washed and resuspended in 500 µl 0.5% BSA PBS (Schlesinger and 
Horwitz, 1991). 
To confirm that serum opsonization of PGL-1-coated microspheres results in the 
fixation of C3 on the particle surface, we incubated opsonized particles with FITC-
conjugated anti-human C3c antibody and analysed the immunofluorescence by flow 
cytometry (Figure 5.8a). Opsonized PGL-l_coated microspheres were 95 .6% positive 
for staining with anti-C3c-FITC compared to 4.9% of unopsonized PGL-1-coated 
rnicrospheres (Figure 5.8b). 
Both sets of beads were incubated with the CR3-expressing cells and CHO-WT cells, 
grown on glass coverslips, for 24 hours in serum-free DMEM/F12 (incubation media), 
at 37°C, with 5% CO2. Cells were washed repeatedly to remove the non-adherent 
microspheres, cross-linked with 2.5% glutaraldehyde for 1 hour at 4°C, and then 
briefly counter stained with Trypan blue, for contrast. The cells were examined under 
light microscopy using a 1 OOx objective, and the results were quantitated by estimating 
the percentage of cells that bound one or more microspheres, as well as the number of 
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microspheres bound per cell. Approximately 100-200 cells were counted per coverslip 
(Figure 5.9). 
5.2.2.10 Transient Transfections of pJ4n and pEE14 Clones: 
Because of initial difficulties in obtaining stably transfected cells, we also established 
transient transfections of CDI lb and CD18 in CHO cells. The transient transfections 
were based on the plasmids already described, namely pnCD 11 b, pnCD 18, 
pEECDl lb, and pEECD18. The transfection methods were identical to those used for 
stable transfections, but selection with either G4 l 8 or MSX was omitted. Instead, the 
cells were used within 72 hours of transfection. Receptor expression in these clones 
was verified by means of indirect or direct immuno-fluorescence before use in in vitro 
assays. 
5.3 CLONING AND TRANSFECTION RESULTS: 
5.3.1 Expression of CR3: 
5.3.1.1 FACS Results ofpJ4.QClones: 
FACS was used to identify the number of transfected CHO cells expressing CDllb, 
CD 18, or both CD 11 b and CD 18, on their cell surface. The pn-transfected CHO cells 
were incubated with either FITC-labelled anti-CD I lb MAb or RPE-labelled anti-CD18 










Microspheres were coated with PGL-1 and opsonized with fresh human serum. To 
confirm the opsonization, beads were incubated with FITC-conjugated anti-human C3c 
antibody and analysed by flow cytometry (A). Similarly, beads coated only with PGL-
1 were used as controls (B). 
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Figure 5.9: Binding of C3bi-coated microspheres to CD11b/CD18-expressing 
CHO cells 
• 
Cells grown overnight on glass coverslips were incubated with (A) microsphere coated 
with PGL-1 and fresh serum or (B) with microspheres only incubated in fresh serum to 
indicate the functional activity of the CR3 expressed in CHO cells, with regard to 
binding of CR3 ligand C3bi. 
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MAb for the single transfected cells, and dual labelling with both MAbs for the co-
transfected CHO cells. CHO-WT and CHO-MAC-1 cells were used as negative and 
positive controls, respectively. 
Three weeks after selecting the pO transfected clones for resistance to G4 l 8, the cells 
were lifted off the tissue culture dishes and incubated with. the above fluorescent-
labelled MAbs and screened with FACS. Dead cells were gated out using forward and 
side light scatter parameters. Of the 2000-6000 cells screened in this manner for each 
transfection, only 4-18% of the CDllb-transfected CHO cells, 44-55% of the CD18-
transfected CHO cells, and 2-31 % of the dually transfected CHO cells were positive, 
as compared to the negative control CHO-WT cells and the relevant isotypic controls 
(Table 5.3). Due to the low number of cells expressing the various transfected 
receptors, immunopanning was used to attempt to enrich the cell population for those 
expressing the required receptor only. 
Once the immunopanned cells had increased in number, they were rescreened by 
F ACS, to assess whether enhancement of receptor expression had been achieved. 
These results indicated two cell populations of differing cell size in each of the 
transfected cell lines, suggesting a mixed cell population, but both populati~ns of cells 
evidenced enhanced receptor expression. As indicated in Table 5.4a, CD llb 
expression was enhanced to 18% and 87%, CD18 expression to 7.2% and 18%, and 
CDllb/CD18 dual expression to 54% and 64%, for each of the subpopulations, as 
compared to the positive control, CHO-MAC-I cells, and negative control, CHO-WT 
cells (Figure 5.10). 
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Table 5.3: FACS Analysis of pQCDllb/CD18-Transfected CHO Cells 
SUBUNIT CLONE % 
NUMBER EXPRESSION 















Cells were grown to 75% confluence, lifted in 5 mM EDTA/HBSS and resuspended at 
±2 x 106 cells/100µ1 in 1: 100 dilution of MAb. Cells were incubated on ice for 15 
minutes, after which 500µ1 of lM paraformaldehyde was added to each sample. 
Samples were kept at 4°C until screening. 
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Due to the relatively good enrichment of receptor expression by immunopanning, a 
second round of panning was performed to purify the cell population further. At this 
stage the transfected cells were 9 weeks post transfection. The repanned cells were 
prepared for F ACS as before. Both populations of cell were again visible in each of 
the transfected cell clones. The expression of these repanned cells had decreased 
substantially to 1.5% and 2.2% for the CDI lb transfectants, 1.9% and 1.9% for the 
CD18 cells, and 5.0% and 3.8% for the dual transfectants, for each subpopulation. 
These results were not much above background expression as indicated in Table 5.4b, 
suggesting transient expression of the transfected receptors. Subsequent cloning was 
pursued with the pEE14 vector, as described. 
5.3.1.2 Immunofluorescence: 
Using a combination of anti-CD I lb and anti-CD18 MAbs, CHO cells transfected with 
both pEECDllb and pEECD18, either transiently (CHO-CR3T) or stably (CHO-
CR3S), and CHO-MAC-I cells expressed fluorescence. Approximately 60% of the 
cells were moderately fluorescent, with 10% of the cells fluorescing brightly. In 
comparison, the CHO-WT cells fluoresced only weakly or not at all (Figure 5.6). 
When using direct immunofluorescence, 65% of all the cells were fluorescent, with 
relatively similar amounts of CD 11 b and CD 18 fluorescing. 
5.3.1.3 Cell-Bead Immunoassay: 
Protein A beads coated with a MAb to CDllb (2LPM19c) rosetted with 92% of 
CHO-MAC-1 cells, 97% of CHO-CR3S, and only 12% of CHO-WT cells. Similar 
results were obtained with beads coated with an anti-CD18 MAb (MHM23), in that 
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Table 5.4a: FACS Analysis of pQCDllb/CD18 Clones after First 
Immuno-panning 
SUBUNIT CLONE % EXPRESSION % EXPRESSION 
NUMBER POPULATION 1 POPULATION 2 
CDllb 15 18 87 
CD18 31 7 18 
CDl lb/CD18 8 50 64 
8b 30 77 
CHO-WT 4 
(FITC) 




Table 5.4b: FACS Analysis of pQCDllb/CD18 Clones after Second 
Immuno-panning 
SUBUNIT CLONE % EXPRESSION % EXPRESSION 
NUMBER POPULATION 1 POPULATION 2 
CDllb 15 1.5 2.2 
CD18 31 1.9 1 .9 
CD1 lb/CD18 8 5.0 3.8 
CHO-MAC-1 53 93 
(Dual) 
CHO-WT (Dual) 2.2 1.9 
(FITC) 2.2 4.4 
(PE) 1.7 1.4 
0.2 % 
.·· 8.9 % 
. ········· . . ····· ············ :::: .:.:::::·· .... ······· .. .... ... .. . .. .. . . · .. . ······ 
Figure 5.10: FACS results of CHO-MAC-1 cells 
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CD18 
Cells were labelled with both FITC-conjugated mouse anti-human CD 18 and RPE-
conjugated mouse anti-human CD 11 b, or with similarly conjugated irrelevant mouse 
IgGl as the isotypic (negative) control. 
2.5 % 
. : . .. 
1 
1.5 % I 
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Table 5.5: Cell-immunobead Results 
CELL TYPES MAbs 
CDllb CD18 
(2LPM19c) (MHM23) 
CHO-CR3S 97% 94% 
CHO-MAC-1 92% 90% 
CHO-WT 12% 10% 
Protein A beads coated with a MAb to either CD 11 b or CD 18 were incubated with 
cells expressing CD11b/CD18 for 30 minutes at room temperature. The cells were 
scored by light microscopy as to the number of cells associated with the beads. 
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90%, 94%, and 10% rosetting was observed with CHO-MAC-1, CHO-CR3S, and 
CHO-WT, respectively (Table 5.5). These results indicate that the CHO cells 
transfected with pEECD 11 b and pEECD 18 express CD 11 b and CD 18 at levels 
comparable to the well documented CHO-MAC-1 cell line (Diamond et al., 1993). 
5.3.2 Functional Binding Activity of CRJ: 
Functional activity of the recombinant CR3 expressed in CHO cells was assessed by 
the ability of transfected cells to bind C3bi, a well characterised ligand of CR3 . For 
ligand binding to occur, the a. and B subunits must associate as conformationally active 
heterodimers, with exposure of the epitopes required for ligand binding (Arnaout, 
1990). The cells transfected with the pEE constructs were compared to CHO-WT 
(negative control) and CHO-MAC-1 (positive control) cells. An additional negative 
control consisted of untreated microspheres that have no C3bi bound to their surface. 
C3bi-coated polystyrene microspheres and control microspheres were incubated with 
the cells and the percentage of cells associated with beads determined. Association of 
microspheres was observed in 53% of the CHO-MAC-1 cells, 76% of the CHO-CR3S 
and in 12% of the CHO-WT cells (Table 5.6). With the. use of the control 
microspheres, 12% ofCHO-MAC-1, 18% of CHO-CR3S and 15% of CHO-WT were 
associated with microspheres. These results indicate that at least a proportion of 
surface-expressed CD 11 b and CD 18 subunits have associated to form active CR3 
heterodimers that bind the ligand C3bi. 
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Table 5.6: C3bi-coated Microsphere Assay Results 
CELL TYPES C3bi-COATED CONTROL 
MICRO SPHERES MICROSPHERES 
CHO-CR3S 76% 18% 
CHO-MAC-1 53% 12% 
CHO-WT 12% 15% 
The functional activity of CR3 expressed in transfected CHO cells was assessed by 
incubating CD1 lb/CD18 expressing cells with microspheres coated with PGL-1, which 
when incubated with fresh serum activates the classical complement pathway, leading 
to the deposition of C3bi on the surface of the microsphere. Microspheres incubated 
in serum alone were used as a control. 
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5.4 DISCUSSION 
The subcloning of the CDllb and CD18 cDNAs and their transfection into CHO cells 
presented a number of specific problems and difficulties. During the subcloning 
procedure, the use of intermediate cloning steps, as with the general cloning vector 
pBS, allowed us to plan the most convenient cloning strategy for the vectors of our 
choice, and also allowed us to sequence the cloned product and ensure that the cDNA 
was in the correct frame for expression. This also proved useful for mapping, as not 
much was known about the internal restriction sites in the two cDNAs, and we 
therefore had the opportunity to test various restriction enzyme digest combinations, 
thereby providing a more detailed restriction digest map of the two subunits for further 
cloning steps. 
The results obtained by F ACS analysis of the pD.CD 11 b and pD.CD 18 clones were 
confusing and disappointing. They seem to suggest that the CHO cells had only been 
transiently transfected, resulting in the initial expression of the receptor, but upon 
subsequent selection expression was lost. This may have been due to reorganisation of 
the chromosomes resulting in cells containing the SV2Neo gene only, which confers 
survival in G418-containing media. Although our knowledge is limited about the 
mechanism(s) of insertion of transfected DNA into the cell chromosome, it can be 
speculated that although the cDNAs were integrated initially, they were not essential 
for the survival of the cells and may have placed too great a physiological stress on the 
cell, resulting in the splicing out of the CR3 cDNAs during cell division. Another 
explanation for the transient expression may be the lack of a stringent cloning 
technique, which resulted in a pooled population of selected cells at the initial level of 
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selection. These cells may have contained predominantly the SV2Neo minigene, 
because of overgrowth of these cells with respect to the CDl lb- and CD18-transfected 
cells, which may require a longer culture period for adequate gene expression and cell 
division. 
This would explain the initial results, but not the two subpopulations of cells seen for 
each clone after immunopanning. We have no clear understanding of this, but it has 
been suggested that cells struggling to survive in adverse conditions may become large 
and flat in appearance, thus giving rise to the larger cell population (Bebbington et al., 
1987) .. 
During the lifting of the cells, an EDT A solution was used to chelate the metals 
essential for CAM function. This may also have affected the MAb-receptor 
interaction, leading to poor F ACS results, as a functional heterodimer is required for 
correct epitope exposure. All of these interpretations are speculations, however, as we 
do not have sufficient data to reach a firm conclusion. Therefore, since the level of 
expression of CD 11 b/CD 18 with the pf! vector was insufficient for our requirements 
we turned to the pEE system for subsequent transfections. This was prompted in part 
by the report on high-level stable expression of CR3 in CHO cells using a 
methotrexate-amplifiable system (Diamond et al. , 1993). Indeed, we have acquired 
these cells, CHO-MAC-I cells, as a positive control for our experiments. 
Nevertheless, because of our interest in generating CHO cell lines expressing mutant 
CR3 receptors - for example, secreted CR3 with truncated transmembrane domains, 
CR3 with the cytoplasmic domains deleted, or single-subunit expression - we have 
persisted with our efforts to generate stable lines of CHO cells expressing CR3 . 
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Using the pEECDllb and pEECD18 expression vectors we have demonstrated that 
functionally active CR3 is expressed on the cell surface of non-phagocytic CHO cells 
transfected with these constructs. As judged by indirect and direct 
immunofluorescence and an immunobead assay, the levels of surface expression of 
both subunits, CD 11 b and CD 18, are comparable to those expressed by the CHO-
MAC-1 cells (from Springer' s laboratory). (Figure 5.6). Moreover, we have 
established that the pEECDl lb/pEECD18-transfected cells (designated CHO-CR3 
cells to distinguish them from the Springer CHO-MAC-1 cells) express functionally 
active CR3 at the cell surface, as determined by binding of C3bi-coated microspheres 
(Table 5.6). Consequently, both the CHO-MAC-1 cells and the CHO-CR3 cells 
generated here were used in the in vitro infection studies described in Chapter Six. 
In addition to transiently transfected CHO-CR3 cells, attempts were made to establish 
true stable CHO-CR3 cell lines. These were generated in glutamine-deficient medium 
containing 25µM methionine sulfoximine (MSX). Following this, a small number of 
MSX-resistant colonies (approximately 8) survived, which were isolated, grown up, 
and two chosen for further selection. These were exposed to progressively higher 
doses of MSX (up to 200µM), over a period of 4-8 weeks. One of the clones resistant 
to 200µM MSX was chosen for further work, designated CHO-CR3 S cells, and these 
cells were analysed for CD 11 b/CD 18 expression and function as described. 
However, at some time during the 4-month period after transfection, the CHO-CR3 S 
cells lost the expression of CDllb. This was first noticed by RT-PCR with primers 
specific for the CD 11 b I domain, with which no specific PCR product was detected in 
the CHO-CR3 S cells, whereas this message was clearly detected in the CHO-MAC-1 
cells. Moreover, no PCR product could be amplified with the same primers from 
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genomic DNA from the CHO-CR3S cells, unlike the CHO-MAC-1 cells, which were 
positive. These results were confirmed by immunofluorescence, which failed to detect 
the CD 11 b subunit on the cell surface. However, use of CD 18-specific primers 
revealed, by RT-PCR, that expression of CD18 was retained by the CHO-CR3S, and 
this subunit could be detected on the cell surface by immunofluorescence. (This work 
was performed in the laboratory by N. Godiner and is reported here as a personal 
communication.) Retention of the CD 18 gene explains how these cells could remain 
resistant to high levels of MSX (which requires high expression of glutamine 
synthetase, as provided on the pEE vector). 
These results indicate that, although the CHO-CR3 S cells are stable transfectants, they 
express only the CD 18 subunit, and that at some point the CD 11 b was lost. It is 
curious that CD 18 can be expressed on the cell surface in the absence of CD 11 b, 
which is contrary to what was reported in human kidney 293 cells, in which only the 
CD 11 b subunit was able to reach the cell surface in the absence of its partner (Berman 
et al. , 1993). We intend to determine by immunoprecipitation whether the CD18 is 
present on the surface as an isolated subunit, or more likely, whether it has dimerised 
with endogenous CHO cell a subunits such as as. (This work falls outside the scope 
of this thesis and will be reported elsewhere.) In the infection studies presented in 
Chapter six, we have used the CHO-MAC-1 cells as well as the CHO-CR3T and the 
CHO-CR3 S cells; most of these studies were performed within 4-8 weeks of 
generating the CHO-CR3 S cells and we know that during this time CD 11 b/CD 18 
expression was maintained. 
To overcome the problems with the CHO-CR3S cells, the following modifications to 
the transfection protocol can be suggested. First, the pEECD 11 b and pEECD 18 
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vectors should be cotransfected together with pSV2Neo, which confers neomycm 
resistance. This is based on unpublished observations (T. Dower and E . Sturrock, 
personal communications) indicating that initial selection with neomycin analogue 
G4 l 8 followed later by selection and amplification with MSX greatly improves the 
yields of transfectants. Second, mindful of the apparent instability of the CD 11 b gene, 
we should carefully monitor and select for CD 11 b-expressing transfectants. This can 
be done by enriching the fraction of CD 11 b-expressing cells by immunopanning with 
the MiniMacs magnetic bead system, using the anti-CDllb MAb OKM-1. Enriched 
fractions should be checked by immunofluorescence and flow cytometry for both 
CD 11 b and CD 18 expression. Promising lines should then be cloned by limiting 
dilution in an attempt to select out a stable clone expressing high levels of the 
CD 11 b/CD 18 heterodimer. 
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CHAPTER SIX 
EUKARYOTIC CELL INFECTIONS 
6.1 INTRODUCTION: 
Invasion of host cells may lead to the protection or destruction of the pathogen, 
depending on the route of entry and type of cell invaded. There are two broad types of 
invasive bacteria, firstly those that are obligate intracellular pathogens, such as M 
leprae, which are dependent on the intracellular environment for survival, and secondly 
the facultative intracellular pathogens, such as M tb and Yersinia spp., which prefer the 
intracellular environment, but can survive on non-living extracellular material. Bacteria 
must orchestrate their pathway of entry carefully, to minimise the host's defence 
mechanisms and to provide a niche for optimal survival and growth. Many 
intracellular pathogens target the monocyte-macrophage cells as their initial host cells, 
to aid in their dissemination via the lympho-hematogenous route. The initial evasion of 
host defences enables the bacteria to establish adequate infections or colonisation 
before the activation of the host's specific cell-mediated immune response, after which 
bacteria may be killed or restrained in the immune-competent host. 
To enter cells bacteria need to adhere to the cell membrane, and then gain access to the 
cell's interior, either within membrane-bound vacuoles or free within the cytoplasm. 
The extent of their success is determined by the nature of the receptor that is targeted 
by bacteria, the strength with which the bacteria can bind to the receptor, the number 
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of receptors the bacteria can bind to and whether or not the bacteria can orchestrate 
the activation of the receptor, to induce internalisation. When examining integrin-
mediated entry of bacteria into host cells, the a subunit of integrin heterodimers 
usually dictates the ligand specificity, whereas manipulation of the B subunit enables 
direct interaction with the cell cytoskeleton and intracellular signalling pathways 
(Isberg et al. , 1994). Often the engagement of one integrin may allow upregulation of 
a second integrin which in tum mediates internalisation, as seen in fibronectin (Fn) 
binding and the subsequent activation of CR3 (Hazenbos et al. , 1993). 
The association between the bacterium and the host cell may be advantageous for the 
bacterium, but also induces a number of functional changes in both the eukaryotic cell 
and the bacterium. The ability to adhere to the cell membrane enables the bacterium to 
avoid physical removal associated with coughing and sneezing. Bacteria have 
established a number of infection mechanisms that are adhesion molecule-dependent, 
of which the three best described strategies, are lectin binding, masking, and mimicry 
(Tuomanen, 1993). Lectin binding involves the adherence of bacteria to a 
carbohydrate moiety of a cell surface glycoprotein, as seen with pathogenic strains of 
E. coli. Masking entails the adsorption of serum proteins, such as complement 
component C3bi, onto the surface of the bacteria, which in tum forms a bridge to 
interact with the I domain of the integrin CR3, as demonstrated by Legionella spp. and 
M leprae . Mimicry involves the existence of a bacterial cell surface moiety that 
mimics a natural integrin ligand, and therefore engages a host cell integrin directly. B. 
pertussis uses this strategy to mimic factor X's interaction with integrin CR3, by 
producing filamentous haemagglutinin (FHA) that shares sequence homology with this 
natural ligand (Zierler and Galan, 1995). 
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One of the host's most potent defence mechanisms is the ability of phagocytic cells to 
recognise and phagocytose foreign particles. The expression of the Fe receptor (FcR) 
complex aids in the recognition of antibody-coated particles, as well as providing the 
required link between the phagocytic effector cell and the B lymphocyte's ability to 
secrete lg for opsonisation of particles. The FcRI and FcRII are structurally integrated 
with the cell's cytoskeleton and are therefore involved in phagocytosis. The FcRIII in 
contrast, is devoid of a transmembrane and cytoplasmic domain and linked to the 
membrane only by inositol phosphatidyl groups, suggesting that it cannot be involved 
in transmembrane signalling and cytoskeletal manipulation events. Recent studies have 
demonstrated that co-operation between receptors is an increasingly recognised 
phenomenon, as an activating mechanism, and to aid recognition and phagocytosis. 
Such complementary functions are demonstrated by the binding and internalisation of 
IgG-coated erythrocytes by non-phagocytic cells expressing FcRIII and CR3 . Cells 
expressing CR3 only are unable to bind or phagocytose these particles, whereas cells 
expressing FcRIII only bind IgG-coated erythrocytes but cannot internalise them 
(Mosser, 1994; Krause et al., 1994). 
Manipulation of host defences is particularly well illustrated by respiratory pathogens, 
which exploit protective barriers to their own advantage. In many instances these 
pathogens target CR3 on macrophages, (the highest expressors of CR3), but often 
these cells must first be recruited to the site of infection. A complex array of cytokines 
and chemotactic signals is dispatched by both the inflamed endothelium and the 
bacteria, which induce the circulating monocytes to migrate to the site of pathology. 
After first upregulating P-selectin and later E-selectin on the damaged endothelium of 
the blood vessels and lung tissue, leukocyte integrin 13 subunits are activated, and 
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tethering, diapedesis and migration are enhanced (Tuomanen, 1993; Cooper et al., 
1994). An additional component of the activation of integrins by chemotaxis are 
conformational changes with resultant structural exposure of new binding epitopes that 
may be advantageous to the bacteria at the site of infection (Cooper et al., 1994). 
6.1.1 Mechanisms of Invasion: 
Successful invasion strategies are best illustrated by a description of the interactions of 
well-studied intracellular pathogens with their respective host cells. 
6.1.1.1 Opsonic Binding to Complement Receptors: 
The first set of organisms to be discussed are those that utilise complement component 
C3bi as an opsonin that is fixed to their cell surface, by either the classical pathway or 
the alternative complement cascade (masking). Leishmania spp., Legionella spp., 
Rhodoccocus equi and Mycobacterium leprae are well known for their ability to enter 
phagocytes via the CR3-C3bi route. R. equi, a Gram-positive respiratory pathogen 
that is fast becoming a major cause of granulomatous, cavitating pneumonia in AIDS 
patients, binds to and invades alveolar macrophages (ALM0) in a strictly serum-
dependent manner. These bacteria are able to fix complement on their surfaces by 
means of activation of the alternative complement pathway, and then induce rapid 
phagocytosis by engaging both the CRl and CR3 (Hondalus et al. , 1993). Legionella 
pneumophilia, an obligate intracellular pathogen, uses a similar strategy, initiated by its 
major outer membrane proteins (MOPS), to activate the alternate complement 
139 
pathway and enhance CRl- and CR3-C3bi interactions. It has recently been suggested 
that these bacteria are also able to interact with the CR3 in a complement-independent 
manner, by binding to the lectin binding site on CR3 (Bellinger-Kawahara and 
Horwitz, 1990; Yamamoto et al., 1994). 
Leishmania major also activates the alternate complement pathway, in this case by the 
presence of a lipophosphoglycan (LPG) outer layer, associated with the metacyclic 
growth stage, and the gp63, a metalloproteinase, of the promastigote, which both 
allow interaction with CR3 and CRl . Unlike L. major, L. mexicana does not appear 
to require complement to interact with CR3, indicating different evolutionary strategies 
used by closely related species of the same pathogen (Titus et al. , 1994). 
Similarly, Mycobacterium leprae contains a cell wall component, phenolic glycolipid-1 
(PGL-1), that actively binds complement component C3 , and activates its breakdown 
via the alternative complement pathway, to display C3bi on its surface. This, as with 
R. equi, Leishmania spp. and Legionella pneumophila, enables direct interaction of the 
fixed C3 bi with the I domain of the a subunit of CR3 . In common with many of the 
pathogens that use this invasion route, a small percentage (10%) of M leprae bind to 
macrophages in the absence of complement, suggesting that an alternative route of 
entry is also possible. To favour M leprae 's interaction with CR3, the normal down 
regulation of CR3 by IFN-gamma is inhibited by M leprae, so as to enhance the 
interaction with the host cell during inflammation, suggesting a further manipulation by 
invading pathogens of inherent host mechanisms (Schlesinger et al. , 1991b). 
An accessory mechanism to C3bi binding is the deposition of fibronectin (Fn) on the 
surfaces of bacteria, by means of Fn-binding proteins. This in tum allows binding to 
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the a.5I31 (VLA-5) integrin and consequent activation of CR3, via signal transduction 
pathways, enabling enhanced interaction between CR3 and the pathogen. This is an 
interesting demonstration of the communication that exists between cell surface 
receptors (Isberg, 1991 ; Hazenbos et al., 1993). 
6.1.1.2 Nonopsonic Binding to Complement Receptor Type 3: 
Bordetella pertussis and Histoplasma capsulatum have also evolved mechanisms for 
binding to CR3 in a complement-independent manner. However, the epitopes used by 
these pathogens seem to be distinct from the C3bi-binding site on the I domain of the a 
subunit, but these nevertheless stimulate the internalisation mechanisms Bordetella 
pertussis is a classic host-specific and tissue-specific pathogen that has evolved to 
maximise its ability to adhere to lung cilia and penetrate specific host macrophages to 
establish a non-invasive lung infection. To mediate this highly specific interaction, B. 
pertussis produces two secreted proteins, FHA and pertussis toxin which interact in 
distinct ways to allow progression of disease. Absence of these two proteins inhibits 
the bacterium from binding to the host cells and enables the host to clear the bacteria 
from the bronchial passages by mechanical means, such as coughing. 
Pertussis toxin is a 105 kDa ADP-ribosylating toxin that consists of a number of 
subunits, which together disable the host cell by increasing intracellular cAMP. In 
addition, a 921-Da tracheal cytotoxin released from the peptidoglycan of the bacteria 
causes destruction of the cilia, which frequently accompanies the disease process. 
Toxicity is not only of bacterial origin, but is also related to the ability of the bacteria 
to induce IL-1 and nitric oxide production by the host epithelial cells. Subunits S2 and 
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S3 of the pertussis toxin, which interact with host cell glycoproteins and glycolipids, 
target ciliated epithelial cells and human macrophages, respectively. These subunits 
have a high sequence similarity to mammalian C-type lectins, which may explain their 
specificity for these cell types. The pertussis toxin also acts synergistically with FHA, 
by upregulating the expression of CR3 on the macrophages by means of the selectin-
like component of pertussis toxin which is similar to the effect of P-selectin on 
inflamed endothelium thereby enhancing the number of receptors available for 
interaction with FHA. 
FHA is a 220-kDa secreted protein that consists of several epitopes to enhance 
bacterial-cell interactions. These include an N-terminal heparin binding domain that 
interacts with sulphated polysaccharides and heamagglutinin, an N-terminal lectin 
domain that binds to sialic acids and heamagglutinin, a second lectin domain that aids 
adherence to cilia, and an RGD domain that contains two regions that mimic binding 
sites for factor X, a known ligand for CR3 . These FHA epitopes allow the bacteria to 
invade host macrophages without evoking a respiratory burst (by binding to CR3)and 
provide them with an adequate intracellular niche to promote bacterial growth, without 
causing tissue destruction. If the bacteria are unable to invade the host cells they 
remain adherent to the cilia carbohydrate moieties and continue to cause extracellular 
damage ( Tuomanen, 1993; Cundell and Tuomanen, 1995; Cooper et al. , 1994; 
Reiman et al., 1990; Newman et al. , 1990). Recent data have suggested that B. 
pertussis also binds additional integrins on the host cell, such as a5Bl , by means ofFn, 
thereby utilising the cell's intracellular signalling pathway to upregulate the preferred 
receptor CR3, again manipulating the cell ' s normal functions for optimum targeting 
(Hazenbos et al. , 1993). 
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Histoplasma capsulatum (He), a well known respiratory pathogen, also enters host 
ALM0 in a complement-independent manner, so as to establish an intracellular 
infection before the host cellular immune response is initiated. He, long thought to 
bind to similar receptor epitopes as zymosan, has in fact been shown to adhere to the 
B2 subunit of leukocyte integrins in a temperature- and cation-dependent manner, 
which is distinct from the zymosan-dependent binding site of most other yeast species 
(Bullock et al. , 1987). Extensive experiments indicate that unlike C3bi-opsonised 
bacteria that bind to the I domain and induce internalisation via polymerisation of the 
microtubules, the He cell surface moiety uses different cell signal pathways to interact 
with the actin microfilaments of the host cell cytoskeleton, which suggests that there 
are two independent methods of cytoskeletal manipulation by engagement of different 
CR3 epitopes. The method of internalisation utilised by the He may result in the 
limited intracellular survival of the organism, as engagement of the B2 subunit does not 
protect the pathogen from a respiratory burst in immune-activated macrophages (Ross 
et al. , 1985; Newman et al. , 1990). This has been confirmed by incubation of He with 
B2 subunit-deficient LAD leukocytes, which are unable to internalise the organism 
(Ross et al. , 1985; Graham and Brown, 1991). 
6.1.1.3 Nonopsonic Invasion of Nonphagocytic Cells: 
In contrast to opsonin-dependant binding to integrin receptors, certain of the Yersinia 
spp have evolved to express. invasin, a 103 kDa cell-surface protein that binds directly 
to members of the Bl integrin family expressed on epithelial cells. To induce 
phagocytosis in non-phagocytic cells, bacteria must compete with natural ligands for 
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adherence, and Yersinia' s invasin interacts with a higher binding affinity for the I3 l 
integrin than fibronectin, the natural ligand, thereby favouring adhesion and subsequent 
internalisation. This binding allows effective manipulation of the host cytoskeleton, by 
inducing alterations in signal transduction pathways to allow internalisation. 
Many non-phagocytic cell surfaces have defence mechanisms to prevent bacterial 
colonisation and penetration, such as ciliation, peristalsis and continual flushing, which 
mechanically decrease the physical interaction between pathogens and host cells. To 
overcome these non-specific defences and to ensure rapid colonisation of the host 
epithelium, Yersinia expresses high levels of invasin on initial infection to allow fast 
and effective adhesion and penetration. Subsequently, a second protein, produced by 
the ail gene, is expressed, induced by the increased temperature within the host, 
suggesting a specific involvement in cellular interactions. Moreover to prevent 
phagocytosis of the bacteria by circulating macrophages, Yersinia produce a third class 
of protein called Yaps, which prevent internalisation by entering the host cell and 
paralysing the cytoskeleton (Isberg, 1991; Young et al. , 1992; Isberg and Van Nhieu, 
1994; Zierler and Galan, 1995; Bliska et al. , 1993). 
Salmonella typhimurium, another intestinal pathogen that invades non-phagocytic cells 
to establish an infection, exploits host signal transduction pathways to induce uptake. 
These bacteria adhere to intestinal microvilli and induce membrane ruffling at the point 
of adhesion, followed by internalisation. This appears to involve a complex series of 
events, which include depolarisation and disruption of tight junctions, intracellular 
calcium fluxes, activation of inositol triphosphate secretion, enhanced epidermal 
growth factor receptor expression, mitogen-activated protein kinase and leukotriene 
D4 activation, and induction of cytoskeletal rearrangement. Once the bacterium has 
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invaded the cell, the cytoskeletal disturbances cease and the cell returns to normal 
functions (Zeirler and Galan, 1995; Finlay and Seiber, 1995; Galan, 1994). 
Although the mechanisms are different, the common aim of all these intracellular 
pathogens is to invade the host cell successfully and to optimise conditions for 
replication. The manipulation and subversion of normal host cell functions by the 
pathogen are striking and appear to have evolved at a faster rate than the host defence 
mechanisms. For respiratory pathogens, the leukocyte adhesion protein CR3 seems to 
be the most manipulated, providing the safest route of entry and the establishment of 
disease. 
Many studies have been designed to identify pathways of entry, but a key variable that 
is often overlooked, and which seems to be important in determining the true relevance 
of the host-pathogen interaction, is the cell type studied. As revealed by more recent 
studies, neutrophils, monocytes, and macrophages have different functions and abilities 
to recognise and respond to ligands. The same ligand may not adhere at all to 
neutrophils, weakly to monocytes, but strongly to macrophages, even though it targets 
the same receptor. This may be a function of receptor expression or conformation, i.e. 
epitope exposure, as dictated by host cell signalling pathways to control ligand 
specificity. This would be a plausible regulatory mechanism, as these integrins are not 
designed primarily for pathogen recognition, but mainly for host cell-cell and cell-
substratum interactions. It would be disastrous if various receptors were upregulated 
on different cell types all the time and with the same ligand specificity. It is thus 
remarkable how pathogens have evolved to use these differing specificity' s to their 
own advantage (Hondalus et al. , 1993; Zhou et al. , 1994; Hazenbos et al. , 1993; 
Bullock et al. , 1987; Krauss et al. , 1994; Newman et al. , 1990). 
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Numerous studies have investigated the interaction of live, virulent Mtb. with 
macrophages, but the importance and characteristics of binding to CRJ are still not 
clearly delineated. It is well known that M tb. uses CRJ to invade host cells, but what 
the relative importance is of this receptor versus other macrophage receptors and 
whether the binding is predominantly opsonic or nonopsonic remains unclear. It is 
difficult to study these questions in macrophages, because these cells present a 
complex array of cell-surface receptors and are also able to synthesise endogenously 
various opsonins, including complement components, as described in Chapter 4. We 
have therefore decided to use CRJ-expressing CHO cells as macrophage surrogates in 
order to answer two questions a) can Mtb. use CRJ alone as a receptor for adherence 
and invasion, and b) is complement essential for this interaction ? 
We hope that these experiments can provide some new insights into the mechanisms 
that M tb. uses to establish infection and disease. 
6.2 MATERIALS AND METHODS: 
6.2.1 Bacteria: 
Mycobacterium tuberculosis (M.tb.) strain H37Rv (ATCC 27294) was grown as in 
Kirchner ' s broth and stock suspensions frozen at -20°C in 0.5 ml aliquots, described in 
Chapter 3. 
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6.2.1.1 Quantitation of bacteria: 
Bacteria were quantitated as described previously and resuspended to provide an 
inoculum of approximately 12 x 108 organisms/ml. 
Bacteria were diluted and quantitated via optical density at 550 nm with reference to a 
standard curve calibrated by enumeration of serially diluted bacteria stained by ZN. 
Prior to infection, the bacteria were defrosted at room temperature vortexed, and then 
syringed to resuspend the bacteria. These bacterial suspensions contained single 
bacteria and small clumps of two to five organisms, as seen on ZN staining. 
6.2.2 Mammalian Cells: 
6.2.2.1 Monocyte derived Macrophages: 
Human monocyte derived macrophages (MDMs), were obtained, from human 
peripheral blood mononuclear cells (PBMC) as described in Chapter 3, and grown in 
RPMI-1640 with 5% autologus, fresh serum and 1: 10 "cytokine-containing" 
supernatant. Cells were cultured at 37°C, 5% CO2 for a minimum of 5 days, before 
being classified as macrophages. 
6.2.2.2 Transfected CHO cell lines: 
CHO-WT, CHO-CR3T and -CR3S, and CHO-MAC-1 were cultured as described in 
Chapter 5. Cells were cultured in tissue culture flasks in complete media as 
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appropriate for the specific cell line (Addendum A.2.), grown to 60% confluence, and 
then seeded for infection studies. 
6.2.2.3 Seeding of cells: 
All cells were washed with PBS after removal of culture media, treated with ice cold 
SmM EDTA/HBSS, and incubated at 37°C, 5% CO2 for 5 minutes, to enable lifting of 
the cells from the culture dish without proteolysis of the adhesion receptors. The lifted 
cells were washed off the tissue culture flask with PBS, resuspended in 10 ml PBS, and 
transferred to 10-ml sterile plastic centrifuge tubes. The cells were pelleted at 2000 
rpm for 3 minutes and washed in PBS to remove all traces of EDT A. The cell pellet 
was resuspended in 1 ml of PBS and prepared for counting as described in Addendum 
A.1.14. Cells were quantitated by a Coulter counter or heamocytometer, and 
resuspended at approximately 1 x 106 cells/ml. 
Cells were seeded at 1 x 105 cells/coverslip onto 12-mm glass coverslips in 24 well 
tissue culture plates, refed with 1 ml of complete media, and incubated at 3 7°C, 5% 
CO2 to allow adherence. Cells were left for 4 hours, to adhere. Each cell line was 
seeded in duplicate or triplicate per parameter per experiment. 
6.2.2.4 Media Conditions: 
To establish the role of complement in promoting adherence and internalisation, the 
cells were incubated in 50% DMEM/Fl2 alone or supplemented with 10% heat-
inactivated (HI) FCS, 10% fresh FCS, or 10% fresh human. serum. No antibiotics or 
selection agents were present in these media. Cells were washed in PBS 1 hour prior 
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to infection, to remove any debris, and then maintained in the appropriate media at 
37°C, 5% CO2. 
6.2.2.5 Monoclonal Antibodies (MAbs): 
MAbs added in an attempt to block binding of bacteria to CRJ , were used either as 
hybridoma supernatants or purified from ascites fluid. Anti-CD 11 b antibodies 
included: LM2/1.6.11 , a mouse IgGl anti-human MAb from ATCC, was used as the 
hybridoma supernatant; 2LPM19c, a mouse IgGl anti-human MAb from Dako, and 
YFCl 18.3, a rat IgG2b anti-human MAb from Serotec, were purified from ascites 
fluid . The anti-CD 18 MAbs were all mouse IgG 1 anti-human MAbs: TS 1/18.1.2.11 
from ATCC was used as the hybridoma supernatant, whereas MHM23 and Clone 44, 
from Dako and Serotec, respectively, were purified from ascites fluid ( McMichael, 
1987). 
6.2.3 Infections: 
The cells, incubated in their appropriate media, were infected with between 5 and 50 µl 
of bacterial Kirchner' s suspension, depending upon the bacterial concentration, to 
achieve infection ratios of 50: 1 and 500: 1, bacteria to cells, for the MDMs and CHO 
cell, respectively. The tissue culture plates were swirled briefly to distribute the 
bacteria, and incubated at 37°C, 5% CO2 for 24 hours or less depending upon the 
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experiment. All work with live, virulent strains of M tb. was performed in a modified 
P2 facility as described in Chapter 3. 
6.2.3.1 Antibody Inhibition: 
Wells containing cells seeded onto glass coverslips were washed after 4 hours 
incubation to remove the serum-containing media and 25-30 µg/ml of each MAb was 
added per well and incubated for 30 minutes at 37°C, 5% CO2, after which the 
appropriate culture media were added and the cells infected at a 500: 1 bacterial/cell 
ratio with H37Rv, as described above. To pre-coat the coverslips, 25-30 µg/ml of the 
MAb was added to each coverslip and incubated for 3 hours at 4°C. The coverslips 
were washed with PBS containing 1 % BSA and again with PBS only, before allowing 
the cells to adhere (Rozdzinski and Tuomanen, 1994; Newman et al. , 1990). When 
hybridoma supematants were used, no attempt was made to determine the 
concentration of the MAb. Supematants were used at 250 µl per ml of culture media 
in all experiments. Cells were incubated with the bacteria for 24 hours, stained and 
fixed, and the percentage of cells associated with bacteria determined as described 
below. 
6.2.4 Fixing and Staining of Infected Cells: 
The cell cultures were removed from the incubators and washed at least three time 
with room temperature PBS, to remove any non-adherent bacteria and dead cells. The 
cells were fixed in 2.5% glutaraldehyde (GA), and kept at 4°C for 60 minutes before 
staining for microscopy. 
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Cells were washed again with room temperature PBS to remove the GA and flooded 
with 1.4 mg/10 ml acridine orange for 1 minute at room temperature, and then washed 
with PBS to remove excess acridine orange. To quench the extracellular fluorescent 
bacteria, 5 mg/10 ml of crystal violet was added to the coverslip for 30 seconds at 
room temperature, and then removed with PBS. Coverslips were inverted onto glass 
microscope slides and adhered with clear nail varnish. The slides were kept at 4 °C in 
the dark for less than one hour before examination under fluorescence microscopy. 
6.2.4.1 Quantitation of Associated Bacteria: 
One hundred to two hundred cells were examined at random per coverslip to 
quantitate the association of fluorescent bacteria with the cells. The results were 
expressed as the percentage of cells associated with bacteria. Slides were analysed 
with a Zeiss Axiovert fluorescence microscope fitted with a 1 OOx acromat planar lens. 
6.2.5 Electron Microscopy: 
To determine qualitatively whether the bacteria were intracellular, rather than 
extracellular, both CHO-WT and transfected CHO cell lines were examined by 
transmission electron microscopy (TEM). The cells were infected as described, 
incubated for 24 hours, then lifted in 5 mM EDTNHBSS and fixed in a cacodylate 
buffer containing 0.1 M sucrose, 5 mM Ca2+, 5 mM Mg2+ and 2.5% GA, at 4°C 
overnight. The cells were then washed twice with the cacodylate buffer and the cell 
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Table 6.1: Mycobacterium tuberculosis Binds to CR3-expressing 
CHO cells in the Presence and Absence of Serum 
SERUM % CELLS THAT BOUND M th. 
CHO-WT CHO-CR3S CHO-MAC-1 
Fetal Bovine Serum 
Fresh 14 ±3 77 ± 5 80 ± 9 
None 17 ± 6 79 ± 6 79 ±4 
Human Serum 
Fresh 15 ±2 81 ± 6 57 ± 6 
Heat-inactivated 16 ± 3 79 ±3 58 ± 5 
None 19 + 5 82 ± 8 69 ± 7 
CHO-WT, CHO-CR3S, and CHO-MAC-1 cells were incubated with M tb. (300:1), 
washed, stained, and the number of cells that associated with one or more bacteria 
counted and expressed as a percentage. Values are means ± SD derived from 5 
(bovine serum) and 5 (human serum) separate experiments, where n = 3-9 per cell line 
per experimment. 
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pellet was stained with 1 % osmium tetroxide in a sucrose-free cacodylate buffer for 1 
hour before embedding in resin. Sections were examined on a Hitachi H600 TEM. 
6.3 RESULTS: 
6.3.1 Binding of Mtb. to CR3-Expressing CHO Cells: 
Tranfected and untransfected CHO cells were infected with M tb as described. Each 
coverslip was examined under fluorescence microscopy to determine the percentage of 
cells associated with the bacteria. No attempt was made to distinguish between 
intracellular and extracellular bacteria. The infections were performed in various media 
conditions as discussed, i.e .. supplemented with fresh serum, heat-inactivated serum, or 
no serum. 
The MDM cells were infected in much the same way, but at a far lower infection rate, 
because of the greater phagocytic ability of these cells. At ratios higher than 50: 1 
bacteria to MDM, bacteria filled the cell to capacity, which often resulted in cell lysis. 
The infections were performed in media conditions comparable to those used with the 
transfected cells. The infection ratios for MDMs are comparable to reports in the 
current literature. In contrast to infection ratios of 50: 1 for the MDMs, ratios up to 
500: 1 were used with the CHO cells, which we found was necessary to achieve useful 
results with this non-phagocytic, fibroblast cell line. 
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Figure 6.1: Infection of CHO-CR3 cells and CHO-WT with Mtb. 
(A) CHO-CR3 infected cells indicate large numbers of acridine orange stained M tb. 
associated with the cells, in comparison to the few bacteria seen in (B) CHO-WT 
infected cells, suggesting the dependence of CR3 for bacterial-cell association. 
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The two most striking results of the binding of M tb. to CHO cells were, (a) binding 
of M tb. to CR3-expressing CHO cells was consistently 5-fold greater than to wild-
type CHO cells; and (b) the binding of M tb. to CR3-expressing CHO cells was 
essentially identical in the presence of fresh serum, heat-inactivated serum, or no serum 
(Table 6. land Figure 6.1). Overall, in 7 separate experiments, the percentage of CR3-
expressing CHO cells that bound M tb. was 67 ± 13% in the presence or absence of 
serum, versus 14 ± 3% of wild-type CHO cells. Specifically, in the presence of 10% 
fresh FCS, bacteria associated with 77 ± 5% (1.25 ± 0.21 bacteria/cell) of CHO-CR3T, 
80 ± 9% (1.95 ± 0.77 bacteria/cell) of CHO-MAC-1, and only 14 ± 3% (0.18 ± 0.05 
bacteria/cells) of CHO-WT cells. Similar results were obtained in infection studies 
with no serum present: 79 ± 6% (1.59 ± 0.35 bacteria/cell) of CHO-CR3T, 79 ± 4% 
(1.87 ± 0.50 bacteria/cell) of CHO-MAC-1 cells, and 17 ± 6% (0.18 ± 0.07 
bacteria/cell) of CHO-WT were associated with bacteria in these assays, suggesting 
that serum opsonins are not required for the interaction of Mtb. with CR3 expressed in 
CHO cells (Table 6.1). 
A second set of infections performed in the presence of human serum gave similar 
results. In the case of fresh human serum, HI human serum and no serum, 
respectively, 56 ± 5% (1.04 ± 0.15 bacteria/cell), 58 ± 4% (0.95 ± 0.21 bacteria/cell), 
and 66 ± 4% (1.60 ± 0.32 bacteria/cell) of CHO-MAC-1 were associated with 
bacteria, and under the same conditions, 15 ± 2% (0.20 ± 0.05 bacteria/cell), 16 ± 3% 
0.15 ± 0.08 bacteria/cell), and 17 ± 4% (0.25 ± 0.09 bacteria/cell), respectively, of 




















































































































































































































































































































































































































































































































































identified between fresh and HI serum, suggesting that no additional opsonins present 
in either serum, were able to enhance the bacteria assocciation to the cells. 
6.3.2 MAb Inhibition of Association: 
The specificity of the binding of M tb. to CR3 in the transfected CHO cells was 
confirmed by the use ofMAbs to human CR3 . Pre-treatment oftransfected CHO cells 
with a combination of anti-CDl lb and anti-CD18 MAbs, or adherence of the cells 
onto MAb-coated coverslips, reduced the binding of M tb. to the CR3-expressing 
CHO cells by an average of 68%, but had no effect on the binding of M tb. to the 
CHO-WT cells (Table 6.2). Pre-treatment with anti-CD18 MAb MHM23 alone 
reduced binding by 37%. Of the anti-CDl lb MAbs, pre-treatment with MAb 
2LPM19c alone resulted in no inhibition of binding, whereas MAb LM2/l .6.11 
inhibited binding by 59% (Table 6.2). MAb 2LPM19c binds to an epitope that 
includes the C3bi-binding site (Diamond et al. , 1993), suggesting that M tb. does not 
bind to the C3bi-binding site in the absence of complement, but rather to an epitope 
distinct from the C3bi site. Results were similar whether the cells were preincubated 
with MAbs or seeded onto MAb-coated coverslips. 
6.3.3 Electron Microscopy : 
Infected CHO-MAC-1 cells contained numerous intracellular bacteria, either singly or 
in small clumps, that reside in large, membrane-bound vacuoles (Figure 6.2), an 
appearance that resembles that seen in infected mononuclear phagocytes. In contrast, 
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Figure 6.2: Electron micrograph of CHO-MAC-1 cells infected with M. tb. 
CR3 expressing CHO cell containing single bacteria in well-defined phagosomes with 
seemingly tight opposing phagosome membranes, similar to those seen in MDMs 
infected withM th. 
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the CHO-WT cells contain few intracellular organisms, although the vacuole seems 
similar as to that seen in the CHO-MAC-1 cells. From these micrographs it is evident 
that a proportion oftheM tb. bound to CHO-MAC-1 cells is internalised and resides 
in a vacuolar compartment that is presumably equivalent to a phagosome. 
6.4 DISCUSSION: 
In recent years, the literature has been studded with descriptions of mechanisms used 
by pathogens to gain entry into mammalian cells. As discussed, this provides the 
pathogens with the opportunity to invade host cells and establish an infection. The 
exploitation of host cell surface integrins, seems to occur either by direct interaction 
with the a or f3 subunit of the receptor, or by prior opsonisation with a natural ligand 
for the receptor. The initial specificity of binding by the pathogen will dictate the 
subsequent host response and cellular events, resulting either in effective disposal of 
the pathogen or in successful invasion of the host cell. 
Predominant binding to the a subunit epitopes, seems to provide the pathogen an easy 
and safe passage into the cell, without the involvement of host defence mechanisms 
such as a toxic respiratory burst that usually accompanies internalisation of opsonised 
foreign particles. Bacteria that bind only to the C3bi epitope or the lectin-binding site 
on CR3 fail to initiate this toxic response. Presumably adequate adherence to these 
sites will involve signalling to the f3 subunit, which is in direct contact with the host cell 
cytoskeleton, and allow internalisation. In contrast to this mode of entry, pathogens 
that interact directly with the f3 subunit, such as He, are not as effective in evading host 
defence mechanisms, as a respiratory burst does accompany this interaction, but the 
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defence mechanisms, as a respiratory burst does accompany this interaction, but the 
pathogens are nevertheless able to survive in this toxic environment and establish 
infection (Bullock and Wright, 1987). Stimulation of the respiratory burst in this 
instance may not be solely the result of binding to the ~ subunit of CR3, but instead 
may reflect binding to additional cell surface receptors, such as LFA-1 and CR4, or 
could possibly be communication between CR3 and the FcRIII, which has been 
described previously to result in the respiratory burst, even though binding to either 
receptor alone does not elicit this response (Newman et al. , 1990; Bullock and Wright, 
1987; Zhou et al. , 1994; Zhou et al. , 1993; O'Toole et al. , 1994). 
The affinity with which the pathogen interacts with the host receptor and the number 
of receptors engaged may dictate the type of phagocytosis involved and, in fact, 
whether the pathogen is able to invade at all or merely remain attached to the host cell 
surface. As described previously, Yersinia 's invasin protein binds with a higher affinity 
to ~ 1 integrins than the natural ligands, which induces the host cell receptor to interact 
with the bacterial ligand, thereby encasing the bacterium in a pseudopod sleeve. This 
interaction was first described by Griffin and Silverstein (1974), as "zippering" 
phagocytosis. Although this may be so for most opsonised particles that interact with 
complement receptors or the FcR, other pathogens, such as Salmonella, have evolved 
to interact directly with the host cytoskeleton by infl1i1encing signal transduction 
pathways and triggering cytoskeletal rearrangement, by which they are engulfed. 
Aptly, this mode of entry is referred to as "triggering" phagocytosis (Swanson and 
Baer, 1995). Both these mechanisms result in internalisation of pathogens, but it has 
been suggested that "zipper" phagocytosis may in general be more destructive for the 
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pathogen, providing an excellent rationale for Yersinia 's ail gene, which protects the 
bacteria after entry (Isberg and van Nhieu, 1994). 
Use of various complement receptors by intracellular pathogens has been known for 
many years, but the molecular details of this mode of entry are only now being 
elucidated, as described by studies on Histoplasma capsulatum, Legionella spp. and 
Yersinia spp. In contrast to other CRs, CR3 has been identified as a privileged 
receptor, in that it allows pathogens to gain entry in to the cell without evoking the 
respiratory burst, thus giving the bacteria a better chance of establishing an infection 
(Hynes, 1992; Isberg and van Nhieu, 1994). 
The study of pathogen interactions with integrin heterodimers has led to the discovery 
of many novel proteins and mechanisms in both the pathogen and the host, but the 
mode of binding of M th. to CR3 has not yet been clearly defined, other than that this 
may depend on complement coating of the bacteria. Binding to CR3 frequently 
depends on deposition of a host protein on the bacterial surface, thereby indirectly 
providing a ligand that binds to the receptor. Unlike the active C3bi-masking of M 
leprae, Legionella and Leishmania, no surface or secreted moiety has been identified 
in M th. that can activate the alternate complement pathway to deposit C3bi on the 
bacterial surface. This suggests that M th. is opsonised non-specifically like most 
foreign particles, rather than an active process initiated by the pathogen. More 
recently, bacteria have been identified that interact directly with CR3. These bacteria 
express proteins, such as the FHA of B. pertussis, on their surface that bind directly to 
exposed receptor epitopes, leading to tight binding of the bacteria to CR3 , with 
subsequent manipulation of the receptor. In some cases of non-opsonic binding to 
CR3, such as by He, 13-glucan and zymosan, the ligands bind to epitopes distinct from 
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the I domain, which seem to involve the f3 subunit, as significant inhibition of binding 
and entry occur after treatment with f3-specific MAbs. These complement-independent 
ligand-receptor interactions appear to be independent of microtubule polymerisation, 
but instead are dependent upon actin microfilament involvement (Bullock and Wright, 
1987; Zhou et al., 1994; Newman et al. , 1990). 
We decided to examine the documented phenomenon that M tb. can enter 
mononuclear phagocytes in the absence of complement at up to 30% of the efficiency 
achieved in the presence of opsonins (Schlesinger et al. , 1991a; Schelsinger et al. , 
1990b). Between 10 and 30% of this non-opsonic binding may be to CR3 . The 
hypothesis that CR3 may be the receptor that is partly responsible for non-opsonic 
binding to M tb . is plausible, as mononuclear phagocytes are high expressors of CR3, 
which is activated by their migration to the site of pathology, or could possibly be 
induced by the presence of antigens secreted by the bacilli to upregulate the expression 
and migration of phagocytes, in much the same manner as pertussis toxin affects these 
processes (Tuomanen, 1993; Cundell and Tuomanen, 1995). Moreover, a number of 
unrelated pathogens have been shown to bind non-opsonically to CR3, including B. 
pertussis and H. capsulatum (Lee and Falkow, 1990). 
The experiments described in this chapter indicate that M th. can bind to CR3 in a 
complement-independent manner, and that this binding leads to invasion of mammalian 
cells. Not only was the bacterial association 5-fold greater with CHO cells expressing 
CR3, but in this system the ability to associate was unaltered by the absence of 
exogenous complement, suggesting that in these in vitro conditions the bacteria can 
interact directly with a receptor epitope. 
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To confirm that the binding of M tb. to the transfected cells is indeed mediated by the 
recombinant CRJ, it is important to specifically inhibit binding of M tb. to CRJ-
expressing CHO cells. Preincubation with MAbs raised to various epitopes of the 
receptor provided us with useful information, not only about the receptor and its 
binding sites, but also about the ligand and its interaction with the receptor (Wright et 
al., 1983; Diamond et al., 1993). Based on the reduction in binding observed with 
MAbs, our initial observation is reinforced, that M tb. can bind to CRJ-expressing 
CHO cells in the absence of complement, and that this binding is to the recombinant 
CRJ, as it is specifically inhibited by peincubation of the cells with anti-CD 11 b and/ or 
anti-CD 18 MAbs. Our results indicate further that the epitope is distinct from the 
C3bi-binding site and therefore is not in direct competition with complement-mediated 
binding, as similarly described in resident murine macrophages (Stokes et al., 1993). 
This is inferred from the use of MAb 2LPM19c, which binds to the C3bi-binding 
epitope and which failed to inhibit the binding of M tb. to CRJ-expressing CHO cells. 
These data suggest that the bacteria are able to bind directly to the activated CR3 , by 
means of a surface component expressed by M tb. 
The significance of complement-independent binding of M tb. to macrophage-
expressed CRJ in vivo remains to be determined. Although various in vitro infection 
studies with macrophages have clearly shown a strong serum- and complement-
dependent enhancement of M tb. binding (Schlesinger et al. , 1990b), the reported data 
do not allow a clear distinction to be made between the relative contributions of CR3, 
CRl , or CR4 to this binding. Moreover, in vivo, in the complement-poor alveolar 
space, complement-independent binding may be significant during the initial infection, 
and binding to CRJ may constitute the most advantageous portal of entry for M tb. 
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into the macrophage, gtvmg the orgarusm an early advantage m establishing a 
persistent infection. 
A component of nonopsonic binding may be mediated by the mannose receptor 
(Schlesinger, 1993), although this is limited to M th. strains with mannose-capped 
lipoarabinomannan moieties (Schlesinger et al. , 1994), and may be restricted to resting 
macrophages, as activated macrophages downregulate expression of this receptor 
(Harris et al. , 1992; Mokoena and Gordon, 1985). However, expression of the 
mannose receptor may be upregulated in macrophages stimulated with surfactant 
protein A, which results in enhanced phagocytosis of M th. (Gaynor et al. , 1995). 
Moreover, complement-indepenndent binding of M tb. to alveolar macrophages may 
also be mediated in part by direct opsonization with surfactant protein A (Downing et 
al. , 1995). Nonopsonic binding to CR3 has been claimed for a number of different 
pathogens, including M th. , based on in vitro studies with macrophages in the absence 
of exogenous complement (Mosser et al. , 1992), but these data may be spurious 
because the macrophage synthesises complement component C3 itself (Blackwell et 
al. , 1985; Ezekowitz et al., 1985; Wozencraft et al. , 1986). Indeed, a rigorous 
reanalysis of the binding of Leishmania spp. to CR3, previously thought to occur 
directly in the absence of complement, revealed that complement-independent binding 
of Leishmania to CR3 is very unlikely (Mosser et al. , 1992). There are, however, at 
least two examples of pathogen ligands that bind directly to CR3 in the absence of 
complement: filamentous hemagglutinin from Bordetella pertussis (Reiman et al. , 
1990) and neutrophil inhibitory factor from the hookworm Ancylostoma caninum 
(Mayer, 1961 ; Rieu et al. , 1994). There is therefore no reason why such a ligand 
should not exist in M tb. 
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One could at this stage speculate that analogous to Yersinia or B. pertussis, M tb. 
expresses high levels of a surface protein upon entry of the host, which interacts 
directly with the non-C3bi epitope of CR3 on alveolar macrophages in the absence of 
opsonins like C3bi, and induces cytoskeletal rearrangements and subsequent 
internalisation, possibly by the "zipper" mechanism. Moreover, after internalisation 
this surface moiety may serve as a tight regulator of the phagosome, preventing 
lysosomal fusion or phagosomal maturation, thereby protecting the bacilli and allowing 
growth .. 
The fact that we have removed CR3 from its normal environment in the mononuclear 
phagocyte, where it is able to interact with other receptors, such as CRl , MR, and 
FcR, simplifies the analysis by removing competing receptors, but it does make the 
system artificial. A potential complication that is introduced in our model are 
uncontrolled influences of the cell type (in this case CHO cells) on the expression and 
phagocytic ability of CR3, as well as the epitopes exposed (i.e., the activation state), 
which may not be available for interaction under normal circumstances. Similarly, the 
intracellular signal transduction pathways present in CHO cells may affect the ligand 
specificity and affinity in a way different from that seen in the macrophage. A 
theoretical possibility, therefore, is that the non-opsonic binding observed here 
between M tb. and CR3 is a consequence of a CHO cell-dependent functional 
conformation of CR3 that is not attained in macrophages. However, the use of CHO 
and other non-phagocytic cells (eg. COS cells) as heterologous hosts for CR3 in 
studies aimed at defining parameters involved in pathogen binding has been described 
by others, for example in experiments with Rhodococcus equi and Leishmania spp. 
(Hondalus et al. , 1993; Titus et al. , 1994). Clearly, data derived from such model 
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systems must be interpreted with caution, especially when extrapolating to the in vivo 
situation. Nevertheless, such studies, by isolating a phagocytic receptor of interest, 
provide insights into possible modes of interaction that are ambiguous when studied in 
the complete in vivo setting. 
Despite these conclusions, our result that serum opsonization was completely 
ineffective in enhancing the binding of M tb. to CHO-CR3 cells was unexpected. A 
careful analysis of the literature reveals that it has been clearly established that serum, 
and specifically C3, opsonization enhances the binding of M tb. to mononuclear 
phagocytes, and that serum-enhanced binding is mediated by complement receptors, 
including CR3 (Schlesinger et al., 1990b; Schlesinger, 1993; Hirsch et al., 1994). 
However, as noted before, in some studies it was also noted that M tb. can bind 
nonopsonically to monocyte/macrophage complement receptors, predominantly CR3 
(Stokes et al., 1993; Schlesinger, 1993), although no attempt was made to control for 
macrophage-derived C3. It is evident from these results that the extent of nonopsonic 
binding to CR3 specifically can be difficult to dissect in studies with mononuclear 
phagocytes because C3 deposition leads to enhanced binding to multiple complement 
receptors, and addition of anti-CR3 antibodies blocks both opsonic and nonopsonic 
binding to CR3 . Nevertheless, antibodies such as Leu-156, which is specific for the 
CDl lb C3bi-binding site, moderately block the binding of opsonized M tb. to MDMs 
(by 34-39%) (Schlesinger et al., 1990b), and therefore it it reasonable to conclude that 
a component of the binding of M tb. to MDM CR3 is opsonic. We can offer two 
explanations for the apparent discrepancy between this conclusion and our result that 
binding of M tb. to CHO cell-expressed CR3 is completely serum independent. First, 
the opsonin dependence of binding to CR3 may be strain dependent. Stokes et al. , 
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(1993) observed considerable variations among different M th. complex strains and 
other mycobacterial species in the extent of nonopsonic binding to murine 
macrophages. Moreover, Antal et al. , (1992) noted that the C3-independent binding 
of group B streptococci to CR3 is likely strain dependent. The reported studies on 
M th. binding to monocyte/macrophages complement receptors were performed 
predominantly with Erdman strain (Schlesinger et al. , 1990b; Schlesinger, 1993) or the 
H37Ra strain (Hirsch et al. , 1994) grown in rich media (7H9 broth). Our studies were 
performed throughout with the H37Rv strain grown in a minimal medium (Kirchner' s 
broth). We propose that in our studies, M th. strain H37Rv expresses an endogenous 
CR3 ligand, which binds CR3 with similar or greater affinity than C3bi, since binding is 
not augmented by opsonization in serum. Second, it is possible that the heterologous 
expression of CD 11 b/CD 18 in CHO cells confers cell-specific activation signals on 
CR3 that enable the receptor to bind M th. nonopsonically to an exyenet not typical in 
its native environmment, the mononuclear phagocyte. This is a theoretical 
consideration that arises from the observeation by cell-specific signals that dictate both 
their affinity state as well as adhesion-modulating postreceptor events (Peter and 
O'Toole, 1995; O'Toole et al. , 1994). The quantitative significance of this possibility 
can only be formally evaluated once the putative M th. CR3-binding ligand has been 
isolated in homogeneous form and its ability to bind macrophage-expressed CR3 has 
been determined. It should be noted, that the CHO-Mac-1 cells ysued here have been 
studied extensively with respect to the binding of four dostinct CR3 ligands, and no 
anomalies were detected (Diamond et al. , 1993). Moreover, these and related CHO 
cell transfectants were used to study the nonopsonic binding of zymosan to CR3, and 
again no significant differences were observed in comparison to leukocyte-expressed 
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CRJ (Thornton et al. , 1996), making this possibility unlikely. Nevertheless, in a study 
with murine macrophages, the nonopsonic binding of M tb. was strongly dependent on 
macrophage phenotype, even though the binding was mediated predominantly by CRJ 
and levels of CRJ expression were comparable in each of the macrophage populations 
studied (Stokes et al. , 1993). These results led the authors to conclude that the CRJ 
epitope binds M tb. nonopsonically exists in a phenotype-dependent active or inactive 
state (Stokes et al. , 1993). It is therefore possible, similarly, that in transfected CHO 
cells CRJ is expressed with the nonopsonis, M tb. -binding epitope constitutively 
active. A detailed survey of human macrophages of various phenotypes has to be 
undertaken in regard to phenotype-dependence of nonopsonic binding to M tb. An 
additional conideration relevant to the question of the functional equivalence of 
recombinant CRJ expressed in CHO cells compaared with macrophages CRJ , arises 
from the recent observation that CRJ associates with glycosylphosphatidylinositol-
linked proteinssuch as CD 14 and CD 16b in neutrophils and urokinase plasminogen 
activator receptor in monocytes (Petty and Todd, 1996). This association involves the 
CRJ 13-glucan lectin site (Petty and Todd, 1996; Krauss et al., 1994), and it is 
therefore possible that if the nonopsonic binding of M tb. to CRJ involves this or a 
related site, then a subset of CRJ on monocyte/macrophages is unavailable for 
nonopsonic binding, unlike in transfected CHO cells in which CRJ likely does not form 
I such multi-protein complexes. Interestingly, the CRJ/CD 14 complex in neutrophils 
dissociates upon cell spreading and adherence (Petty and Todd, 1996) which, it can be 
speculated, may provide an explanation for the phenotype-dependence of the 
nonopsonic binding to M tb. to murine macrophages (Stokes et al. , 1993). 
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Unidentified at present is the presumed endogenous M tb. ligand that binds directly to 
CR3. Although we have raised the possiblity that the binding of M tb. to CR3 may 
involve the CR3 lectin site, this is at present speculation. Schlesinger et al. (1990b) 
have shown that the attachment and ingestion of Erdman strain of M tb. by human 
monocytes was not inhibited by laminarim, a soluble P-glucan. It is possible that if 
other strains of M tb. are examined, or if a wider range of soluble sugar antagonists of 
the CR3 lectin site (Thornton et al., 1996) are tested, that an inhibitory effect is 
observed. The sugar specificity of the CR3 lectin site is broader than originally 
suspected and includes mannose-containg polysaccharides (Thornton et al., 1996), 
which are prominent in the mycobacterialcell wall, and thuis this heparin warrants 
further investigation. It has been shown recently that CR3 also binds to heparin and 
heparin sulfate glycans. The lectin site mediating this binding is istuated in the I 
domain and therefore appears to be distinct from the P-glucan site (Diamond et al., 
1995). It is doubtful that M tb. binds to the heparin site, since this site is inhibited 
strongly by MAb 2LPM19c and weakly by LM2/l and OKMl (Diamond et al., 1995), 
which is the reverse of what we have found for inhibition of the binding to M tb. to 
CHO-CR3 cells. Nevertheless, the M tb. cell wall is rich in diverse saccharides, 
including glycolipids, peptidoglycolipids, glycoproteins, and acyl trehalose 2' -sulfates 
(sulfolipids) (Brennan and Nikaido, 1995), and it is conceivable that one or more of 
these can function as a ligand for one or the other CR3 lectin site. Notwithstanding 
these considerations, we can not exclude the possibility that M tb. expresses a protein 
that functions as a ligand for CR3 . 
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CHAPTER SEVEN 
DISCUSSION AND CONCLUSION 
The use of adhesion receptors is a recurring theme among intracellular pathogens, and 
mycobacteria are no exception. Mycobacteria are part of a phylogenetically diverse 
group of organisms that bind to adhesion molecules of mononuclear phagocytic cells. 
These adhesion proteins play an essential role in cell-cell and cell-extracellular matrix 
interactions, but are subverted by pathogens to allow entry into the intracellular milieu 
without evoking defence mechanisms, such as the toxic respiratory burst (Wright and 
Silverstein, 1983a), which usually accompanies bacterial entry. The specific pathogens 
may differ, but the process of invasion almost invariably involves manipulation of host 
cell signal transduction pathways and cytoskeletal rearrangements (Falkow et al., 
1992; Bliska et al., 1993). The B2 integrins CR3 and CR4 are used by Mtb. for 
adherence to host cells (Schlesinger et al., 1990a and b; Stokes et al., 1993; Hirsch et 
al., 1994); these integrins constitute a family of adhesion receptors intimately involved 
in the migration and extravasation of lymphoid and myeloid cells (Hynes, 1992; Larson 
and Springer, 1990). In addition to its cell adhesive functions, CR3 is the primary 
phagocytic receptor for C3bi-opsonised particles (Larson and Springer, 1990), as well 
as for the ligands ICAM-1, fibrinogen and factor X (Diamond et al., 1993). CR4, the 
second adhesion receptor that binds C3bi (Diamond et al., 1993), is less well 
understood, but may play an important role in different phenotypes of phagocytic cells, 
as suggested by Hirsch et al. (1994). Although CR4 may be dominant in alveolar 
macrophages, it is interesting that CR3 is apparently the preferred portal of entry for 
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many pathogens, including mycobacteria, Leishmania spp., Histoplasma capsu/atum, 
and Bordetel/a pertussis (Falkow et al., 1992, Bullock and Wright, 1987; Newman et 
al. , 1990). The use of CR3 may be favoured by these pathogens because it allows 
them to avoid the respiratory burst and provides entry into a safe niche before 
activation of cell-mediated immunity in the host (Reiman et al., 1990; Hondalus et al., 
1993). This evasion of host defence mechanisms does not seem to hold true for entry 
via other integrins, for example, LFA-1 and CR4, as these are accompanied by 
destruction of the ingested pathogen (Berton et al. , 1992). 
The ability of M tb. to adhere to CR3 has been demonstrated in a number of previous 
reports ( Schlesinger et al. , 1990b; Schlesinger, 1993; Stokes et al., 1993; Hirsch et al., 
1994), but its ability to bind to CR3 in a non-opsonic fashion still remains to be 
established conclusively. The complement-independent binding of Mtb. to CR3 would 
provide a mechanism for the rapid invasion of alveolar macrophages in the 
complement-poor environment of the lung, and is therefore potentially of real 
importance (Stokes et al. , 1993; O'Niell et al., 1984). The mannose receptor 
(Schlesinger, 1993) plays a role in mediating non-opsonic binding of Mtb. to 
phagocytic cells, but this interaction seems to be dependent upon strains of M tb. that 
express mannose-capped lipoarabinomannan (Schlesinger et al. , 1994), and may only 
occur in resting or bystander macrophages, as the mannose receptor is down regulated 
in activated phagocytes (Mokoena and Gordon, 1985) and constitutively activated 
alveolar macrophages (Adams and Hamilton, 1992). Non-opsonic adherence to 
phagocytes has been claimed for many pathogens (Mosser et al. , 1992), but most of 
these claims are based on studies done in vitro with macrophages, which are thought 
to be able to produce their own opsonic components in the absence of exogenous 
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complement (Wozencraft et al., 1986). Recently, Leishmania spp., a protozoan once 
thought to interact with CR3 non-opsonically, has been demonstrated to be 
complement-dependent in more rigorous assays (Mosser et al. , 1992). 
However, the non-opsonic CR3 interactions by Bordetella pertussis (Reiman et al. , 
1990) and the hookworm Ancylostoma caninum (Moyle et al. , 1994) appear to be 
undisputed, and therefore these examples allow the real possibility that non-opsonic 
binding to CR3 may be the initial route of entry for M tb. into mononuclear 
phagocytes. To study this phenomenon rigorously, in the face of equivocal existing 
data, we have expressed CR3 in non-phagocytic CHO cells, so as to avoid the 
complicating factors encountered with endogenously synthesised complement and 
competing macrophage receptors for M tb. 
Our results have established that, first, CR3 is a receptor for M tb. , and second, that 
the CR3-Mtb. interaction may occur in a complement-independent fashion. The 
finding that there is no real increase in adherence in the presence of serum is, on the 
face of it, unexpected, as enhancements of between 3-4 fold (Schlesinger et al. , 1990b; 
Schlesinger, 1993) and greater (Hirsch et al. , 1994) have been recorded in the presence 
of 2 to 70% serum for the binding of M tb. to human mononuclear phagocytes. This 
increase in opsonic adherence could be due to the presence of CRl , CR4 and perhaps 
other receptors found on human mononuclear cells. It is possible that in our CHO cell 
system, the CR3 is both constitutively activated (Mosser et al. , 1992; Diamond et al. , 
1993; Hondalus et al. , 1993), and expressed in a manner that exposes epitopes that 
bind an endogenous M tb. ligand tighter than the competing C3 . The exact 
conformation of the recombinantly expressed receptor, as well as the putative M tb. 
surface ligand, still require further investigation. 
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The putative Mtb. CR3-binding surface ligand may not necessarily be a protein, as 
lectin-like properties have been attributed to CR3, as in the binding of various 
saccharides (Ross et al., 1985). Of great interest is the finding that Mtb. binds to CR3 
at a site distinct from the C3bi-binding epitope, which is consistent with reports on 
nonopsonic binding of Mtb. in mouse macrophages (Stokes et al., 1993). 
We therefore conclude that the heterologous expression of CR3 alone on the surface 
of non-phagocytic CHO cells is sufficient to confer phagocytic capabilities on this 
fibroblast cell line, to an extent greater than its inherent ability. Our results support the 
Isberg (1991) proposal, suggesting that integrins and other receptors are capable of 
internalising surface bound particles, providing that the adhesion is sufficiently strong. 
In summary, Mtb. binds to CR3 in a complement-independent manner to a site distinct 
from the C3bi-binding site. Binding is sufficiently tight to promote uptake into a non-
phagocytic cell transfected with CR3 . This predicts that M tb. expresses a high-affinity 
ligand for CR3 on its surface. If identified, such a ligand could be a useful target for 
the design of novel preventive and therapeutic strategies in tuberculosis. 
173 
BIBLIOGRAPHY 
Adams, D.O., and T.A. Hamilton. 1992. Molecular basis of macrophage activation: 
diversity and its origins. In The Macrophage. C.E. Lewis, and J. O'D. McGee, editors. 
IRL Press, Oxford.75-114. 
Albelda, S.M., and C.A. Buck. 1990. Integrins and other cell adhesion molecules. 
FASEB J. 4:2868-2880. 
Altieri, D.C., and T.S. Edgington. 1988a. A monoclonal antibody reacting with 
distinct adhesion molecules defines a transition in the functional state of the receptor 
CD11b/CDI8 (Mac-I). J. Immunol. 141:2656-2660. 
Altieri, D.C., and T.S. Edgington. 1988b. The saturable high affinity association of 
factor X to ADP-stimulated monocytes defines a novel function of the Mac-I receptor. 
J. Biol. Chem. 263 :7007-7015. 
Altieri, D.C., R. Bader, P.M. Mannucci, and T.S. Edgington . 1988. 
Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible 
recognition specificity for fibrinogen . J. Cell Biol. 107:1893-1900. 
Altieri, D.C., F.R Agbanyo, J. Plescia, M.H. Ginsberg, T.S. Edgington, and E.F. 
Plow. 1990. A unique reconition site mediates the interaction of fibrinogen with the 
leukocyte integrin Mac-I (CDl lb/CD18). J. Biol. Chem. 265 :12119-12122. 
174 
Antal, J.M., J.V. Cunningham, and K.J. Goodrum. 1992. Opsonin-independent 
phagocytosis of grouip B streptococci: role of complement receptor type three. Inject. 
Immun. 60: 1114-1121. 
Arnaout, M.A., E. Remold-O'Donnell, M.W. Pierce, P. Harris, and D.G. Tenen. 
1988a. Molecular cloning of the a subunit of human and guinea pig leukocyte adhesion 
glycoprotein Mo 1: Chromosomal localisation and homology to the a subunits of 
integrins. Proc. Natl. Acad Sci. USA 85:2776-2780. 
Arnaout, M.A., S.K. Gupta, M.W. Pierce, and D.G. Tenen. 1988b. Amino acid 
sequence of the alpha subunit of human leukocyte adhesion receptor Mo 1 
(Complemebt Receptor Type 3). J Cell Biol. 106:2153-2158. 
Arnaout, M.A. 1990a. Structure and function of the leukocyte adhesion molecules 
CDl l/CD18. Blood 75: 1037-1050. 
Arnaout, M.A. 1990b. Leukocyte adhesion molecules deficiency: Its structural basis, 
pathophysiology and implications for modulating the inflammatory response. Immunol. 
Rev. 114:145-180. 
Arnaout, M.A., N. Dana, S.K. Gupta, D.G. Tenen, and D.M. Fathallah . 1990c. 
Point mutations impairing cell surface expression of the common l3 subunit (CD18) in a 
patient with leukocyte adhesion molecule (Leu-CAM) deficiency. J Clin. Invest. 
85 :977-981. 
Auger, M.J., and J.A. Ross . 1992. The biology of the macrophage. In The 
Macrophage. C.E. Lewis, and J. O'D. McGee, editors. IRLPress, Oxford. 1-74. 
175 
Bajt, M.L., T. Goodman, and S.L. McGuire. 1995. f32 (CD18) Mutations abolish 
ligand recognition by I domain integrins LFA-1 (aLf32, CDlla/CD18) and MAC-1 
(aMf32, CDl lb/CD18). J. Biol. Chem. 270:94-98. 
Balzac, F., S.F. Retta, A. Albini, A. Melchiorri, V.E. Koteliansky, M. Geuna, L. 
Silengo, and G. Tarone. 1994. Expression of f31B integrin isoform in CHO cells 
results in a dominant negative effect on cell adhesion and motility. J. Cell Biol. 
127:557-565 . 
Baranji, K., L. Baranyi, T. Yoshida, N. Okada, and H. Okada. 1994. A low 
molecular weight phagocytosis-inhibitory factor obtained from human erythrocyte 
membranes specifically down-regulates Mac-1 activity on tetradecanoyl phorbol 
acetate-stimulated monocytic cell lines in a Ca2+ -dependent manner. J. Immunol. 
153 : 1724-1735. 
Barclay, R, and P.R Wheeler. 1989. Metabolism of Mycobacteria in Tissues. In 
The Biology of Mycobacteria. C. Ratledge, J. Stanford, and J.M. Grange, editors. 
Academic Press, London, UK. 37-106. 
Bebbington, C.R, and C.C.G. Hentschel. 1987. The use of vectors based on gene 
amplification for the expression of cloned genes in mammalian cells. In DNA Cloning: 
A Practical Approach, vol III. D.M. Glover, editor. IRL Press, Oxford. 163-188. 
Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar, S.T. Furlong, and M.B. 
Brenner. 1994. Recognition of a lipid antigen by CDl-restricted aJt T cells. Nature 
372:691-694. 
Bellinger-Kawahara, C., and M.A. Horwitz. 1990. Complement component C3 
fixes selectively to the major outer membrane protein (MOMP) of Legionella 
176 
pneumophila and mediates phagocytosis of liposome-MOMP complexes by human 
monocytes. J. Exp. Med 172:1201-1210. 
Berlin, O.G.W. 1990. Mycobacteria. In Bailey and Scott' s Diagnostic Microbiology. 
E.J. Baron, and S.M. Finegold , editors. The C.V. Mosby Company, St. Louis. 597-
640. 
Berman, P.W., G.R. Nakamura, L. Riddle, H. Chiu, K. Fisher, M. Champe, 
A.M. Gray, P. Ward, and S. Fong. 1993 . Biosynthesis and function of membrane 
bound and secreted forms of recombinant CDllb/CD18 (Mac-1). J. Cell. Biochem. 
52: 183-195. 
Berton, G., C. Laudanna, C. Sorio, and F. Rossi. 1992. Generation of signals 
activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not 
CR3, are able to stimulate the respiratory burst of human neutrophils. J. Cell Biol. 
116: 1007-1011. 
Blackwell, J.M., R.A.B. Ezekowitz, M.B. Roberts, J.Y. Channon, R.B. Sim, and 
S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania 
in the absence of serum. J. Exp. Med. 162:324-331. 
Blackwell, J.M., C.H. Barton, J.K. White, F. Searle, A-M. Baker, H. Williams, 
and M-A. Shaw. 1995. Gemonic organisation and sequence of the human NRAMP 
gene: Identification and mapping of a promotor region polymorphism. Mo!. Medicine 
1: 194-205. 
Bliska, J.B., J.E. Galan, and S. Falkow. 1993 . Signal transduction in the mammalian 
cell during bacterial attachment and entry. Cell 73 :903-920. 
177 
Boesen, H., B.N. Jensen, T. Wilcke, and P. Andersen. 1995. Human T-cell 
responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 
63 : 1491-1497. 
Bothamley, G.H., and J.M. Grange. 1991. The Koch phenomenon and delayed 
hyersensitivity: 1891-1991. Tubercule 72:7-11. 
Brennnan, P.J., and J.H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. 
Biochem. 64:29-63 . 
Bretscher, M.S. 1992. Circulating integrins: a5I31, a6f34 and Mac-1, but not a3f31, 
a4l31 or LFA-1. EMBO J. 11 :405-410. 
Bullock, W.E., and S.D. Wright. 1987. Role of the adherence-promoting receptors, 
CR3, LFA-1 , and p150,95, in binding of Histoplasma capsulatum by human 
macrophages. J. Exp. Med. 165:195-210. 
Buschman, E., T. Taniyama, R. Nakamura, and E. Skamene. 1989. Functional 
expression of the Beg gene in macrophages. Res. Immunol. 140:793-797. 
Celada, A., and C. Nathan. 1994. Macrophage activation revisited. Immunol. Today 
15 :100-102. 
Clemens, D.L., and M.A.Horwitz. 1992. Membrane sorting during phagocytosis: 
Selective exclusion of major histocompatibility complex molecules but not complement 
receptor CR3 during convential and coiling phagocytosis. J. Exp. Med 175: 1317-
1326. 
178 
Cohen, S.N., A.C.Y. Chang, and L. Hsu. 1972. Nonchromosomal antibiotic 
resistance in bacteria: Genetic transformation of Escherichia coli by R-factor DNA. 
Proc. Natl. Acad. Sci. USA 69:6139-6146. 
Cooper, A.M., and J.L. Flynn. 1995. The protective munune response to 
Mycobacterium tuberculosis. Curr. Opin. Immunol. 7:512-516. 
Cooper, D., C.M. Butcher, M.C. Berndt, and M.A. Vadas. 1994. P-Selectin 
interacts with a 132-integrin to enhance phagocytosis. J. Immunol. 153 :3199-3209. 
Corbi, A.L., T.K. Kishimoto, L.J. Miller, and T.A. Springer. 1988. The human 
leukocyte adhesion glycoprotein Mac-1 (Complement Receptor Type 3, CDllb) a 
subunit. J. Biol. Chem. 263 : 12403-12411 . 
Crocker, P.R., and G. Milon. 1992. Macrophages in the control of haematopoiesis. 
In The Macrophage. C.E. Lewis, and J. O'D. McGee, editors. IRL Press, Oxford.115-
158. 
Crowle, A.J. 1988. The tubercule bacillus-human macrophage relationship studied in 
vitro. In Mycobacterium tuberculosis interactions with the immune system. Bendinelli, 
B., and J. Friedman, editors. Plenum, USA. 99-135. 
Crowle, A.J., and N. Elkins. 1990. Relative permissiveness of macrophages from 
black and white people for virulent tubercule bacilli. Infect. Immun. 58:632-638 . 
Condell, D.R., and E. Tuomanen. 1995. Attachment and interaction of bacteria at 
respiratory mucosal surfaces. In Virulence mechanisms of bacterial pathogens. J.A. 
Roth, C.A. Bolin, K. A. Brogden, F.C. Minion, and M.J. Wannemuehler, editors. ASM 
Press, Washington, D.C. 3-20. 
179 
Current Protocols in Molecular Biology. F.M. Ausubel, R. Brent, R.E . Kingston, 
D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. John Wiley and Sons, 
New York. Section III, Unit 16.12. 
Dagert, M., and S.D. Ehrlich. 1979. Prolonged incubation in calcium chloride 
improves the competence of Escherichia coli cells. Gene 6:23-28 . 
Dana, N., D.M. Fathallah, and M.A. Arnaout. 1991. Expression of a soluble and 
functional form of the human 82 integrin CDllb/CD18. Proc. Natl. Acad Sci. USA 
88 :3106-3110. 
Dannenberg, Jr., A.M. 1991. Delayed-type hypersensitivity and cell-mediated 
immunity in the pathogenesis oftuberculosis. Jmmunol. Today 12:228-233 . 
Dannenberg, Jr., A.M., and G.A.W. Rook. 1994. Pathogenesis of pulmonary 
tuberculosis: an interplay of tissue-damaging and macrophage-activating immune 
responses-dual mechanisms that control bacillary multiplication. In Tuberculosis: 
Pathogenesis, Protection, and Control. B.R. Bloom, editor. American Society for 
Microbiology, Washington, DC. 459-483 . 
Davis, BD., R. Dulbencco, H.N. Eisen, H.S. Ginsberg, and W.B. Wood. 1967. 
Mycobacteria. In Microbiology. Harper and Row, New York. Ch 32, 841-868. 
De Graaf-Miltenburg, L.A.M., K.E. van Vliet, T.L.M. Ten Hagen, J. Verhoef, 
and J.A.G. van Strijp. 1994. The role of HSY-induced Fe- and C3b(i)-receptors in 
bacterial adherence. J. Med. Microbial. 40:48-54. 
Detmers, P.A., D. Zhou, and D.E. Powell. 1994. Different signaling pathways for 
CD18-mediated adhesion and Fe-mediated phagocytosis. J. Immunol. 153 :2137-2145 . 
180 
Diamond, M.S., D.E. Staunton, A.R de Fougerolles, S.A. Stacker, J. Garcia-
Aguilar, M.L. Hibbs, and T.A. Springer. 1990. ICAM-1 (CD54): A counter-
receptor for Mac-1 (CD11b/CD18). J Cell Biol. 111:3129-3139. 
Diamond, M.S., J. Garcia-Aguilar, J.K. Bickford, A.L. Corbi, and T.A. Springer. 
1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 
(CD 11 b/CD 18) for four distinct adhesion ligands. J Cell Biol. 120: 1031-1043 . 
Diamond, M.S., R Alon, C.A. Parkos, M.T. Quinn, and T.A. Springer. 1995. 
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD1 lb/CD18). J Cell 
Biol. 130: 1473-1482. 
Donelson, J.E., and A.B. Fulton. 1992. Skirmishes on the border. Nature 356:480-
481. 
Downing, J.F., R Pasula, J.R Wright, H.L. Twigg ill, and W.J. Martin II. 1995. 
Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar 
macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad 
Sci. USA 92:4848-4852. 
Dubovsky, H. 1991. The management of tuberculosis in the pre-chemotherapeutic era. 
In A Century of Tuberculosis: South African perspectives. H.M. Coovadia and S.R. 
Benatar, editors. Oxford University Press, Cape Town. 32-41. 
Edwards, D., and C.H. Kirkpatrick. 1986. The immunology of Mycobacterial 
diseases. Am. Rev. Respir. Dis. 134: 1062-1071. 
181 
Ehlers, M.R.W., Y-N.P. Chen, and J.F. Riordan. 1991. Purification and 
characterisation of recombinant human testis angiotensin-converting enzyme expressed 
in Chinese hamster ovary cells. Protein Expression and Purification 2: 1-9. 
Ehlers, M.R. W. 1993 . The wolf at the door: Some thoughts on the biochemistry of 
the tubercule bacillus. SAMJ. 83 : 900-903 . 
Ehlers, M.R. W. 1995. Biology of Mycobacterium tuberculosis and the host-pathogen 
relationship. In Childhood tuberculosis: Modem imaging and clinical concepts. B.J. 
Cremin and D .H. Jamieson, editors. Springer, Great Britian. 7-18 . 
Epidemiological Comments. Department of Health, Republic of South Africa. 1993 . 
Epidemiological Comments. Department of Health, Republic of South Africa. 1995. 
Ezekowitz, R.A.B., R.B. Sim, G.G. MacPherson, and S. Gordon. 1985. Interaction 
of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan 
in vitro. J. Clin. Invest. 76:2368-2376. 
Ezekowitz., R.A.B., and P.D. Stahl. 1988. The structure and function of vertebrate 
mannose lectin-like proteins. J. Cell Sci. 9 (Suppl.) :121-133. 
Falkow, S. 1991 . Bacterial entry into eukaryotic cells. Cell 65 : 1099-1102. 
Falkow, S., R.R. lsberg, and D.A. Pornoy. 1992. The interaction of bacteria with 
mammalian cells. Annu. Rev. Cell Biol. 8:332-337. 
Fenton Hall, B., and K.A. Joiner. 1991. Strategies of obligate intracellular parasites 
for evading host defences. lmmunoparacy tology Today 12:A22-A27. 
Finch, P.J., F.J.C. Millard, and J.D. Maxwell. 1991. Risk of Tuberculosis m 
immigrant Asians: culturally acquired immunodeficiency? Thorax 46: 1-5 . 
182 
Finlay, B.B., and A. Siebers. 1995. Mechanisms of mucosal colonisation and 
penetration by bacterial pathogens. In Virulence mechanisms of bacterial pathogens. 
J.A. Roth, C.A. Bolin, K. A. Brogden, F.C. Minion, and M.J. Wannemuehler, editors. 
ASM Press, Washington, D.C. 33-45 . 
Galan, J.E. 1994. Salmonella entry into mammalian cells: different yet converging 
signal transduction pathways? Trends Cell Biol. 4: 196-199. 
Gaynor, C.D., F.X. McCormack, D.R. Voelker, S.E. McGowan, and L.S. 
Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of 
Mycobacterium tuberculosis by a direct interaction with human macrophages. J. 
Immunol. 155 :5343-5351. 
Goldner, M., H. Farkas-Himsley, A. Kormendy and M. Skinner. 1983 . Bacterial 
phagocytosis monitored by flourescence and extracellular quenching: Ingestion and 
intracellular killing. Lab. Med. 14:291-294. 
Gordon, S., V.H. Perry, S. Rabinowitz, L. Chung, and H. Rosen. 1988. Plasma 
membrane receptors of the mononuclear phagocyte system. J. Cell. Sci. 9(Suppl.) : 1-
26. 
Gotch, F. 1987. Workshop structure and protocols. In Leukocyte Typing III, White 
Cell Differentiation Antigens. A.J. McMichael, editor. Oxford University Press, 
Oxford. 3-7. 
Graham, I.L., H.~. Gresham, and E.J. Brown. 1989. An immobile subset of plasma 
membrane CD 11 b/CD 18 (Mac-I) is involved in phagocytosis of targets recognized by 
multiple receptors. J. Immunol. 142:2352-2358. 
183 
Graham, I.L., and E.J. Brown. 1991. Extracellular calcium results in a 
conformational change in Mac-1 (CDllb/CD18) on neutrophils. J. Immunol. 146:685-
691. 
Greenberg, S. 1995. Signal transduction of phagocytosis. Trends in Cell Biol. 5:93-
99. 
Griffin, F.M., and S.C. Silverstein. 1974. Segmented response of the macrophage 
plasma membrane to a phagocyte stimulus. J. Exp. Med. 139:323-336. 
Griffin, F.M. Jr, J.A. Griffin, J.E. Leider, and S.C. Silverstein. 1975. Studies on 
the mechanisms of phagocytosis. I. Requirements for circumferential attachment of 
particle-bound ligands to specific receptors on the macrophage plasma membrane. J. 
Exp. Med. 142:1263-1282. 
Griffin, J.P., and I.M. Orme. 1994. Evolution of CD4 T-cell subsets following 
infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect. 
Immun. 62:1683-1690. 
Gros, P ., E. Skamene, and A. Forget. 1981. Genetic control of natural resistance to 
Mycobacterium bovis (BCG) in mice. J. Immunol. 127:2417-2421. 
Haas, T.A., and E.F. Plow. 1994. Integrin-ligand interactions: a year in review. Curr. 
Op. Cell Biol. 6:656-662. 
Harris, N., M. Super, M. Rits, G. Chang, and RA.B. Ezekowitz. 1992. 
Characterization of the murine mannose receptor: Demonstration that downregulation 
of receptor expression mediated by interferon-y occurs at the level of transcription. 
Blood 80:2363-2373 . 
184 
Hazenbos, W.L.W., B.M. van den Berg, and R van Furth. 1993 . Very late 
antigen-5 and complement receptor type 3 cooperatively mediate the interaction 
between Bordetella pertussis and human monocytes. J. Immunol. 151 :6274-6282. 
Heesemann, J., and R. Laufs. 1985. Double immunofluorescence microscopic 
technique for accurate differentiation of extracellularly and intracellularly located 
bacteria in cell culture. J. Clin. Microbial. 22: 168-17 5. 
Hermanowski-Vosatka, A., J.A.G. van Strijp, W.J. Swiggard, and S.D. Wright. 
1992. Integrin modulating factor-I: A lipid that alters the function of leukocyte 
integrins. Cel/ 68 :341-352. 
Hibbs, M.L., A.J. Wardlaw, S.A. Stacker, D.C. Anderson, A. Lee, T.M. Roberts, 
and T.A. Springer. 1990. Transfection of cells from patients with leukocyte adhesion 
defeciency with an integrin f3 Subunit (CD18) restores lymphocyte function-associated 
antigen-I expression and function. J. Clin. Invest. 85 :674-681. 
Hibbs, M.L., H.Xu, S.A. Stacker, and T.A. Springer. 1991. Regulation of adhesion 
to ICAM-1 by the cytoplasmic domain of LF A-1 integrin I3 subunit. Science 251 : 1611-
1613 . 
Hirsch, C.S., J.J. Ellner, D.G. Russell, and E.A. Rich. 1994. Complement receptor-
mediated uptake and tumor necrosis factor-A-mediated growth inhibition of 
Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-
753 . 
Hondalus, M.K., M.S. Diamond, L.A. Rosenthal, T.A. Springer, and D.M. 
Mosser. 1993 . The intracellular bacterium Rhodococcus equi requires Mac- I to bind 
to mammalian cells. Infect. Immun. 61:2919-2929. 
185 
Horwitz, M.A. 1982. Phagocytosis of microorganisms. Rev. Infect. Dis. 4: 104-123 . 
Hostetter, M.K. 1994. Interactions of Candida albicans with eukaryotic cells. ASM 
News 60:370-374. 
Hynes, RO. 1987. Integrins: A family of cell surface receptors. Cell 48 :549-554. 
Hynes, RO. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. 
Cell 69:11-25. 
Isberg, RR., and J.M. Leong. 1990. Multiple Bl chain integrins are receptors for 
invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 
60:861-871. 
Isberg, R.R. 1991. Descrimination between intracellular uptake and surface adhesion 
of bacterial Pathogens. Science 252:934-938. 
Isberg, RR, and G.T. Van Nhieu. 1994. Binding and internalization of 
microorganisms by integrin receptors. Trends Microbial. 2: 10-24. 
Isberg, RR, and G.T. Van Nhieu. 1995. The mechanism of phagocytic uptake 
promoted by invasin-integrin interaction. Trends Cell Biol. 5: 120-124. 
Ish-Horowicz, D., and J.F. Burke. 1981. Rapid and efficient cosmid cloning. Nucl. 
Acids Res. 9:2989-2998. 
Kaufmann, S.H.E. 1995. Immunity to intracellular bacteria and protozoa. The 
Immunologist. 3 :221-225 . 
Kirchhofer, D., J. Grzesiak, and M.D. Pierschbacher. 1991. Calcium !iS a potential 
physiological regulator of integrin-mediated cell adhesion. J. Biol. Chem. 266:4471-
4477. 
186 
Krahenbuhl, J.L. 1995. Role of mycobacterial constituents m regulation of 
macrophage effector function. In Virulence Mechanisms of Bacterial Pathogens. J.A. 
Roth, C.A. Bolin, K. A. Brogden, F.C. Minion, and M.J. Wannemuehler, editors. ASM 
Press, Washington, D .C. 99-114. 
Krauss, J.C., H. Poo, W. Xue, L. Mayo-Bond, RF. Todd ill, and H.R. Petty. 
1994. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fe-
gamma receptor IIIB and the complement receptor type 3. J. Immunol. 153 : 1769-
1777. 
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. Nature 227:680-685 . 
Larson, R.S., and T.A. Springer. 1990. Structure and function of leukocyte 
integrins. Immunol. Rev. 114: 181-209. 
Lee, C.A., and S. Falkow. 1990. The ability of Salmonella to enter mammalian cells 
is affected by bacterial growth state. Proc. Natl. Acad Sci. USA 87:4304-4308. 
Lin, Y., M. Zhang, F.M. Hofman, J. Gong, and P.F. Barnes. 1996. Absence of a 
prominent Th2 cytokine response in human tuberculosis. Infect. Immun. 64: 13 51-
1356. 
Little, P.F.R, R Treisman, L. Bierut, B. Seed, and T. Maniatis. 1983 . Plasmid 
vectors for the rapid isolation and transcriptional analysis of human 8-Globin gene 
alleles. Mo!. Biol. Med. I :473-488. 
Loftus, J.C., J.W. Smith, and M.H. Ginsberg. 1994. Integrin-mediated cell 
adhesion: The extracellular face. J. Biol. Chem. 269:25235-25238 . 
187 
Lucas, S.B. 1988. Histopathology ofleprosy and tuberculosis - an overview. Br. Med. 
Bull. 44:584-599. 
Lucas, S.B. 1989. Metabolism of Mycobacteria in tissues. In The biology of 
Mycobacteria. C. Ratledge, J. Stanford, and J.M. Grange, editors. Academic Press, 
London, UK. 108-176. 
Malhotra, R, S. Thiel, K.B.M. Reid, and R.B. Sim. 1990. Human leukocyte Clq 
receptor binds other soluble proteins with collagen domains. J. Exp. Med 172:955-
959. 
Manchester, K. 1984. Tuberculosis and leprosy m antiquity: an interpretation. 
Medical History 28 : 162-173 . 
Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular cloning. A laboratory 
manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 
Marrack, P., and J. Kappler. 1994. Subversion of the immune system by pathogens. 
Cell 76:323-332. 
Mayer, M.M. 1961. Complement and complement fixation. In Experimental 
Immunohistochernistry. E.A. Kabat and M.M. Mayer, editors. Charles C. Thomas, 
Springfield, IL. 133-240. 
McDonough, K.A., Y. Kress, and B.R. Bloom. 1993 . Pathogenesis of tuberculosis: 
Interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 
61 :2763-2773 . 
McMichael, A.J. 1987. Leukocyte Typing III, white cell differentiation antigens. 
Oxford University Press, Oxford. 829-866. 
188 
Metcalf, C. 1991. A history of tuberculosis. In A Century of Tuberculosis: South 
African Perspectives. H.M. Coovadia and S.R. Benatar, editors. Oxford University 
Press, Cape Town. 1-31. 
Michishita, M., V. Videm, and M.A. Arnaout. 1993. A novel divalent cation-
binding site in the A domain of the I32 integrin CR3 (CDllb/CD18) is essential for 
ligands binding. Ce/l 72:857-867. 
Miller, V.L., and S. Falkow. 1988. Evidence for two genetic loci in Yersinia 
enterocolitica that can promote invasion of epithelial cells. Infect. Immun. 56: 1242-
1248. 
Miller, V.L. 1995. Tissue-culture invasion: fact or artefact? Trends Microbial. 3: 69-
71. 
Mokoena, T., and S. Gordon. 1985. Human macrophage activation: modulation of 
mannosyl, fucosyl receptor activity in vitro by lymphokines, gamma and alpha 
interferons, and dexamethasone. J. Clin. Invest. 75 :624-631. 
Molloy, A., P.A. Meyn, K.D. Smith, and G. Kaplan. 1993 . Recognition and 
destruction of Bacillus Calmette-Guerin-infected human monocytes. J. Exp. Med. 
177: 1691-1698. 
Molloy, A., P. Laochumroonvorapong, and G. Kaplan. _ 1994. Apoptosis, but not 
necrosis, of infected monocytes is coupled with killing of intracellular Bacillus 
Calmette-Guerin. J Exp. Med. 180:1499-1509. 
Morse, D. 1967. Prehistoric tuberculosis in America. Am. Rev. Resp. Dis. 83 :489-504. 
189 
Mosser, D.M., T.A. Springer, and M.S. Diamond. 1992. Leishmania promastigotes 
require opsonic complement to bind to the human leukocyte integrin Mac-1 
(CD1 lb/CD18). J. Cell Biol. 116:511-520. 
Mosser, D.M. 1994. Receptors on phagocytic cells involved in microbial recognition. 
In Macrophage-Pathogen Interactions. B.S . Zwilling and T.K. Eisenstein, editors. 
Marcel Dekker, Inc., New York.99-113 . 
Moyle., M., D.L. Foster, D.E. McGrath, S.M. Brown, Y. Laroche, J. De Meutter, 
P. Stanssens, C.A. Bogowitz, V.A. Fried, J.A. Ely, H.R. Soule, and G.P. Vlasuk. 
1994. A Hookworm glycoprotein that inhibits neutrophil function is a ligand of the 
integrin CD1 lb/CD18. J. Biol. Chem. 269: 10008-10015. 
Muchowski, P.J., L. Zhang, E.R. Chang, H.R Soule, E.F. Plow and M. Moyle. 
1994. Functional interaction between the integrin antagonist neutrophil inhibitory 
factor and the I domain ofCD1 lb/CD18. J. Biol. Chem. 269:26419-26423. 
Myrvik, Q.N., E.S. Leake, and M.B. Goren. 1988. The tubercule bacillus-human 
macrophage relationship studied in vitro. In Mycobacterium tuberculosis interactions 
with the immune system. Bendinelli, B., and J. Friedman, editors. Plenum, USA. 305-
325 . 
Naegel, G.P., K.R Young. Jr, and H.Y. Reynolds. 1984. Receptors for human IgG 
subclasses on human alveolar macrophages. Am. Rev. Resp. Dis. 129:413-418. 
Newman, S.L., C. Bucher, J. Rhodes, and W.E. Bullock. 1990. Phagocytosis of 
Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and 
alveolar macrophages. J. Clin. Invest. 85:223-230. 
190 
Noel, G.J., D.M. Mosser, and P.J. Edelson. 1990. Role of complement in mouse 
macrophage binding of Haemophilus influenzae type b. J. Clin. Invest. 85 :208-218. 
O'Farrell, P.H. 1975. High resolution two-dimensional electrophoresis of proteins. J. 
Biol. Chem. 250:4007-4021. 
O'Neill, S.J., E. Lesperance, and D.J. Klass . 1984. Human lung lavage surfactant 
Enhances Staphylococcal phagocytosis by alveolar macrophages. Am. Rev. Respir. 
Dis. 130: 1177-1179. 
O'Toole, T.E., Y. Katagiri, RJ. Faull, K. Peter, R Tamura, V. Quaranta, J.C. 
Loftus, S.J. Shattil, and M.H. Ginsberg. 1994. Integrin cytoplasmic domains 
mediate inside-out signal transduction. J Cell Biol. 124:1047-1059. 
O'Toole, T.E., J. Ylanne, and B.M. Culley. 1995. Regulation of integrin affinity 
states through an NPXY motif in the f3 Subunit cytoplasmic domain. J. Biol. Chem. 
270:8553-8558. 
Ofek, I., R.F. Rest, and N. Sharon. 1992. Nonopsonic phagocytosis of 
microorganisms. ASM News 58:429-435 . 
Pacifici, R, J. Roman, R Kimble, R Civitelli, C.M. Brownfield, and C. Bizzarri. 
1994. ligand binding to monocyte a.581 integrin activates the a.281 receptor via the a.5 
Subunit cytoplasmic domain and protein kinase C. J. Jmmunol. 153 :2222-2233 . 
Packard, RM. 1991. Holding back the tide: TB control efforts in South Africa. In A 
Century of Tuberculosis: South African perspectives. H.M. Coovadia and S.R. 
Benatar, editors. Oxford University Press, Cape Town. 42-57. 
191 
Peter, K., and T.E. O'Toole. 1995. Modulation of cell adhesion by changes in a.LP2 
(LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J. Exp. Med 
181:315-326. 
Petty, H.R., and R.F. Todd, ill. 1996. Integrins as promiscuos signal transduction 
devices. Immunol. Today 17:209-213 . 
Pollack, S., and A. Etzioni. 1992. Macrophages in autoimmunity and primary 
immunodeficiency. In The Macrophage. C.E. Lewis, and J. O'D. McGee, editors. IRL 
Press, Oxford.285-313 . 
Porcelli, S., C.T. Morita, and M.B. Brenner. 1992. CD1b restricts the response of 
human CD4-CD8- T lymphocytes to a microbial antigen. Nature 360:593 . 
Reiner, N.E. 1994. Altered cell signalling and mononuclear phagocyte deactivation 
during intracellular infection. Immunol. Today 15 :374-381. 
Reiman, D., E. Tuomanen, S. Falkow, D.T. Golenbock, K. Saukkonen, and S.D. 
Wright. 1990. Recognition of a bacterial adhesin by an integrin: Macrophage CR3 
(a.M/32, CDI lb/CD18) binds filamentous hemagglutinin of Bordetel/a pertussis. Cell 
61 :1375-1382. 
Reynolds, H.Y., and R.E. Thompson. 1973 . Pulmonary host defenses. II. Interaction 
of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. J. 
Immunol. 111 :369-380. 
Reynolds, H.Y., J.A. Kazmierowski, and H.H. Newball. 1975. Specificity of 
opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human 
alveolar macrophages. J. Clin. Invest. 56:376-385 . 
192 
Rieu, P., T. Ueda, I. Haruta, C.P. Sharma, and M.A. Arnaout. 1994. The A-
domain of B2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived 
neutrophil Adhesion inhibitor NIF. J. Cell Biol. 127:2081-2091. 
Rook, G.A.W., R. Al Attiyah, and E. Filley. 1990. New insights into the 
immunopathology of tuberculosis. Pathobiol. 59: 148-152. 
Ross, G.D., J.A. Cain, and P.J. Lachmann. 1985. Membrane complement receptor 
type three (CR3) has lectin-like properties analogous to bovine conglutinin and 
functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for 
iC3b. J. Immunol. 134:3307-3315 . 
Roubey, R.A.S., G.D. Ross, J.T. Merrill, F. Walton, W. Reed, R.J. Winchester, 
and J.P. Buyon. 1991. Staurosporine inhibits neutrophil phagoctosis but not iC3b 
binding Mediated by CR3 (CD1 lb/CD18). J. Immunol. 146:3557-3562. 
Rozdzinski, E., and E. Tuomanen. 1994. Interactions of Bacteria with Leukocyte 
Integrins. Methods in Enzymol. 236:333-345 . 
Ruoshlahti, E., and M.D. Pierschbacher. 1987. New perspectives in cell adhesion: 
RGD and integrins. Science 238:491-497. 
Sadick, M.D. 1992. Macrophages in parasitic infections. In The Macrophage. C.E. 
Lewis, and J. O'D . McGee, editors. IRL Press, Oxford.265-284. 
Safley, S.A., and H.K. Ziegler. 1994. Antigen processing and presentation. In 
Macrophage-Pathogen Interactions. B.S. Zwilling and T.K. Eisenstein, editors. Marcel 
Dekker, Inc., New York.115-129. 
193 
Salo, W.L., A.C. Aufderheide, J. Buikstra, and T.A. Holcomb. 1994. Identification 
of Mycobacterium tuberculosis DNA in a Pre-Columbian Peruvian mummy. Proc. 
Natl. Acad. Sci. USA 91:2091-2094. 
Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-
terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467. 
Schlesinger, L.S., and M.A. Horwitz. 1990a. Phagocytosis of leprosy bacilli ts 
mediated by complement receptors CRl and CR3 on human monocytes and 
complement component C3 in serum. J. Clin. Invest. 8 5: 13 04-1314. 
Schlesinger, L.S., C.G. Bellinger-Kawahara, N.R Payne, and M.A. Horwitz. 
1990b. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte 
complement receptors and complement component C3 . J. Immunol. 144:2771-2780. 
Schlesinger, L.S., and M.A. Horwitz. 1991 a. Phagocytosis of Mycobacterium leprae 
by human monocyte-derived macrophages is mediated by complement receptors CRl 
(CD35), CR3 (CDl lb/CD18), and CR4 (CDl lc/CD18) and IFN-gamma activation 
inhibits complement receptor function and phagocytosis of this bacterium. J Immunol. 
147:1983-1994. 
Schlesinger, L.S., and M.A. Horwitz. 1991b. Phenolic glycolipid-1 of 
Mycobacterium leprae binds complement component C3 in serum and mediates 
phagocytosis by human monocytes. J. Exp. Med. 17 4: 1031-103 8. 
Schlesinger, L.S. 1993. Macrophage phagocytosis of virulent but not attenuated 
strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to 
Complement receptors. J. Immunol. 150:2920-2930. 
194 
Schlesinger, L.S., S.R Hull, and T.M. Kaufman. 1994. Binding of the terminal 
mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium 
tuberculosis to human macrophages. J. Immunol. 152:4070-4079. 
Seed, B. 1983 . Purification of genomic sequences from bacteriophage libraries by 
recombination and selection in vivo. Nucl. Acid Res. 7:2427-2445 . 
Shelley, C., and M.A. Arnaout. 1991. The promoter of the CDllb gene directs 
myeloid-specific and developmentally regulated expression. Proc. Natl. Acad. Sci. 
USA 88 : 10525-10529. 
Sigal, L.J., and D.E. Wylie. 1994. A semiquantitative rosetting assay for detection of 
cell-surface class I major histocompatibility complex molecules. BioTechniques 
17:776-780. 
Silverstein, S.C., S. Greenberg, F. Di Virgilio, and T.H. Steinberg. 1989. 
Phagocytosis. In Fundamental immunology. W.E. Paul, editor. Raven Press, New 
York. 
Simms, H.H., M.M. Fra~k, T.C. Quinn, S. Holland, and T.A. Gaither. 1989. 
Studies on phagocytosis in patients with acute bacterial infections. J. Clin. Invest. 
83 :252-260. 
Smibert, RM. and N.R Krieg. 1994. Phenotypic characterization. In Methods for 
General and Molecular Bacteriology. P. Gerhardt, R.G.E. Murray, W.A. Wood and 
N.R. Krieg, editors. ASM press, Washington. Ch 25 :648-662. 
195 
Smith, J.W., Z.M. Rugger, T.J. Kunicki, and D.A. Cheresh. 1990. Interaction of 
integrins aVf33 and glycoprotein Ilb-Illa with fibrinogen . J. Biol. Chem. 265 :12267-
12271. 
Snider Jr, D.E. 1994. Tuberculosis: the world situation. History of the disease and 
efforts to combat it. In Tuberculosis back to the Future. J.D.H. Porter and K.P.W.J. 
McAdam, editors. John Wiley and sons, Chichester, England.13-33 . 
Southwick, F.S., and T.P. Stossel. 1986. Phagocytosis. In Manual of Clinical 
Laboratory Immunology. N.R. Rose, H. Friedman, and J.L. Fahley, editors. ASM 
Press, Washington. Ch 47:326-331. 
Speert, D.P. 1992. Macrophages in bacterial infection. In The Macrophage. C.E. 
Lewis, and J. O'D. McGee, editors. IRL Press, Oxford.215-263 . 
Springer, T.A. 1990. Adhesion receptors of the immune system. Nature 346:425-434. 
Stead, W.W. , J.W. Senner, W.T. Reddick, and J.P. Lofgren. 1990. Racial differences 
in sucepitbility to infection by Mycobacterium tuberculosis. N Eng. J. Med. 322:422-
427. 
Stewart, C.C., M.C. Riedy, and S.J. Stewart. 1994. Introduction: The proliferation 
and differentiation of macrophages. In Macrophage-Pathogen Interactions. B.S. 
Zwilling and T.K. Eisenstein, editors. Marcel Dekker, Inc., New York.3-27. 
Stokes, R W., I.D. Haidl, W.A. Jefferies, and D.P. Speert. 1993 . Mycobacteria-
macrophage interactions. J. Immunol. 151:7067-7076. 
196 
Strebel, P.M. and R. Seager. 1991. Epidemiology of tuberculosis in South Africa. In 
A Century of Tuberculosis: South African Perspectives. H.M . Coovadia and S.R. 
Benatar, editors. Oxford University Press, Cape Town. 58-90. 
Swanson, J.A., and S.C. Baer. 1995. Phagocytosis by zippers and triggers. Trends 
Cell Biol. 5:89-93 . 
Swartz, R.P., D. Naai, C-W. Vogel, and H. Yeager. 1988. Differences in uptake of 
mycobacteria by human monocytes: a role for complement. Infect. Immun. 56:2223-
2227. 
Szabo, T., J.L. Kadish, and J.K. Czop. 1995. Biochemical properties of the ligand-
binding 20-kDa subunit of the I3-glucan receptors on human mononuclear phagocytes. 
J. Biol. Chem. 270:2145-2151. 
Tabor, S., and C.C. Richardson. 1987. DNA sequence analysis with a modified 
bacteriophage T7 DNA polymerase. Proc. Natl. Acad. Sci. USA 84:4767-4771 . 
Tenner, A.J., S.L. Robinson, J. Borchelt, and J.R. Wright. 1989. Human pulmonary 
surfactant protein (SP-A), a protein structurally homologous to Clq, can enhance 
FcR- and CRl-mediated phagocytosis. J. Biol. Chem. 264:13923-13928. 
Thornton, B.P., V. Vetvicka, M. Pitman, R.C. Goldman, and G.D. Ross. 1996. 
Analysis of the sugar specificity and molecular location of the P-glucan-binding lectin 
site of complement receptor type 3 (CDl lb/CD18). J. Immunol. 156: 1235-1246. 
Titus, R.G., C.M. Theodos, A.H. Shankar, and L.R. Hall. 1994. Interactions 
between Leishmania major and macrophages. In Macrophage-Pathogen Interactions. 
197 
B.S. Zwilling, and T.K. Eisenstein, editors. Marcel Dekker, Inc., New York. Ch 26: 
437-460. 
Tuomanen, E. 1993 . Subversion of leukocyte adhesion systems by respiratory 
pathogens. ASM News 59:292-296. 
Unkeless, J.C. 1989. Function and heterogeneity of human Fe receptors for 
immunoglobulin G. Clin. Invest. 83 :355-361. 
Van Oss, C.J. 1986. Phagocytosis: An Overview. Methods Enzymol. 132:3-15. 
Van Strijp, J.A.G., D.G. Russell, E. Tuomanen, E.J. Brown, and S.D. Wright. 
1993 . Ligand specificity of purified complement receptor type three (CD11b/CD18, 
a.Ml32, Mac-1). J. Immunol. 151 :3324-3336. 
Vidal, S.M., D. Malo, K. Vogen, E. Skamene, and P. Gros. 1993 . Natural 
resistance to infection with intracellular parasite: Isolation of a candidate for Beg. Cell 
73 : 469-485 . 
Wayne, L.G. 1994a. Dormancy of Mycobacterium tuberculosis and latency of 
disease. Eur. J. Clin. Microbial. Infect. Dis. 13 :908-914. 
Wayne, L.G. 1994b. Cultivation of Mycobacterium tuberculosis for research 
purposes. In Tuberculosis: Pathogenesis, Protection, and Control. B.R. Bloom, 
editor. American Society for Microbiology, Washington, DC. 73-83 . 
Weitzman, J.B., C.E. Wells, A.H. Wright, P.A. Clark, and S.K.A. Law. 1991. The 
gene organisation of the human I32 integrin subunit (CD18). FEBS Lett. 294:97-103 . 
Wellmann, K.F. 1970. Kokopelli of Indian paleology. Hunchbacked rain priest, 
hunting magician, and Don Juan of the old southwest. J.A.MA. 212: 1678-1682. 
198 
Williams, M.J., P.E. Hughes, T.E. O'Toole, and M.H. Ginsberg. 1994. The inner 
world of cell adhesion: integrin cytoplasmic domains. Trends Cell Biol. 4: 109-112. 
World Health Organization Report. 1995. 
Wozencraft., A.O., G. Sayers, and J.M. Blackwell. 1986. Macrophage type 3 
complement receptor mediate serum -independent binding of Leishmania donovani: 
detection of macrophage-derived complement on the parasite surface by immuno-
electron microscopy. J. Exp. Med. 164: 1332-1335. 
Wright, S.D., and S.C. Silverstein. 1982. Tumor-promoting phorbol esters stimulate 
C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes. J. Exp. 
Med. 156:1149-1164. 
Wright, S.D., and S.C. Silverstein . 1983. Receptor for C3b and C3bi promote 
phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 
158:2016-2021. 
Wright, S.D., P.E. Rao, W.C. van Voorhis, L.S. Craigmyle, K. Iida, M.A. Talle, 
E.F. Westberg, G. Goldstein, and S.C. Silverstein. 1983 . Identification of the C3bi 
receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. 
Natl. Acad. Sci. USA 80:5699-5703 . 
Wright, S.D., M.R Licht, L.S. Craigmyle, and S.C. Silverstein. 1984. 
Communication between receptors for different ligands on a single cell: Ligation of 
fibronectin receptors induces a reversible alteration in the function of complement 
receptors on cultured human monocytes. J. Cell Biol. 99:336-339. 
199 
Wright, S.D. P.A. Detmers, M.T.C. Jong, and C. Meyer. 1986. Interferon-gamma 
depresses binding of ligand by C3b and C3bi receptors on cultured human monocytes, 
an effect reversed by fibronectin. J. Exp. Med 163 :1245-1259. 
Yamamoto, Y., T.W. Klein, and H. Friedman. 1994. Legionella and macrophages. 
In Macrophage-Pathogen Interactions. B.S. Zwilling, and T.K. Eisenstein, editors. 
Marcel Dekker, Inc., New York. Ch 20:329-348. 
Young, V.B., S. Falkow, and G.K. Schoolnik. 1992. The invasin protein of Yersinia 
enteroco/itica: Internalisation of invasin-bearing bacteria by eukaryotic cells is 
associated with reorganisation of the cytoskeleton. J. Cell Biol. 116: 197-207. 
Young, D.B., and S.T. Cole. 1993 . Leprosy, Tuberculosis, and the new Genetics. J. 
Bact. 175 :1-6. 
Young, D.B., and K. Duncan. 1995. Prospects for new interventions in treatment 
and prevention of mycobacterial disease. An. Rev. Micro. 49:641-673 . 
Zhou, M., RF. Todd ill, J.G.J. van de Winkel, and H.R. Petty. 1993 . Cocapping 
of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-
associated antigen-I with Fe-gamma receptor III on human neutrophils. J. lmmunol. 
150:3030-3041. 
Zhou, M., and E.J. Brown. 1994. CR3 (Mac-1 , aM/32, CDllb/CD18) and FcRIII 
cooperate in generation of a neutrophil respiratory burst: Requirement for FcRII and 
tyrosine posphorylation. J. Cell Biol. 125:1407-1416. 
200 
Zierler, M.K., and J.E. Galan. 1995. Paradigms in bacterial entry into host cells. In 
Virulence Mechanisms of Bacterial Pathogens. J.A. Roth, C.A. Bolin, K. A Brogden, 
F.C. Minion, and M.J. Wannemuehler, editors. ASM Press, Washington, D .C. 21-32. 
201 
ADDENDUM 
STANDARD METHODS, BUFFERS AND MEDIA 
A.1 Standard Methods: 
A.1.1 Large-scale isolation of E. coli plasmid DNA: 
The preparation was based on the method of !sh-Horowitz and Burke (1981). Five-
hundred millilitres of Luria broth (Addendum A.2) containing the appropriate selective 
pressure and was inoculated with E. coli grown overnight at 3 7°C, with good aeration 
at 200 rpm. Cells were pelleted by centrifugation at 5000 rpm for 10 minutes at 4°C, 
and resuspended in 10 ml of cold TEG (Addendum A.2) and 10 ml of 2 mg/ml 
lysozyme per 500 ml sample. Cells were incubated on ice for 30 minutes, with 
occasional agitation, before adding 40 ml of fresh, 0.2 M NaOH, 1 % SDS per 500 ml 
sample and returning to ice for 10 minutes. Thirty millilitres ofKAc (Addendum A.2) 
was added per sample and incubated for a further 30 minutes on ice, before 
centrifugation at 6000 rpm for 20 minutes. The supernatant was decanted into a clean 
centrifuge bottle, before precipitating the DNA by adding 1 volume of Isopropanol and 
incubating for 15 minutes at room temperature. The DNA was pelleted by 
centrifugation at 7000 rpm for 20 minutes and dissolved in 6 ml sterile, distilled water 
and 7 ml SM LiCl and 0.05M MOPS, pH 8.0. The DNA was incubated on ice for 15 
minutes before centrifugation at 60 000 rpm for 20 minutes at 4 °C. The supernatant 
was again decanted and extracted with 1 volume of chloroform/isoamyl alcohol [24 : 1 ], 
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before pelleting by centrifugation at 6000 rpm for 20 minutes. The precipitated pellet 
was then washed with 5 ml of 70% cold ethanol and left to airdry overnight. The 
pellet was redissolved in 2.4 ml TE (Addendum A.2) and 100 µg/ml RNase A was 
added before incubation at 37°C for 15 minutes. The dissolved plasmid DNA was 
further purified by isopycnic CsCl-EthBr ultracentrifugation (Addendum A.1.3). 
A.1.2. Small-scale isolation of E. coli plasmid DNA: 
Plasmid DNA was extracted by an adapted Ish-Horowicz method. One-and-a-half 
millilitres of a 5 ml overnight culture of E.coli, grown at 37°C with shaking in LB 
broth with appropriate selective pressure, was pelleted in an Eppendorf microfuge for 
3 minutes. The supernatant was aspirated and discarded and the pellet resuspended in 
50 µl of TE buffer (Addendum A.2). One-hundred microlitres of cold 
phenol/chloroform was added to each resuspended pellet and vortexed for 2-3 minutes 
at room temperature. The Eppendorfs were centrifuged in the rnicrofuge for 5 minutes 
at room temperature, to separate the proteins from the suspended DNA. Fifty 
rnicrolitres of the top layer was carefully aspirated and transferred to a clean 
Eppendorf, before adding 18 µl of 7. SM NH4Ac and 140 µl ice-cold ethanol and 
incubating at -20°C for 15 minutes, to precipitate the DNA. The DNA was pelleted by 
centrifugation in a rnicrofuge for 15 minutes and washed with cold 75% ethanol, 
before being resuspended in 20 µl of TE and 1 µl of 10 mg/ml RNase A. 
In the case of E. coli strains that contain active exo- and endonucleases, the following 
steps were added to the isolation procedure. 
203 
A sample of 20 µl of isolated DNA was removed and incubated together with 5 µl of 
10% SDS, 0.5 µl of 10 mg/ml Proteinase K, and 76.5 µl of TE, to make up a final 
volume of 100 µl, at 65°C for 1 hour. The sample was further purified by using a 
Qiaex or Talent DNA purification kit as described in the package insert. 
A.1.3. Plasmid purification by isopycnic CsCI-EthBr density gradient 
ultracentrifugation: 
Plasmid purification by this means was performed as described by Maniatis et al. 
(1982). The crude plasmid extracts, as described in Addendum A.1.1. , were 
resuspended in TE containing 1 g/ml final concentration of CsCl, and 400 µg/ml 
EthBr. The samples were decanted into Beckman Quickseal ultracentrifuge tubes, and 
sealed as instructed. Samples were centrifuged at 55 000 rpm for 18 hours at 15°C in 
a Beckman T. 70i rotor, with the brake off The plasmid bands were illuminated with 
ultraviolet light (350 nm) and the lower, covalently closed, circular plasmid band was 
aspirated with a syringe and a wide-gauge needle (approximately 3 ml DNA). To 
remove the contaminating EthBr, the samples were diluted with 2 volumes of 90% 1-
Butanol with 1 % SDS, vortexed briefly and centrifuged to separate out the EthBr in 
the top phase. This phase was removed and the procedure repeated until no trace of 
EthBr remained. The DNA sample was further purified to remove any contaminating 
salts by dialysis against 1 litre of TE, pH 8.0 for 48 hours at 4°C, with one buffer 
change. The purified DNA was then precipitated by adding 0.5 volumes of SM 
NH4Ac and 2 volumes of cold 100% ethanol and incubating at -70°C for 1 hour, 
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followed by centrifugation in a microfuge for 20 minutes. The pellet was further 
washed with 100 µl of cold 75% ethanol and the pellet left to airdry, before being 
dissolved in 100 µl of TE. The concentration of nucleic acids was determined 
spectrophotometrically by absorbance at 260 nm. 
A.1.4. Restriction endonuclease digestion and DNA ligation reactions: 
The methods are an adaptation of those described by Maniatis et al. (1982). 
Restriction endonuclease digests were performed in a total volume of 20 µl per 
reaction, with a restriction enzyme concentration of 3 units/µg DNA. Restriction 
enzyme buffers as supplied by the manufacturers were used (Boehringer Manneheim 
and Stratagene). Reactions were incubated at the suggested temperatures for between 
1 and 3 hours. 
Ligation reactions were all performed at room temperature for 9-16 hours in a total 
volume of 20 µl containing the supplied ligation buffer and 1 or 2 units of T4 DNA 
ligase (Boehringer Mannheim) per µg of purified DNA for sticky and blunt-end 
reactions, respectively. The total concentration of plasmid DNA present in vector-
insert ligations was 10 to 15 pmole and 1 pmole for single-cut ligations. The vector 
and insert DNA ratios were at a molar ratio of 1 :2 per ligation reaction. To control for 
ligase activity, a sample of single-cut plasmid DNA was included as a control. 
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A.1.5. Kienow reaction: 
Previously digested and cleaned DNA suspended in TE was used in these reactions. 
To approximately 1 µg of DNA was added 2 units of Kienow (Boehringer 
Manneheim) and 1.5 µl of lOx reaction buffer M, as well as 2.25 µl of 1.25 mM 
dNTP' s. The 15-µl reaction volume was incubated at 37°C for 15 minutes to enhance 
filling-in of the overhang, and then the Kienow was heat-inactivated at 65°C for 20 
minutes. The sample was cleaned once again with either Qiaex or Talent Kits, to 
remove any contaminating dNTP' s. 
A.1.6. Preparation and transformation of competent E. coli cells: 
A modified method of Cohen et al. (1972) and Dagert and Ehrlich (1979), was used 
for the preparation of competent E. coli cells. One viable colony of E. coli was picked 
from a fresh agar plate and inoculated into 10 ml of LB (Addendum A.2) and 
incubated overnight at 37°C with good aeration. The following morning, 2 ml of the 
overnight culture was inoculated into 100 ml of prewarmed LB and incubated at 3 7°C 
with shaking for approximately 2 hours, until a reading of 0.2 was reached at OD600· 
The culture was then incubated on ice slush for 5 minutes, and all subsequent 
procedures were performed at 4°C to maintain cell integrity. Cells were harvested by 
centrifugation at 2000 x g for 5 minutes, followed by a wash in 10 ml cold O. lM 
MgCl2 and recentrifugation at 2000 x g for 5 minutes. The pelleted cells were washed 
in 10 ml of cold 0. lM CaCl2 and incubated on ice for 30 minutes, before repelleting at 
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2000 x g for 5 minutes and resuspension in 2 ml of O.lM CaCl2. Cells were allowed 
to mature on ice for approximately 3 hours. 
After the cells had aged, 50-200 ng of plasmid DNA was added to an aliquot of 100 µI 
of competent cells and kept on ice for approximately 10 minutes. The cell mixture was 
then heat-shocked at 42°C for 5 minutes and then quickly returned onto ice for 2 
minutes, before adding 400 µI of LB to each aliquot in preparation for a 45-60 minute 
expression incubation at 37°C. Once the selective antibiotic expression was complete, 
a 100µ1 sample was plated onto LB agar plates containing the selective antibiotic. To 
control for spurious results and to monitor transformation efficiency, the following 
samples were included: competent cells with no added plasmid DNA or with uncut 
plasmid DNA. A transformation efficiency of approximately 5000 colonies/ng of 
plasmid-transformed cells was routinely observed. 
A.1.7. DNA agarose gel electrophoresis: 
Horizontal gel electrophoresis gel systems were used to separate DNA fragments . 
Agarose concentrations of between 0.8 and 2% were used together with TBE/EthBr 
buffer (Addendum A.2), depending on the DNA fragment sizes. Samples were loaded 
into agarose gel wells with a 25% final volume of DNA sample loading buffer 
(Addendum A.2) . DNA bands were visualised with the aid of an ultraviolet (254 nm) 
Transilluminator and photographed using a Polaroid camera and Polaroid 667 film. 
The DNA fragments were sized by comparison to a standard curve obtained by the log 
molecular mass of known DNA fragment sizes versus their relative mobilities. 
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Standard DNA fragments were obtained by digesting ). DNA with Hind III, Pst I, Eco 
RI or Pvu II. 
A.1.8. SDS-Polyacrylamide gel electrophoresis: 
Laemmli (1970) and O'Farrell (1975) SDS-polyacrylamide gels (6%) methods were 
used with Biorad minigel apparatus. Acrylamide gel mixes were prepared as described 
in Addendum A.2. The gel mix was filtered through a bottle-top filter and the mixture 
retained on ice. A fresh 600µ1 aliquot of 10% ammonium persulphate (O.lg/ml) was 
added to 100 ml of gel mix, together with 65 µl of cold TEMED. Glass sequencing 
plates that had been clamped together, to provide a 0.2 mm internal space, were filled 
with the gel mix and allowed to set overnight at room temperature. 
A.1.9. DNA sequencing: 
Double-stranded DNA sequencmg by the dideoxy xhain-terrnination method was 
performed as described in the Sequenase DNA sequencing manual (US Biochemical 
Corporation, Cleveland, Ohio). DNA sequencing templates were prepared as 
described in Addendum A.1.3 . The 3-5µg of supercoiled, double stranded DNA was 
denatured by boiling for 3 minutes and placing on dry ice for 3 0 seconds, before 
preincubating with 12 ng of T3 or T7 primer on dry ice. Two microlitres of supplied 
reaction buffer were added and the tubes vortexed and centrifuged briefly to ensure 
contact of all components, before incubating at 37°C for 15 minutes. DNA chains 
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were radiolabelled with [35s]dATP (Amersham). Sequencing gels were resolved on 
0.2 mm 6% acrylamide gels as described in Addendum A.1.7. Gels were exposed on 
Kodak XAR-5 X-ray film for 24 hours to 5 days at -70°C. 
A.1.10. Transfection or eukaryotic cells by the calcium phosphate precipitate 
method: 
Cells were transfected in a manner similar to that described in Current Protocols in 
Immunology (1992). Exponentially growing CHO cells (Addendum A.1.11) were split 
and seeded at 1 x 106 cells/dish into 10 cm tissue culture dishes on the day prior to 
transfection. Cells were refed with complete media 3 hours prior to transfection, while 
10-30 µg CsCl-purified plasmid DNA (Addendum A.1.3 .) was ethanol-precipitated 
and redissolved in 450 µl of sterile water and 50 µl of 2.5M CaCl2. Five-hundred 
millilitres of 2 x HeBS (Addendum A.2) was placed in a sterile 15 ml tube, and then 
the DNA/CaCl2 solution was slowly added drop by drop and bubbled through with air. 
The DNA solution was allowed to incubate for 20 minutes at room temperature to 
produce a fine precipitate, which was added slowly to the 10 cm dish of adherent CHO 
cells. The cells were incubated with the precipitate at 3 7°C, 5% CO2 for 4 hours, after 
which the precipitate was removed and the cells were glycerol-shocked with 2 ml of 
sterile 10% glycerol for 3 minutes at room temperature, to enhance transfection 
efficiency. The cells were washed with 5 ml of PBS 3 times and refed with complete 
media (Addendum A.2). 
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A.1.11. Culturing of CHO cell lines and hybridomas: 
CHO cell lines were obtained as either frozen stocks or actively growmg cells. 
Actively growing cells were pelleted by centrifugation at 1600 rpm for 5 minutes and 
resuspended in 1 ml of PBS, before being split 1: 10 or 1: 15 into fresh complete media 
(Addendum A.2) and seeded into tissue culture flasks . Cells were grown at 37°C with 
5% CO2 until confluent. Media were changed every 2-3 days. 
Hybridomas were cultured as suspended cells in complete media (Addendum A.2) . 
Confluent tissue culture flasks were decanted into 10ml tubes and the cells pelleted by 
centrifugation at 1500 rpm for 5 minutes. The cells were resuspended and split 1:5 
into fresh media and a new tissue culture flask. Cells were grown at 3 7°C with 5% 
CO2 and split every 3 days. 
A.1.12. Freezing and thawing of cell lines: 
Freezing: 
Confluent, exponentially growing cells were lifted from the tissue culture flasks with 2 
ml of 5rnM EDTNHBSS and washed by pelleting the cells gently in PBS. The pellet 
was then resuspended gently in 1 ml ice-cold Fetal Calf Serum ( Gib co) with 10% 
DMSO (BDH). Point-five millilitre aliquots of cells were decanted into prelabelled 
Cryotubes (Nunc), tissue wrapped and placed at -70°C for two to three days before 




Aliquots of cells were removed from the -70°C freezer or liquid nitrogen and 
immediately thawed, with agitation in a 37°C water bath. The cells were then gently 
aspirated from the cryotube and placed into a sterile 10 ml tube and topped up with 
PBS. The cells were gently pelleted at 1000 rpm for 5 minutes, to remove the 
contaminating DMSO and resuspended in media containing 20% FCS, before seeding 
into tissue culture flasks and grown overnight at 37°C with 5% CO2. The next day, 
the medium was removed and the cells reincubated with complete media. 
A.1.13. Harvesting of hybridoma supernatant: 
Actively growing cells were allowed to multiply until they started dying. The cells 
were spun down and discarded, and a fresh aliquot of actively growing cells was 
reincubated with the removed media. These cells were then grown in the media until 
their death, after which the cells were spun down and discarded. The supernatant was 
further purified of cell debris by centrifugation at 7000 rpm for 10 minutes. The 
culture supernatant was buffered with 1:20 volume of IM Tris, pH 8.0, and 0.02% 
sodium azide added before storage at -20°C. If the supernatant was to be used in in 
vivo assays the supernatant may be filter-sterilised after buffering and then stored. 
With these harvesting methods a supernatant containing 20-50 µg/ml of antibody was 
expected. 
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A.1.14. Cell counting by haemocytometer: 
Cells were pelleted and resuspended in 1 ml of PBS. A 10µ1 aliquot of cells was 
removed and resuspended with 90 µl of Turk's solution (Addendum A.2), providing a 
1: 10 dilution of cells. The cells were then injected underneath the weighted coverslip 
with a P200 tip and counted under a light microscope. 
A.1.15. Ziehl-Neelsen staining of M.tb.: 
M tb. were harvested and an aliquot airdried onto a glass slide. Once the bacteria had 
dried onto the slide, they were heat-fixed by passing over a flame. The heat-fixed 
bacteria were then flooded with carbol fuchsin (Addendum A.2) and heated until 
steaming, three times. The carbol fuschin was washed off with water and the glass 
slides washed with copious amounts of acid alcohol (Addendum A.2), to remove all 
trace of stain. The slides were rinsed with water and counterstained with methylene 
blue (Addendum A.2) for 5 minutes. The slides were washed with running water and 
blotted dry before inspection under light microscopy, using 60x or 1 OOx oil-immersion 
objectives. 
A.1.16. Single-cell suspensions of M. th.: 
To obtain more or less single-cell suspensions of bacteria, 1 ml aliquots of the bacteria 
in Kirchner's medium (Addendum A.2) were transferred into 10 ml plastic tubes. The 
212 
bacteria were drawn up and forced through a series of syringe needles, as indicated 
below, to break up the clumps. Syringing proceeded from the larger to the smaller 
gauge needle, whenever the bacteria were flowing freely through the larger needle. All 
samples were ZN stained ( Addendum A.1 .14. ), to check clumping and shearing, and 
grown to check viability. 
1. Orange needle 1.8 X 40 mm 
2. Pink needle 1.2 X 38 mm (18G) 
3. Green needle 0.8 x40 mm (21G) 
4. Black needle 0.7 X 32 mm 
5. Tuberculin 0.5 X 16 mm (25G) 
6. Brown needle 0.45 X 13 mm (26G) 
7. Insulin 0.36x 12.7 mm 
A.1.17. Calibration curves for OD quantitation of M.tb.: 
To attempt to and quantitate the number of bacteria present in a culture, a 3 ml aliquot 
of various dilutions of Mtb., as compared to McFarland's standards (Addendum A.2), 
was placed in a glass cuvette tube and read on a MSE spectre-plus spectrophotometer 
at 550 nm, previously blanked on 3 ml of fresh Kirchner' s medium (Addendum A.2). 
The readings were compared to McFarland's standards and plated for colony counts to 
validate the results. 
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Number of Bacteria Assa 
6 xl08 organisms/ml 0.408 
3 x 108 organisms/ml 0.202 
1. 5 x 108 organisms/ml 0.104 
1. 5 x 10 7 organisms/ml 0.011 
1. 5 x 106 organisms/ml 0.005 


















Stir on mild heat until dissolved and bring up to 100 ml volume. Filter gel mix through 
bottle top filter and keep on ice. 


















Dissolve fuchsin in ethanol and then resuspend phenol in water. Mix together and 
allow to stand for several days. Filter before using. 







(of final vol) 
Heat-inactivated FBS: 
Serum was heated to 56°C for 30 minutes. 
KAc Solution: 
Potassium acetate 






Kirchner's media containing 1.5% agar. 




Na3-citrate 2.5 g 
Asparagine 5g 
Glycerol 20 ml 
Distilled water 1000 ml 
216 
217 
Loewenstein Jensen Slopes: 
MgS04_7H20 0.24 g 
Magnesium citrate 0.6 g 
KP04 2.4 g 
Asparagine 3.6 g 
Glycerol 12 ml 
Distilled water 600 ml 
Potato flour 30 g 
Homogenised whole eggs 1000 ml 
Malachite green (2% aqueous) 20 ml 
Add potato flour to salts and water, autoclave at 121 °C for 30 minutes. Add 
homogenised eggs to cooled autoclaved solution, together with malachite green 
solution and aliquot. Inspissate the bottles by incubating at 85°C for 50 minutes. 
Store at 4°C for 1 month. 
Luria Agar: 









Distilled water 1000 ml 
Media was autoclaved at 15 lb./sq. inch for 20 minutes. 
McFarland's standards: 
Standard Number of 
organisms/ml 
0.5 1.5 X 108 
1 3 X 108 
2 6 X 108 
3 9 X 108 
4 12 X 108 
5 15 X 108 
6 18 X 108 
7 21 X 108 
8 24 X 108 
9 27 X 108 
10 30 X 108 
Methylene blue counterstain: 
Methylene blue chloride 
Water 







RNase A (pancreatic) 
NaCl (1 M) 












< 5 ml 
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Dissolve above in water and boil for 15 minutes. Allow to reach room temperature 
and store at -20°C. 














0 .1 % final concentration of 8-hydroxyquinoline was added to 100 ml melted phenol. 
The mixture was equilibrated with two volumes of 1.0-M Tris, pH 8.0 and two 
volumes 0.1-M Tris, pH 8.0 with 0.2% f3-mercaptoethanol, by mixing the phases and 
allowing them to separate, repeatedly. The equilibrated phenol was stored under O. lM 
TE buffer in the dark, at -20°C. 







Tissue culture complete media: 
CHO-WT complete media: 
DMEM (Highveld Biological) 
Ham' s Fl2 (Highveld Biological) 
FBS (Gibco ), heat inactivated 
CHO-MAC-1 complete media: 
a-MEM (Gibco) 
Dialysed FB S ( Gib co) 
Thymidine 1.6 mM (Sigma) 
Methotrexate 2 µM (Sigma) 
CHO-CR3 complete media: 
GMEM (Gibco) 
Dialysed FB S ( Gib co) 
Nonessential amino acids lOOx (Gibco) 
Glutamate & Asparagine (Sigma) 
Sodium pyruvate 100 mM (Gibco) 















Nucleoside mix: 35 mg of each:adenosine, guanosine, cytidine, uridine 
and thymidine (Sigma) 
Made up with 100 ml sterile water and filtered . 
Glutamate and Asparagine: 600 mg of both L-glutamate and L-asparagine, 
made up with 100 ml of sterile water. 
Macrophage media: 
RPMI-1640 (Highveld Biological) 90 ml 
Human serum (autologus) 10 ml 
Hybridoma media: 
RPMI-1640 (Highveld Biological) 79 ml 
L-glutamine (200 mM) 1.2 ml 
FBS (Gibco), heat-inactivated 20 ml 
Turk's Stain: 
Gentian violet 
Glacial acetic acid 
Distilled water 
0.02 g 
7.14 ml 
100 ml 
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